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Summary	
	
The	 first	 definitive	 haematopoietic	 stem	 cells	 (HSCs)	 produced	 during	embryonic	development	are	generated	 from	a	specialised	subset	of	endothelial	cells	 known	 as	 haemogenic	 endothelium.	 Recently,	 it	 was	 reported	 that	 the	transcription	 factor	 Gata3	 plays	 a	 dual	 role	 in	 the	 development	 of	 the	sympathetic	nervous	system	and	the	haematopoietic	system.	Specifically,	Gata3	was	demonstrated	to	be	crucial	for	the	production	of	HSCs	through	regulation	of	catecholamine	production	from	the	co-developing	sympathetic	nervous	system.	In	 addition,	 it	 was	 recently	 shown	 that	 Gata3	 is	 expressed	 in	 the	 haemogenic	endothelium	and	 in	haematopoietic	progenitor	cells.	The	aim	of	 this	 thesis	was	therefore	 to	 examine	 if	 Gata3	 is	 expressed	 and	 plays	 a	 role	 in	 the	 precursors	from	 which	 HSCs	 arise	 and	 therefore	 would	 have	 an	 additional,	 more	 direct	function	in	HSC	emergence.		
Using	a	Gata3-GFP	reporter	mouse	line,	we	found	that	Gata3	is	expressed	in	various	cell	types	in	the	HSC	microenvironment,	including	mesenchymal	cells,	endothelial	 cells,	 haematopoietic	 cells	 and	 sympathetic	 nervous	 system	 cells,	with	 the	expression	being	 stage-dependant.	 In	 the	endothelium,	we	discovered	that	 the	 haemogenic	 activity	 is	 enriched	 in	 Gata3-expressing	 cells.	 Within	haematopoietic	 cells,	 we	 found	 that	 Gata3	 marks	 a	 specific	 stage	 along	 the	developmental	 pathway	 towards	 the	 generation	 of	 definitive	 HSCs,	 and	 that	Gata3-expressing	haematopoietic	cells	are	enriched	 for	 the	most	 immature	and	stem	cell-like	progenitors.		
	To	determine	whether	Gata3	plays	an	essential	role	in	the	production	of	HSCs	 from	 the	 endothelium,	 it	 was	 specifically	 knocked	 out	 in	 haemogenic	endothelial	 cells	using	 the	Vec-Cre	 system.	This	 revealed	 that	Gata3	within	 the	haemogenic	 endothelium	 plays	 a	 key	 part	 in	 the	 formation	 of	 haematopoietic	progenitors	and	HSCs.		
Finally,	we	used	transcriptome	analysis	(RNA	seq)	 to	 further	 investigate	the	function	of	Gata3	in	the	haematopoietic	stem	cell	microenvironment	and	HSC	
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precursors	 by	 comparing	 gene	 expression	 in	 the	 Gata3-positive	 and	 Gata3-negative	 cell	 subsets	 in	 each	 compartment.	 The	 genes	 found	 to	 be	 enriched	 in	Gata3-positive	cells	suggest	that	Gata3	plays	a	major	role	in	the	development	and	differentiation	of	 various	 cells	 and	 systems,	 and	 implicate	Gata3	as	 a	 cell	 cycle	regulator.	
In	 summary,	 we	 found	 that	 Gata3-expressing	 cells	 are	 enriched	 for	haemogenic	 endothelium,	 crucial	 for	 haematopoietic	 stem	 and	 progenitor	formation.	Moreover,	within	these	cells,	Gata3	plays	a	key	role	in	the	endothelial	to	 haematopoietic	 transition,	 and	 thus	 the	 formation	 of	 haematopoietic	 stem	cells.				
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G1:	Gap	1	phase	(cell	cycle)		G2:	Gap	2	phase	(cell	cycle)	Gata1:	GATA	Binding	Protein	1	Gata2:	GATA	Binding	Protein	2	Gata3:	GATA	Binding	Protein	3	Gata4:	GATA	Binding	Protein	4	Gata5:	GATA	Binding	Protein	5	Gata6:	Transcription	factor	GATA-6	GFP:	Green	Fluorescent	Protein	HE:	Haemogenic	endothelium	HSPCs:	Hematopoietic	stem	and	progenitor	cells	HSC:	Haematopoietic	stem	cell	Igf-2:	Insulin	like	growth	factor	Il3:	Interleukin	3	Il6:	Interleukin	6	Il7:	Interleukin	7	LMPP:	Lymphoid	primed	multipotent	progenitor	LT-HSC:	Long	term	haematopoietic	stem	cell	LPs:	Lymphoid	progenitors	M:	Mitosis	phase	(cell	cycle)	MEP:	Megakaryocyte-erythrocyte	progenitor	MPP:	Multipotent	progenitor	
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MSCs:	Mesenchymal	Stromal/Stem	Cells	NO:	Nitric	oxide	qPCR:	Quantitative	real-time	PCR		RNA:	Ribonucleic	acid	RNase:	Ribonuclease		Runx1:	Runt-related	transcription	factor	1			S:	Synthesis	phase	(cell	cycle)		Scf:	Stem	cell	factor	ST-HSC:	Short	term	haematopoietic	stem	cell	P75:	Ngfr:	Nerve	Growth	Factor	Receptor	PAS:	Para-aortic	splanchnopleura	PBS:	Phosphate-buffered	saline	PCA:	Principal	Component	Analysis		PCR:	Polymerase	Chain	Reaction		PDGFRb:	Platelet-derived	growth	factor	receptor	beta	PFA:	Paraformaldehyde	Th:	Tyrosine	hydroxylase	Thpo:	Thrombopoeitin	Tnfa:	Tumour	necrosis	factor	a	TEB:	Terminal	end	buds	VE-Cad:	Vascular	Endothelial	Cadherin,	Cdh5,	(Cd144)	YS:	Yolk	sac	
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1-Introduction	
	
1-1-Haematopoiesis:	
Haematopoiesis	refers	to	the	formation	of	blood	cellular	components.	All	these	 components	 originate	 from	 the	 pluripotent	 haematopoietic	 stem	 cell	(HSC),	which	is	the	foundation	of	this	process.		
The	 haematopoietic	 system	 is	 hierarchical,	 with	 the	 multipotent	 HSC	being	 the	mother	 cell	 that	 gives	 rise	 to	 and	differentiates	 into	multipotent	 and	unipotent	intermediates,	resulting	in	the	production	of	functional	mature	blood	cells	(Figure1-1)	(Durand:	2005).	
HSCs	 are	 crucial	 to	 maintaining	 haematopoiesis	 throughout	 life.	Therefore,	 they	 have	 unique	 characteristics	 that	 distinguish	 them	 from	 other	more	 mature	 cells:	 (i)	 self-renewal	 ability;	 (ii)	 high	 proliferation	 ability;	 (iii)	long-term	 activity;	 and	 (iv)	 potential	 to	 differentiate	 into	 all	 blood	 lineages	(Durand:	 2005).	 All	 these	 characteristics	 make	 those	 cells	 the	 most	 clinically	relevant	cells	for	transplants.	
	
1-2-Developmental	Origins	of	Blood	Cells:	
The	 haematopoietic	 system	 is	 characterised	 by	 three	 different	 waves	during	development	 that	 can	be	broadly	divided	 into	primitive	haematopoiesis	(first	wave)	and	definitive	haematopoiesis	(waves	2	and	3).	
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Figure	 1-1:	 The	 haematopoietic	 tree:	 Long-Term	 HSCs	 (LT-HSCs)	 can	 self	 renew	
and	give	rise	to	all	haematopoietic	cells	 in	the	adult	 for	the	entire	 life	span.	HSCs	
can	also	give	rise	to	Short-Term	HSCs	(ST-HSCs),	which	are	able	to	reconstitute	the	
blood	for	a	 limited	time,	and	multipotent	progenitors	(MPP).	These	MPP	have	the	
ability	 to	 differentiate	 into	 lymphoid	 primed	multipotent	 progenitors	 (LMPP)	 or	
common	myeloid	progenitors	(CMP).	The	CMP	then	have	the	ability	to	develop	into	
either	megakaryocyte-erythrocyte	progenitors	(MEP)	to	ultimately	give	rise	to	red	
blood	 cells	 and	 platelets,	 or	 into	 granulocyte-macrophage	 progenitors	 (GMP),	
which	then	develop	into	granulocytes	and	macrophages.	LMPP	also	have	the	ability	
to	give	rise	to	GMP,	in	addition	to	common	lymphoid	progenitor	(CLP)	to	produce	
T-cells,	 B-cells,	 dendritic	 cells	 and	 natural	 killer	 cells	 (NK-cells).	 Adapted	 from	
(Mehta	and	Baltimore:	2016).	
	
1-2-1-Primitive	haematopoiesis:	
Primitive	haematopoiesis	starts	at	E7.5	in	the	murine	yolk	sac	mesoderm.	Based	on	the	needs	of	the	developing	embryo,	this	wave	is	
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Figure	 1-2:	 A	 timeline	 view	 of	 the	 third	 wave	 of	 haematopoiesis	 during	 mouse	
development,	 characterised	 by	 HSC	 generation	 shown	 in	 blue.	 YS:	 yolk	 sac,	 FL:	
foetal	 liver,	 AGM:	 aorta	 gonad	 mesonephros,	 PL:	 placenta,	 BM:	 bone	 marrow.	
Adapted	from	(Ottersbach:	2010.)		
responsible	for	the	rapid	production	of	transient	erythroid	cells.	These	cells	have	a	 higher	 affinity	 for	 oxygen	 binding,	 enter	 the	 circulation	 around	 E8.5	 at	 the	onset	 of	 foetal	 heart	 beating,	mature	within	 the	 circulation,	 and	 persist	 in	 the	circulation	 until	 a	 few	 days	 after	 birth	 (Kingsley:	 2004,	 Kingsley:	 2006;	 De	 la	Chapelle:	 1969).	 	 This	 first	 wave	 gives	 rise	 to	 primitive	 erythrocytes,	macrophages,	and	megakaryocytes.	
	
1-2-2-Definitive	haematopoiesis:	
Shortly	 after	 the	 primitive	 wave	 of	 haematopoiesis	 in	 the	 yolk	 sac,	definitive	 haematopoiesis	 initiates,	 generating	 lineage-restricted	 multipotent	haematopoietic	 progenitor	 cells	 that	 exhibit	 adult-type	 morphology	 (second	wave).	Around	E8.5,	 committed	progenitors	originate	 in	 the	yolk	sac	and	enter	
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the	 circulation	 to	 seed	 the	 liver.	 These	 progenitors	 are	 generated	 during	different	times	and	at	different	haematopoietic	sites	in	the	mouse	embryo.	These	places	 include	 the	 yolk	 sac,	 para-aortic	 splanchnopleura	 (PAS)/AGM,	 placenta,	umbilical	 and	vitelline	arteries,	 and	 the	heart.	These	progenitors	 then	seed	 the	liver,	 where	 they	 differentiate	 into	 the	 first	 definitive	 type	 of	 erythro-myeloid	progenitors	(EMPs)	that	circulate	the	embryo.	These	progenitors	then	generate	definitive	 megakaryocytes,	 erythrocytes,	 macrophages,	 and	 other	 myeloid	lineages	(McGrath:	2015).		
This	wave	also	includes	early	T	and	B	progenitors,	which	are	produced	in	the	 yolk	 sac	 and	 para-aortic	 splanchnopleura	 (Yoder:	 1997);	 and	 immune-restricted	and	lymphoid-primed	progenitors	that	also	originate	from	the	yolk	sac	(Boiers:	2013).	
The	 first	 definitive	HSCs	 (dHSCs)	 emerge	 in	 the	 dorsal	 aorta	within	 the	aorta-gonad-mesonephros	 (AGM)	 region	 at	 E10.5	 initiating	 the	 third	 wave	(Figure	1-2).	dHSC	generation	has	also	been	reported	in	the	head	of	E10.5-E11.5	embryo	(Li:	2012).	At	E11.5	one	dHSC	is	found	in	each	of	AGM,	placenta,	extra-embryonic	 arteries,	 yolk	 sac	 and	 head	 (de	Bruijn:	 2000;	 Gekas:	 2005;	 Gordon-Keylock:	 2013;	 Kumaravelu:	 2002;	 Li:	 2012;	 Mikkola:	 2005;	 Müller:	 1994;	Ottersbach	and	Dzierzak,	2005;	Robin:	2009;	Yoder:	1997).	From	then	on,	HSCs	seed	the	foetal	liver	and	dHSCs	start	to	appear	in	the	embryonic	circulation.	The	liver	then	becomes	the	major	site	of	haematopoiesis	for	the	embryo	until	birth.		
In	this	context,	developmental	haematopoiesis,	the	term	dHSC	refers	to	a	HSC	that	can	give	rise	 to	 long-term	haematopoiesis	 in	an	 irradiated	adult	wild-
		 26	
type	 recipient	 directly	 upon	 transplantation	 without	 any	 culture	 steps	(Ottersbach:	2010;	Muller:	1994;	Medvinsky:	1996;	Medvinsky:	2011).	
	
1-3-	dHSC	Development	and	Specification:	
Definitive	 HSCs	 that	 give	 rise	 to	 the	 whole	 adult	 hematopoietic	 system	emerges	 by	 late	 E10.5–E11.0	 (Dzierzak	 and	 Speck:	 2008;	 Medvinsky:	 2011).	Over	the	years,	a	number	of	theories	have	been	proposed	in	order	to	explain	how	HSCs	 are	 generated	 in	 the	 dorsal	 aorta	 (de	 Bruijn:	 2002),	 the	 most	 widely	accepted	 indicating	 that	 the	 HSC	 lineage	 originates	 from	 the	 endothelium	(Bertrand:	 2010;	 Chen:	 2009;	 de	 Bruijn:	 2002;	 Kissa	 and	 Herbomel:	 2010;	Zovein:	2008:	Jaffredo:	1998).	
The	HSC	lineage	shares	Ve-cadherin	with	endothelial	cells,	which	is	then	downregulated	 during	 development	 (Kim:	 2005;	 Taoudi:	 2005).	 Early	 in	development,	 the	 hematopoietic	 progenitors	 express	 CD41	 and	 only	 become	CD45+	later	in	the	development	(Mikkola:	2003).	Then,	these	cells	undergo	rapid	developmental	 changes	 that	 are	marked	by	 the	upregulation	of	 CD41	 in	 type	 I	pre-HSCs:	 Ve-Cad+CD41lo	 CD45-,	 that	 is	 followed	 by	 upregulation	 of	 CD45	 in	type	II	pre-HSCs:	Ve-Cad+CD45+	before	finally	becoming	dHSCs	(Rybtsov:	2011;	Taoudi:	2008).		
More	recently,	a	new	stage	of	the	HSC	lineage	has	been	identified:	the	pro-HSCs.	These	cells	differ	from	the	subsequent	type	I	and	II	pre-HSCs	in	that	they	
		 27	
require	a	longer	culture	period,	7	days	compared	to	4	days	in	pre-HSCs,	and	they	also	do	not	express	CD43	(Rybtsov:	2014).	
To	 sum	 it	up,	 all	 three	populations,	pro-HSCs	and	pre-HSCs	 I	 and	 II,	 are	Ve-Cad+CD41+c-Kit+	and	can	be	further	divided	based	on	their	CD43	and	CD45	expression:	 the	 less	 mature	 pro-HSCs	 are	 CD43-CD45-,	 type	 I	 pre-HSCs	 are	CD43+CD45-,	 and	 the	 more	 mature	 type	 II	 pre-HSCs	 are	 CD45+CD43+.	 	 More	recently,	 CD27	 has	 also	 been	 identified	 as	 a	 marker	 for	 pre-HSCs	 type	 II	 and	dHSCs	(Li:	2017).	
It	should	be	noted	here	that	haematopoietic	progenitors	(CFU-Cs)	develop	in	parallel	with	 the	HSC	 lineage	and	are	available	 in	 the	major	arteries,	around	500-1000	 progenitors	 with	 lymphoid	 potential,	 and	 they	 also	 share	 markers	with	both	type	II	pre-HSCs	and	dHSCs.	CFU-Cs	expresses	CD43+	and	CD41+	early	in	development,	and	 later	on	 they	start	 to	express	CD45	as	well.	These	CFU-Cs	are	not	able	to	repopulate	irradiated	adult	recipients,	and	unlike	pro/pre	HSCs,	they	are	able	to	give	rise	to	colonies	in	CFU-C	assay.		(Rybtsov:	2014;	Lin:	2014;	Li:	2014;	Mikkola:	2003).	
	
1-4-Haematopoietic	Stem	Cell	Niche:	
Stem	cell	behaviour	is	controlled	by	integration	of	intrinsic	and	extrinsic	factors	that	are	supplied	by	the	surrounding	microenvironment.	Stem	cell	niche	refers	to	the	regulatory	microenvironment	within	a	specific	anatomical	location	where	 stem	 cells	 reside.	 This	 microenvironment	 is	 composed	 of	 cellular	 and	
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acellular	compartments,	which	interact	with	each	other	and	with	the	stem	cells	to	 regulate	 their	 proliferation,	 differentiation,	 localization	 and	 survival	 (Jones:	2008).	
In	 the	haematopoietic	 system,	 this	niche	 is	mainly	 composed	of	 stromal	cells	 and	 soluble	 factors	 that	 are	 secreted	 by	 these	 cells.	 	 These	 stromal	 cells	provide	 HSCs	 with	 cell-cell	 anchorage	 and	 through	 cell-cell	 signalling	 control	their	 survival,	 proliferation,	 differentiation	 and	 trafficking.	 The	 soluble	 factors	can	 regulate	 HSCs	 directly,	 or	 indirectly	 by	 acting	 on	 the	 regulatory	microenvironment,	which	in	turn	acts	on	HSCs.	
The	HSC	has	a	dynamic	nature;	it	has	the	ability	to	adapt	and	respond	to	different	 cues	based	on	 the	physiological	 needs	of	 the	body.	 	Given	 the	niche’s	role	in	regulating	HSC	activity,	it	should	be	expected	that	the	adult	HSC	niche	and	the	embryonic	HSC	niche	would	have	both	common	and	unique	characteristics	based	on	the	needs	of	the	body	at	a	specific	stage	and	time.	
During	 development,	 the	 niche	 of	 the	 HSCs	 can	 be	 found	 at	 different	anatomical	locations	based	on	the	needs	of	the	developing	embryo,	whereas	the	adult	niche	 is	 the	bone	marrow	(BM).	The	different	anatomical	 locations	of	 the	embryonic	niche	at	different	time	points	serve	to	support	different	functions	and	needs	in	the	developing	embryo.	Some	of	these	niches,	such	as	AGM,	yolk	sac	and	placenta,	have	a	transient	nature.	However,	the	main	functions	of	the	adult	HSC	niche	 (BM)	 are	 to	maintain	 highly	 quiescent	 HSCs,	 control	 HSC	 differentiation	and	mobilisation	into	the	blood	(Ottersbach:	2009).		
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1-4-1-	Components	of	the	Niche:	
Cells	 in	 the	HSC	niche	 can	 regulate	HSC	 activity	 either	 through	physical	means	 or	 by	 producing	 chemicals	 to	 regulate	 haematopoiesis.	 This	 regulation	can	be	done	either	by	cells	that	are	found	in	the	immediate	microenvironment	of	HSCs,	endothelial	and	stromal	cells,	or	by	neighbouring	cells	of	other	developing	systems.	
A	 gene	 expression	 profiling	 study	 of	 the	 AGM	 at	 the	 time	 of	 HSC	emergence	has	shown	that	the	upregulated	genes	were	not	restricted	to	the	ones	involved	directly	in	haematopoiesis,	but	also	included	genes	that	are	involved	in	the	 development	 of	 the	 nervous,	 vascular,	 muscular	 and	 skeletal	 systems	(Mascarenhas:	2009).	Given	that,	and	considering	the	close	proximity	of	systems	to	 one	 another	 in	 the	AGM,	 the	 possibility	 that	 signals	 from	one	 system	might	influence	the	development	of	another	seems	plausible.	
Endothelial	cells:	
Recent	 studies	 have	 suggested	 that	 HSCs	 and	 progenitors	 are	 derived	from	 a	 subset	 of	 endothelial	 cells	 that	 is	 called	 the	 haemogenic	 endothelium	(Figure	1-3)	(Bertrand:	2010;	Chen:	2009;	de	Bruijn:	2002;	Kissa	and	Herbomel:	2010;	 Zovein:	 2008).	 The	 process	 by	which	 the	 blood	 cells	 are	made,	 is	 called	endothelial-to-haematopoietic-transition	 (EHT)	 (Figure	 1-4)	 (Lam:	 2010;	 Kissa	and	 Herbomel:	 2010).	 Both	 the	 haemogenic	 endothelium	 and	 EHT	 will	 be	discussed	further	in	the	next	section.	
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Endothelial	 cells	 themselves	have	 the	ability	 to	 support	HSCs	 in	 in-vitro	cultures	 (Imanirad:	 	 2014),	 and	 transplanting	 them	 into	 irradiated	 mice	improved	haematopoietic	stem	cell	reconstitution	in	those	mice	(Salter:	2009).	
Kobayashi	et	al.	have	shown	that	when	endothelial	cells	of	adult	mice	are	activated	through	differential	recruitment	of	Akt	and	P42/44	mitogen-activated	protein	 kinase	 (MAPK)	 signalling	pathways,	 it	 balances	 the	 self-renewal	 of	 LT-HSCs	 and	 differentiation	 of	 hematopoietic	 stem	 and	 progenitor	 cells	 (HSPCs)	(Kobayashi:	2010).		
Another	 study	 activated	 AGM	 EC	 with	 AKT	 to	 generate	 AKT-activated	AGM-derived	 endothelial	 cells	 (AGM	 AKT-ECs),	 and	 thus	 forming	 a	 vascular	niche	 that	 is	 suitable	 for	 co-culture.	These	 cells	were	able	 to	 create	an	 in	vitro	niche	 that	 was	 able	 to	 recapitulate	 embryonic	 HSC	 specification	 and	amplification,	 i.e.	 it	 promoted	 the	 induction	 of	 engrafting,	 non-haematopoietic	precursors	 and	 thus,	 inducing	 endothelial	 to	haematopoietic	 transition	 in	 vitro	(Hadland:	2015).			
More	recently,	Li	et	al.	 (2017)	have	demonstrated	 that	co-culturing	pre-HSCs	 with	 AKT	 activated	 endothelial	 cells	 (AKT)	 supported	 the	maturation	 of	pre-HSCs	into	HSCs	(Li:	2017).	
In	the	spleen	and	bone	marrow,	many	HSCs	are	associated	with	sinusoidal	endothelium	 and	 to	 a	 lesser	 extent,	 some	 of	 the	 HSCs	 were	 associated	 with	endosteum	(Kiel:	2005).	
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Reprogramming	 studies	 have	 illustrated	 that	 the	 expression	 of	 four	transcription	factors	(FOSB,	GFI1,	RUNX1,	and	SPI1)	 in	human	endothelial	cells	or	 in	 adult	 mouse	 endothelial	 cells	 were	 sufficient	 to	 generate	immunocompetent	HSPCs	(Sandler:	2014;	Lis:	2017)	
Furthermore,	 endothelial	 cells,	 in	 addition	 to	 intra-aortic	 clusters	 and	smooth	muscle	cells,	produce	Insulin	like	growth	factor	(Igf2),	which	is	known	to	promote	the	production	of	more	primitive	progenitors	and	erythroid	progenitors	in	the	AGM	(Mascarenhas:	2009).	
Nitric	 oxide	 (NO)	 is	 also	 produced	 by	 the	 endothelium	 in	 response	 to	shear	 stress,	 which	 in	 turn	 increases	 the	 production	 of	 haematopoietic	 and	progenitor	cells	(North:	2009;	Adamo:	2009).		
Mesenchymal	Stromal/Stem	Cells:	
Mesenchymal	stem/progenitor	cells	are	multipotent	stem	cells	that	have	the	ability	to	differentiate	into	cells	of	adipogenic,	chondrogenic	and	osteogenic	lineages	 (Dennis	 and	 Charbord:	 2002).	 During	 development,	 these	 cells	 first	appear	 in	the	AGM	at	the	time	of	HSCs	emergence	(Figure	1-3)(Mendes:	2005).	At	 that	 stage,	 both	 MSCs	 and	 HSCs	 share	 similar	 patterns:	 i)	 they	 appear	 in	waves;	primitive	and	definitive,	 ii)	 they	co-localise	 in	the	AGM	and	other	major	haematopoietic	 sites,	 iii)	 they	 follow	 the	 same	 developmental	 time-line.		However,	 despite	 their	 co-localisation	 in	 haematopoietic	 harbouring	 sites	 and	their	occurrence	in	blood	circulation,	their	presence	at	this	stage	is	independent	of	haematopoietic	development	(Mendes:	2005).	
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Figure	1-3:	A	schematic	view	of	a	cross	section	of	the	E11.5	AGM	microenvironment	
showing	 different	 cell	 types	 that	 make	 up	 the	 HSC	 niche	 in	 the	 AGM.	 The	
haemogenic	 endothelium	 cells,	 pink	 cells,	 are	 lining	 the	 wall	 of	 the	 dorsa	 aorta	
along	with	 non-haemogenic	 endothelium.	 The	 haematopoietic	 cells	 bud	 out	 from	
the	haemogenic	endothelium	and	detach	to	become	a	haematopoietic	cell		
	
MSCs	refer	to	a	heterogeneous	group	of	cells	in	the	adult	mouse.		Some	of	these	 have	 been	 associated	with	HSC	maintenance.	 The	 CXC	 chemokine	 ligand	CXCL-12-abundant	 reticular	 (CAR)	cells	are	a	 subset	of	mesenchymal	 cells	 that	has	 been	 implicated	 as	 a	 niche	 for	 HSCs.	 When	 those	 cells	 were	 deleted	temporarily,	 the	production	of	 the	cytokines	stem	cell	 factor	(Scf)	and	CXCL-12	ceased	and,	as	a	result,	HSCs	were	reduced	in	size	and	numbers	(Omatsu:	2010).		In	 addition,	 Sugiyama	 et	 al.	 (2006)	 has	 shown	 that	when	 the	 receptor	 for	 CXC	chemokine	ligand	CXCL-12	(CXCR4)	was	deleted,	it	resulted	in	a	sharp	decline	of	
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HSC	counts,	and	that	CXCL12-CXCR4	signaling	regulates	the	quiescent	HSC	pool	(Sugiyama:	2006).	
Leptin	receptor	(Lepr)-expressing	perivascular	cells	are	also	a	subgroup	of	mesenchymal	cells	that	is	involved	in	HSC	maintenance.	When	Scf	was	deleted	from	those	cells	or	endothelial	cells,	HSCs	were	depleted	from	the	bone	marrow	(Ding:	2012)	
Similar	 to	 CAR	 and	 Lepr	 cells,	 there	 is	 also	 another	 subset	 of	mesenchymal	 cells	 that	 has	 been	 linked	 to	 HSC	 maintenance;	 the	 filament	protein	nestin-expressing	 cells.	These	 cells	 are	 also	 involved	 in	CXCL12-CXCR4	signalling,	and	are	capable	of	producing	Scf	(Mendez-Ferrer:	2010).			
Stem	 cell	 factor	 (Scf)	 is	 a	 cytokine	 that	 binds	 to	 the	 C-kit	 receptor	(CD117),	 and	 is	 expressed	 by	 all	 HSCs.	 It	 can	 exist	 both	 as	 a	 transmembrane	protein	or	a	soluble	factor	and	is	mainly	expressed	in	the	ventral	stroma	and	the	urogenital	ridges	in	the	AGM.	By	E9.5	Scf	is	clearly	expressed	and	that	expression	is	 highly	 upregulated	 by	 E10.5.	 Scf	was	 found	 to	 be	 essential	 for	 initiating	 the	HSC	lineage	development	as	it	regulates	the	transition	of	pro-HSCs	to	pre-HSCs.	In	 addition,	 Scf	 is	 a	 strong	 trigger	 for	dHSC	development	 from	both	 type	 I	 and	type	II	pre-HSCs		(Rybtsov:	2014;	Souilhol:	2016).		
In	 addition,	 thrombopoietin	 (Thpo)	 is	 expressed	 in	 the	 ventral	mesenchyme	 of	 E11	 AGMs.	 When	 it	 was	 added	 to	 AGM	 explant	 cultures,	 it	enhanced	 the	 haematopoietic	 progenitor	 and	 HSCs	 production	 by	 regulating	their	survival	and	proliferation.	(Mascarenhas:	2016).	
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Bone	morphogenic	protein	4	(BMP4)	is	a	cytokine	that	is	produced	by	the	ventral	mesenchyme	in	the	developing	embryo,	which	was	reported	to	support	haematopoietic	 and	 more	 committed	 progenitor	 cell	 differentiation	 (Chan:	2013).		
Sympathetic	Nervous	System:	
The	presence	of	a	normal	functioning	sympathetic	nervous	system	(SNS)	is	essential	for	the	production	of	HSCs	(Figure	1-3).	Using	a	Gata3	total	knockout	mouse	 model,	 Fitch	 et	 al.	 have	 shown	 that	 when	 Gata3	 was	 deleted	 from	embryos,	the	cells	of	the	SNS	failed	to	differentiate	and	did	not	produce	Tyrosine	Hydroxylase	 (Th),	 a	 rate-limiting	 enzyme	 for	 catecholamine	 synthesis	 that	 is	expressed	in	sympathoadrenal	cells,	and	hence	failed	to	produce	catecholamines.	Those	 embryos	 had	 functionally	 and	 phenotypically	 impaired	 HSC	 production	compared	 to	 their	 wild-type	 littermates.	 	 Adding	 catecholamines	 to	 these	embryos	 via	 the	 drinking	 water	 of	 the	 mother	 rescued	 HSC	 numbers	 (Fitch:	2012).		
Moreover,	 when	 AGMs	 from	 a	 Th	 knockout	 mouse	 line,	 which	 cannot	produce	 catecholamines,	 and	 wild-type	 AGMs	 that	 were	 placed	 in	 an	 explant	culture	 in	 the	 presence	 of	 a	 tyrosine	 hydroxylase	 inhibitor,	 were	 used	 for	transplantation	assays,	 the	 results	 showed	a	marked	reduction	 in	 repopulation	ability.		
Furthermore,	AGM	HSCs	express	 the	beta2-adrenoreceptor,	which	binds	catecholamines,	 indicating	 that	 catecholamines	 released	 from	 the	 developing	SNS	can	act	directly	on	emerging	HSCs	in	the	AGM	(Fitch:	2012).	
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The	 ablation	 of	 adrenergic	 neurotransmission,	 either	 genetically	 or	pharmacologically,	 has	 shown	 that	 signals	 from	 the	 SNS	 supress	 osteoblast	function	 and	 control	 the	 attraction	 of	 HSPCs	 to	 their	 niche	 (Katayama:	 2005).	Catecholamines	were	also	 shown	 to	promote	HSC	proliferation	directly	 via	 the	beta2-adrenoreceptor	(Spiegel:	2007).	
In	the	adult	mouse,	Mendez-Ferrer	et	al.	have	reported	that	the	circadian	release	 of	 HSCs	 from	 BM	 is	 regulated	 by	 norepinephrine	 (NE)	 that	 is	 locally	released	from	nerve	terminals	of	the	SNS	(Mendez-Ferrer:	2010).		
Other	Haematopoietic	Cells:				
Given	the	responsive	and	dynamic	nature	of	HSCs,	it	is	possible	that	more	developed	 haematopoietic	 progeny	 might	 affect	 HSC	 behaviour	 in	 terms	 of	regulating	 the	 supply	 and	 demand	 of	 a	 certain	 blood	 type	 in	 normal	haematopoiesis	and	stress	conditions.	
The	regulation	of	HSCs	by	their	mature	progeny	has	been	demonstrated	in	several	studies.		One	of	the	studies	used	mice	with	mutant	Myb	alleles	that	had	defective	megakaryopoiesis,	and	showed	that	 the	abnormal	 increase	 in	platelet	production	altered	thrombopoietin	levels,	which	in	turn	resulted	in	functionally	impaired	HSCs	that	declined	in	numbers	with	age	(de	Graaf:	2010).	
Another	 study	 demonstrated	 that	 the	 regulation	 of	 HSCs	 by	 mature	progeny	can	happen	through	the	stromal	niche.	BM	macrophages	were	found	to	interact	with	Nestin+	MSCs	to	promote	the	retention	of	HSCs	in	the	BM	(Chow:	2011).	
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During	 development,	 the	 primitive	 myeloid	 population	 was	 found	 to	regulate	 the	 numbers	 of	 haematopoietic	 stem	 and	 progenitor	 cells	 in	 the	AGM	region	by	contributing	to	the	local	inflammatory	response.	In	a	study	by	Li	et	al.	(2014),	mouse	embryos	deficient	in	interferon-g	(IFN-g)	or	IFN-g	and	interferon-a	 (IFN-a)	 had	 lower	 lymphoid	 progenitor	 counts,	 and	 the	 number	 of	transplantable	HSCs	was	lower	in	embryos	lacking	IFN-g	(Li:	2014).		
Furthermore,	 in	the	absence	of	 infection,	proinflammatory	signaling	was	reported	to	be	involved	in	the	HSC	program	development.	Primitive	neutrophils	were	 identified	 by	 Espin-Palazon	 et	 al.	 as	 a	major	 source	 for	 tumour	 necrosis	factor	a	(Tnfa).	The	loss	of	either	neutrophils	or	Tnfa	resulted	in	the	loss	of	HSCs.	It	should	be	noted	that	Tnfa	is	also	produced	by	endothelial	cells,	and	that	it	can	also	contribute	to	the	inflammatory	signaling	from	that	cell	compartment	(Espin-Palazon:	2014).	
Gastro-Intestinal	Cells:	
Haematopoietic	activity	has	been	associated	with	 the	ventral	 side	of	 the	embryonic	dorsal	aorta	in	many	organisms.	Previously,	it	has	been	reported	that	the	 ventral	 region	 of	 the	 dorsal	 aorta	 in	 the	mouse	 contains	most	 of	 the	 HSC	activity	at	E11.5,	and	is	able	to	increase	HSCs	in	explant	culture.	Furthermore,	it	is	 the	 only	 domain	 that	 is	 able	 to	 generate	 HSCs	 in	 E10.5	 explant	 cultures	(Taoudi:	2007).		
In	 another	 study	 (Peeters:	2009),	 the	ventral	 tissues	of	 the	dorsal	 aorta	demonstrated	 a	 positive	 influence	 on	 AGM	 HSC	 generation,	 whereas	 dorsal	tissues	 had	 a	 suppressive	 effect.	 Specifically,	 in	 the	 study	 from	 Peeters	 et	 al.	
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(Peeters:	2009),	 it	was	shown	 that	when	AGMs	 from	early	E10	or	gut	explants	were	 cultured	alone,	 there	was	no	output	 from	either	of	 them;	however,	when	they	 were	 cultured	 together	 in	 an	 early	 E10	 AGM:gut	 explant,	 HSCs	 were	generated	 after	 3	 days	 in	 culture.	 This	 could	 be	 attributed	 to	 the	 presence	 of	certain	 signaling	 pathways	 in	 the	 ventral	 region	 of	 the	 dorsal	 aorta.	 One	 such	pathway	 is	 the	 Hedgehog	 pathway	 that	 originates	 from	 the	 developing	 gut	 at	E10.5.	Hedgehog	proteins	also	regulate	the	expression	of	the	gene	cascades	that	are	 required	 for	 arterial	 development,	 including	 Vegf,	 Notch,	 Ephrin2a	 and	Runx1	(Gering	and	Patient:	2005).		
Explant	 culture	 studies	 then	 revealed	 that	 signals	 from	 the	 gut	 induce	HSCs	 from	 the	 AGM,	 and	 this	 induction	 was	 blocked	 when	 an	 anti-hedgehog	antibody	was	added	to	the	culture	medium.	In	addition,	the	expression	of	one	of	the	 intracellular	 signalling	 components,	 Gli1,	 was	 at	 its	 highest	 within	 the	subaortic	mesenchyme,	thus	indicating	that	hedgehog	signals	from	the	gut	act	on	the	mesenchyme	to	influence	HSC	generation	(Peeters:	2009).			
IL-3	 is	 a	 cytokine	 that	 is	mainly	 produced	 by	 the	 gut	 in	 the	 developing	embryo.	 IL-3	was	 found	 to	be	a	potent	 inducer	of	dHSC	 function	 in	 the	E10.5–11.5	 AGM	 region;	 it	 increases	 HSC	 survival,	 proliferation,	 and	 repopulation	capacity	(Robin:	2006).		
	
1-5-	Haemogenic	Endothelium:	
1-5-1-Generation	of	HSCs	and	Progenitors	from	Haemogenic	Endothelium:	
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Both	 long-term	 HSCs	 and	 progenitors	 originate	 from	 the	 haemogenic	endothelium	 (HE);	 a	 specialised	 subset	 of	 endothelium	 (Bertrand:	 2010;	 Chen:	2009;	 de	 Bruijn:	 2002;	 Kissa	 and	 Herbomel:	 2010;	 Zovein:	 2008).	 The	 idea	 of	blood	cells	emerging	from	haemogenic	endothelium	was	proposed	100	years	ago	based	 on	 the	 observation	 of	 embryos	 using	 simple	microscopy	 (Jordan:	 1916;	Emmel:	1916).	
Given	 the	 association	 of	 haematopoietic	 intra-aortic	 clusters	 with	 the	endothelial	lining	of	the	dorsal	aorta,	it	was	thought	that	HSCs	were	derived	from	these	 endothelial	 cells.	 By	 the	 start	 of	 the	 20th	 century,	 the	 term	 haemogenic	endothelium	was	used	to	describe	the	intra-aortic	clusters	that	were	believed	to	have	endothelial	origins	(Jordan:	1916;	Jordan:	1917;	Emmel:	1916).			
The	 embryonic	 dorsal	 aorta	 has	 been	 known	 to	 be	 associated	 with	haematopoietic	 cells	 for	 some	 time.	 Clusters	 of	 haematopoietic	 cells	 that	 co-express	endothelial	markers	are	attached	to	both	the	dorsal	and	the	ventral	side	of	 the	 aortic	 endothelium	 in	mouse	 embryos	 (Ivanovs:	 2014;	 Ciau-Utiz:	 2014;	Garcia-Porrero:	 1998;	 Tavian:	 1996;	 North:	 1999).	 However,	 only	 the	 ventral	side	of	the	dorsal	aorta	have	shown	to	contain	HSCs	(Taoudi:	2007).	
The	process	by	which	endothelial	cells	commit	to	the	haematopoietic	fate	is	 known	 as	 endothelial	 to	 haematopoietic	 transition	 (EHT).	 Recently,	 time-lapsing	 imaging	studies	have	visualised	 this	 transition	of	endothelium	to	blood	
in-vitro	(Lancrin:	2009;	Eilken:	2009),	in	ex-vivo	explant	cultures	(Boisset:	2010)	and	in	the	zebrafish	embryo	in	vivo	(Bertrand:	2010;	Kissa:	2010;	Lam:	2010).	In	the	 zebrafish	 in	vivo	 imaging	 studies,	 this	process	was	 shown	 to	 start	with	 the	
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endothelial	cell	bending	out	and	rounding	up	to	finally	detach	from	the	vascular	wall	 to	 become	 a	 free-moving	 haematopoietic	 cell	 (Figure	 1-4	 A	 and	 B).	 The	factors	that	regulate	the	process	of	EHT	include	blood	flow-induced	sheer	stress,	signalling	 pathways,	 and	 transcriptional	 regulators	 (described	 further	 below).	However,	 the	 underlying	 mechanism	 of	 this	 process	 and	 the	 accompanying	structural	changes	are	poorly	understood	(Kissa:	2010).	
Figure	1-4:	The	endothelial	 to	haematopoietic	 transition;	 (A)	The	haematopoietic	
cells	bud	out	from	the	haemogenic	endothelium	and	detach	to	become	a	free-living	
haematopoietic	 cell.	 (B)	 the	 haemogenic	 endothelium	 can	 develop	 into	 either	 a	
haematopoietic	 cell,	 which	 is	 Runx1-dependent,	 or	 into	 endothelial	 cells.	 HoxA3	
maintains	the	endothelial	program	in	the	cells	by	antagonising	the	haematopoietic	
program	(Adapted	from	Medvinsky:	2011)						
1-5-2-Characterisation	of	Haemogenic	Endothelium:	
Haemogenic	 endothelium	 displays	 endothelial	 phenotype	 and	morphology,	and	has	the	potential	to	form	endothelial	sheets	and	tubules,	while	also	being	able	 to	 give	 rise	 to	haematopoietic	progeny	 in	 culture.	Defining	and	isolating	 the	haemogenic	endothelium	has	been	difficult.	This	 is	due	 to	 the	 fact	that	 expression	 of	 the	 endothelial	 markers	 CD31,	 Flk-1,	 and	 VE-Cadherin	overlaps	 between	 haemogenic	 endothelium,	HSCs,	 haematopoietic	 progenitors,	
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and	non-haemogenic	endothelium	(Nishikawa:	1998).	Therefore,	a	combination	of	both	endothelial	markers	and	haematopoietic	markers,	such	as	CD41	(Corbel:	2002),	 CD45	 (Ledbetter:	 1979)	 and	 Ter119	 (Kina:	 2000),	 has	 been	 utilised	 to	separate	 haematopoietic	 from	 endothelial	 cells;	 even	 more	 of	 a	 challenge	 has	been	 to	 isolate	 haemogenic	 endothelium	 from	 non-haemogenic	 endothelium.	(Swiers:	2013).		
The	core	binding	factor	family	member	Runx1	is	expressed	in	haemogenic	arteries	before	HSC	emergence.	While	endothelial-specific	deletion	of	Runx1	did	not	 affect	 haemogenic	 endothelium	 generation,	 no	 LT-HSCs	 were	 produced	(Chen:	 2009).	 Thus,	 Runx1	 is	 essential	 for	 the	 EHT	 and	 was	 subsequently	investigated	as	a	tool	for	identifying	HE	(Swiers:	2010).			
In	their	paper,	Swiers	et	al.	have	managed	to	isolate	the	HE	by	developing	a	Runx1	+23	enhancer-reporter	transgenic	mouse	model	(23GFP)	to	investigate	the	 EHT.	 By	 using	 functional	 and	 transcriptional	 assays	 on	 HE,	 identified	 as	23GFP+	cells,	 it	was	demonstrated	 that	 the	haematopoietic	 commitment	of	 the	HE	starts	at	E9.5	while	the	cells	are	still	embedded	in	the	endothelial	layer,	and	those	 cells	 lose	 their	 endothelial	 potential	 before	 HSC	 emergence.	 Thus,	 they	have	 proposed	 a	 new	 model;	 an	 early	 onset	 model	 of	 haematopoietic	programming	 and	 loss	 of	 endothelial	 potential	 for	 the	HE,	 as	 opposed	 to	what	was	believed	before	of	the	HE	of	having	the	potential	to	differentiate	into	either	endothelial	 tubules	 or	 haematopoietic	 progeny.	 They	 also	 reported	 that	 Gata3	was	expressed	at	higher	levels	in	23GFP+HE	than	in	non-haemogenic	endothelial	(NHE)	cells.		
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1-5-3-Types	of	Haemogenic	Endothelium:			
Haemogenic	 endothelium	 appears	 at	 different	 times	 and	 different	locations	 during	 development.	 However,	 it	 was	 still	 unclear	 if	 there	 were	different	types	of	haemogenic	endothelium,	one	that	generates	HSCs	and	another	that	generates	progenitors.	Chen	et	al.	demonstrated	this	in	a	study	where	they	used	CBFb-deficient	embryos	(Chen:	2011).	CBFb	is	the	hererodimeric	partner	of	Runx1,	and	in	its	absence,	embryos	demonstrate	the	same	phenotype	as	Runx1-deficient	 embryos;	 they	 die	 at	 midgestation	 due	 to	 central	 nervous	 system	haemorrhage	 and	 fetal	 liver	 anemia.	 Adding	 GFP-CBFb	 back	 to	 them	 by	 using	two	 different	 tissue-specific	 expression	 cassettes,	 Tie2	 and	 Ly6a,	 rescued	 the	formation	of	erythro-myeloid	progenitors	(EMPs)	and	HSCs,	respectively	in	CBFb	null	embryos.	When	the	Tie2	cassette	was	used,	GFP-CBFb	was	expressed	in	YS	endothelium,	 endothelial	 cells	 of	 the	 dorsal	 aorta	 (DO),	 placenta	 and	 umbilical	and	vitelline	arteries;	however,	only	the	EMPs	were	rescued,	but	not	the	HSCs.	
Interestingly,	 when	 the	 Ly6a	 regulatory	 cassette	 was	 used,	 only	 HSCs	were	 rescued	 but	 not	 EMPs.	 This	 indicates	 that	 EMPs	 and	 HSCs	 differentiate	from	distinct	populations	of	haemogenic	endothelial	cells,	with	Ly6a	expression	specifically	marking	the	HSC-generating	haemogenic	endothelium	(Chen:	2011).		
1-5-4-Intrinsic	regulators	of	EHT:	
SCL/Tal1:		
The	 transcription	 factor	 SCL/Tal1	 is	 essential	 for	 establishing	 the	haematopoietic	 transcription	 program	 in	 haemogenic	 endothelium	 and	
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repressing	its	cardiac	fate.	Using	a	transgenic	mouse	line,	Van	Handel	et	al.	have	shown	 that	 when	 SCL	 was	 deleted,	 the	 cardiac	 transcriptional	 program	 in	 YS	endothelium	 was	 activated,	 indicating	 that	 SCL	 is	 required	 to	 prevent	 the	misspecification	 of	 haemogenic	 endothelium	 to	 cardiomyogenic	 fate	 (Van	Handel:	 2012).	 Interestingly,	 SCL	 is	 not	 required	 for	 haematopoietic	 cell	generation	 once	 the	 haemogenic	 endothelium	 is	 established,	 while	 Runx1	 is	crucial	 for	haematopoietic	cell	generation,	 thus	placing	SCL	upstream	of	Runx1	(Lancrin:	2009).			
More	 recently,	 it	 was	 reported	 that	 SCL	 knockout	 does	 not	 bias	 cells	towards	cardiac	fate.		In	single	cell	transcriptome	experiment	using	a	SCL	(Tal1)	knockout	 mouse	 line	 (Tal-/-	 ),	 Scialdone	 et	 al.	 have	 found	 that	 while	 the	haematopoietic	genes	were	downregulated,	there	was	no	upregulation	of	cardiac	markers,	thus	indicating	that	while	the	primary	function	of	SCL	is	the	induction	of	 the	haematopoietic	program,	 it	doesn’t	 	 directly	 inhibit	 the	 cardiac	program	(Scialdone:	2016).		
Runx1:		
A	large	amount	of	research	has	been	dedicated	to	the	transcription	factor	Runx1	given	its	crucial	role	as	a	master	regulator	of	haematopoiesis,	specifically	its	essential	role	in	EHT	(Figure	1-4	B).		
The	 first	 studies	 reported	 that	 Runx1	 activates	 the	 haematopoietic	program	 while	 repressing	 the	 endothelial	 program	 (Jaffredo:	 2005).	 More	recently,	Runx1	was	found	to	regulate	the	positioning	and	integration	of	HE	cells	before	 haematopoietic	 cell	 release	 (Lie	A	 Ling:	 2014).	 Runx1	 target	 genes	Gfi1	
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and	 Gfi1b	 regulate	 the	 loss	 of	 endothelial	 gene	 expression,	 as	 the	 first	 step	 in	haematopoietic	progeny	formation	from	HE	in	EHT.	Gfi1	and	Gfi1b	were	able	to	trigger	 the	 downregulation	 endothelial	 markers	 in	 Runx1	 null	 haemogenic	endothelium	derived	from	ES	cells.	Those	Gfi1/Gfi1B	transduced	cells	were	able	to	 undergo	 morphological	 changes	 that	 are	 similar	 to	 that	 of	 haematopoietic	progeny	 and	 characteristic	 of	 EHT;	 i.e.	 generating	 a	 round	 cell	 that	 expresses	CD41.	However,	these	cells	were	incapable	of	producing	haematopoietic	colonies	in	 vitro	 unlike	 wild-type	 CD41-expressing	 cells	 that	 are	 either	 isolated	 from	embryos	or	from	ES	culture	(Lancrin:	2012).		
Interestingly,	deleting	both	Gfi1	and	Gfi1b	 from	embryos	resulted	 in	 the	formation	 of	 CD41-expressing	 cells	 that	 maintained	 their	 endothelial	 gene	expression	and	characteristics	and	continued	to	adhere	to	their	cell	layer	in	the	YS.	 However,	 these	 cells	 can	 generate	 haematopoietic	 progenitors	 when	disaggregated	(Lancrin:	2012).		
Using	 an	 ES	 cell	 line	 with	 an	 inducible	 form	 of	 Runx1	 in	 a	 Runx	 -/-	background,	 a	 ChIP-sequencing	 study	 looked	 at	 the	 binding	 pattern	 of	 three	known	haematopoietic	transcription	factors	(SCL,	Fli1,	and	C/EBPα)	during	EHT	and	compared	the	binding	before	and	after	Runx1	induction	(Lichtinger:	2012).	After	Runx1	induction,	the	binding	of	those	factors	was	similar	to	that	found	in	haematopoietic	cells	more	than	to	that	in	HE.	
HoxA3:		
The	 start	 of	 the	 haemogenic	 potential	 of	 the	 endothelium	 that	 lines	 the	walls	of	the	dorsal	aorta	is	associated	with	a	fine	balance	between	the	expression	
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of	 HoxA3	 and	 Runx1.	 HoxA3	 restrains	 haematopoietic	 differentiation	 of	endothelial	 cells	 while	 Runx1	 promotes	 it	 (Figure	 1-4	 B).	 Loss	 and	 gain	 of	function	studies	have	shown	that	expression	of	HoxA3	 is	downregulated	at	 the	onset	 of	 Runx1	 expression,	 and	 re-expressing	 HoxA3	 in	 the	 earliest	haematopoietic	 progenitors	 induces	 their	 reversion	 to	 endothelial	 cells	(Iacovino:	 2010).	 Another	marker	 of	 haemogenic	 endothelium	 that	 was	 found	downstream	of	HoxA3	is	Sox17	(Iacovino:	2010).			
Sox17:	
Sox17	 is	 expressed	 and	 required	 for	 the	 development	 of	 neonatal	 and	fetal	HSCs	but	not	adult	HSCs	(Kim:	2007),	and	the	conditional	deletion	of	Sox17	from	 endothelial	 and	 haematopoietic	 progenitors	 using	 the	 Tie2-Cre	 mice,	 or	only	from	the	endothelial	cells	using	the	Vec-Cre	system	is	embryonically	lethal	(Clarke:	 2013;	 Kim:	 2007).	 When	 Sox17	 was	 over-expressed,	 it	 was	 found	 to	reduce	the	expression	of	endothelial	markers	and	expand	a	cell	population	that	has	haemogenic	potential	(Clarke:	2013).	
Sox17	 was	 identified	 as	 a	 key	 regulator	 of	 haemogenic	 endothelial	development.	Using	a	Sox17-GFP	reporter	mouse	 line,	Clarke	et	al.	have	shown	that	Sox17	is	expressed	in	haemogenic	endothelium	and	emerging	HSCs	and	that	it	 is	 required	 for	 HSC	 development.	 In	 addition,	 Sox17	 is	 also	 expressed	 in	haemogenic	 endothelium	 generated	 in	 vitro.	 Sox17	 acts	 through	 the	 Notch	signalling	 pathway	 to	 regulate	 the	 development	 and	 expansion	 of	 haemogenic	endothelium	(Clarke:	2013).			
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1-6-	Gata3:	
The	 GATA	 family	 of	 transcription	 factors	 are	 master	 regulators	 in	development.	All	GATA	 transcription	 factors	bind	 to	a	WGATAR	DNA	sequence	motif	at	target	genes	to	control	their	transcription	through	two	zinc	fingers;	an	N-terminal	and	a	C-terminal.	Those	fingers	bind	to	different	targets	and	each	one	of	 them	 has	 a	 unique	 function.	 The	 C-terminal	 zinc	 finger	 binds	 to	 the	 GATA	consensus	 sites,	 while	 the	 N-terminal	 zinc	 finger	 facilitates	 the	 interaction	between	 the	 GATA	 transcription	 factor	 and	 other	 specific	 DNA	 sequences	(Martin:	1990;	Trainor:	1996;	Fujiwara:	2009).	 	 In	a	crystallographic	structural	study	 by	 Bates	 et	 al.	 (2008)	 for	 GATA3,	 it	 was	 found	 that	 the	 GATA	 family	members	could	bind	to	DNA	by	either	homo	or	heterodimerizing,	or	directly	by	forming	a	dimer	with	other	GATA	factors	 through	their	 two	C	zinc	 fingers.	 In	a	genome-wide	 ChIP-seq	 experiment,	 Fujiwara	 et	 al.	 (2009)	 reported	 that	 GATA	proteins	preferred	binding	to	WGATAA	sequences	in	vivo	
Each	 GATA	 transcription	 factor	 is	 highly	 conserved	 across	 vertebrates.	For	example,	GATA3	homologs	are	found	in	human,	mouse,	rat,	chimpanzee,	dog,	chicken,	 frog,	 and	 zebrafish.	 GATA3	 shares	 97%	 of	 its	 amino	 acid	 identity	between	mouse	and	human.		
The	GATA	 family	 has	 six	members	 in	 vertebrates,	 and	 the	disruption	of	each	of	 the	GATA	genes,	with	exception	of	GATA5,	 in	mice	during	development	causes	embryonic	lethality.		This	family	is	grouped	into	haematopoietic	(GATA1,	GATA2,	 GATA3),	 and	 endodermal	 (GATA4,	 GATA5,	 GATA6)	 subgroups	 (Burch:	2004).	
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All	 GATA	 factors	 have	 both	 distinct	 and	 common	 biological	 roles	 and	biochemical	characteristics,	and	all	 these	transcription	factors	have	a	restricted	expression	pattern.	However,	to	some	extent,	their	functions	are	interchangeable	(Burch:	 2004).	 For	 example,	 Gata1,	 Gata2,	 Gata3	 and	 Gata4	 can	 activate	interleukin-4	 (IL4)	 and	 IL5	 expression	 in	 T	 cells,	 which	 are	 classically	 target	genes	for	Gata3,	and	repress	the	activation	of	interferon-g	(Ifng)	(Ranganath	and	Murphy:	 2001).	 Moreover,	 Gata3	 knock-in	 can	 partially	 rescue	 erythrocyte	defects	 in	Gata1	 null	mice.	 However,	 Gata3	 cannot	 fully	 rescue	 the	Gata1	 null	mice,	indicating	that	each	Gata	factor	maintains	its	unique	functions	(Tsai:	1998,	Takahashi:	2000).		
The	first	three	of	the	GATA	family	play	essential	roles	in	the	development	and	maintenance	 of	 the	 haematopoietic	 system;	 Gata1	 induces	megakaryocyte	and	 erythrocyte	 development,	 while	 preventing	 granulocyte-monocyte	 and	lymphoid	 commitment.	 It	 is	 also	 expressed	 in	 common	 lymphoid	 and	myeloid	progenitors,	mast	cells	and	eosinophils	(Iwasaki:	2003;	Harigae:	1998).	Gata2	is	necessary	 for	 the	 formation	and	 function	of	HSCs	 (Tsai:	1997).	Gata3	 is	 crucial	for	multiorgan	development	and	 regulates	 tissue-specific	differentiation,	which	will	 be	 discussed	 further	 below.	 Gata4,	 Gata5	 and	 Gata6	 are	 critical	 for	 the	development	of	heart	and	lung,	and	are	expressed	in	tissues	that	originate	from	mesoderm	and	endoderm	(Molkentin:	2000).	
The	 haematopoietic	 group	within	 the	GATA	 factors	 control	 each	 other’s	expression	during	development	in	different	cells,	and	are	capable	of	functioning	consecutively	 during	 cell	 specification	 and	 lineage	 commitment	 in	 a	 process	called	the	GATA	switch.	GATA	switch	refers	to	a	process	where	one	GATA	factor	
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is	replaced	by	another	GATA	at	the	chromatin	site.	GATA	switches	occur	at	many	functionally	critical	loci	during	development.	Some	of	these	GATA	switches	occur	at	 genes	 that	 regulate	 haematopoiesis,	 such	 as	 Gata2,	 which	 indicates	 that	 it	could	control	haematopoiesis	(Bresnick:	2010).	For	example,	Gata2	is	one	of	the	genes	that	are	direct	targets	of	Gata1.	Gata2,	in	the	absence	of	Gata1,	can	bind	to	its	target	region	upstream	of	its	own	promoter,	which	activates	transcription	and	induces	 histone	 acetylation.	 However,	 when	 Gata1	 is	 expressed,	 Gata2	 is	displaced	by	Gata1	at	its	chromatin	site,	which	activates	erythropoiesis	(Suzuki:	2013).	
Transcription	factors	are	often	organized	in	multi-gene	families	and	play	essential	 roles	 in	activating	 target	genes	of	 specific	 cell	 fates	and	 in	 repressing	target	genes	of	alternate	cell	fates.	The	GATA	family	of	transcription	factors	are	such	master	regulators.		
The	 GATA	 factors	 share	 common	 features:	 they	 contain	 two	transactivation	domains	at	the	amino	terminus,	two	zinc	fingers	at	the	carboxyl	terminus	and	a	conserved	basic	region	that	is	located	immediately	after	each	zinc	finger	motif.	 GATA	 family	members	 bind	 to	 a	 consensus	 DNA	 sequence	 (A/T)	GATA	(A/G)	in	the	promoters	of	genes	to	directly	activate	or	repress	expression	of	 target	 genes.	 In	 addition,	 GATA	 factors	 recruit	 chromatin-remodelling	complexes	 to	 remodel	 gene	 loci	 (Takemoto:	 2002;	 Zhou	 and	 Ouyang:	 2003;	Yamashita:	2004).	
	At	the	amino	acid	level,	the	family	members	share	varying	degrees	of	homology.	For	example,	while	GATA2	and	GATA3	are	about	55%	homologous,	GATA3	and	
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GATA4	 are	 only	 20%	 homologous.	 However,	 the	 zinc	 finger	 motifs	 are	 about	80%	homologous	among	all	the	six	members.	
Gata3	plays	a	major	role	in	a	variety	of	cells	in	developmental	stage	and	in	cell	 lineage	 specification.	 It	 is	 crucial	 for	 the	 development	 of	 several	 types	 of	cells,	 tissues,	 and	 organs,	 including	 adipocytes	 (Tong:	 2000),	 kidney	 (Grote:	2006),	 mammary	 gland	 (Asselin-Labat:	 2007),	 skin	 (Kaufman,	 2003;	 Kurek,	2007),	and	sympathetic	nervous	system	(Lim:	2000).	
1-6-1-Gata3	in	development:	
Skin	and	Hair:	
Gata3	plays	an	essential	role	in	the	stem	cell	lineage	determination	in	the	skin.	 It	 is	expressed	at	 the	onset	of	 inner	 root	 sheath	 (IRS)	cell	 specification	 in	hair	follicles.	When	Gata3	was	deleted	using	a	LacZ	knock-in,	the	IRS	progenitors	failed	 to	differentiate	 to	 form	 IRS,	 leading	 to	 the	production	of	a	defective	hair	structure	(Kaufman:	2003)	
In	 addition,	 Gata3	 is	 the	 most	 highly	 expressed	 member	 of	 the	 GATA	family	 in	 the	 interfollicular	 epidermis.	 The	 specific	 deletion	 of	Gata3	 from	 the	epidermal	 layer,	 using	 a	 keratin-14-Cre	 (K14-Cre)	 mouse	 line	 showed	 to	 be	prenatally	 lethal	 due	 to	 impairment	 of	 the	 skin	 selective	 barrier.	 Those	 mice	showed	 defects	 in	 skin	 differentiation,	 abnormal	 hair	 follicle	 organization	 and	delayed	hair	growth	and	maintenance.	Genomic	analysis	of	those	mice	revealed	a	defective	 lipid	 biosynthesis.	 This	 could	 be	 contributed	 to	 the	 loss	 of	 lipid	
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acetyletransferase	 gene	 (Agpat5),	 a	 gene	 that	 is	 a	 direct	 target	 of	 Gata3	 (de	Guzman	Strong:	2006;	Kurek:	2007).	
Kidney:	
Gata3	 is	 the	only	GATA	factor	that	 is	expressed	 in	the	urogenital	system	prior	 to	E12.5.	 It	 is	necessary	 for	 the	normal	development	of	 the	nephric	duct.	Using	 a	HoxB7-Cre	transgenic	 line,	 Grote	 et	 al.	 (2008)	 have	 specifically	 deleted	Gata3	 from	 the	 nephric	 duct,	 which	 resulted	 in	 severe	 abnormalities	 in	 the	urogenital	 system,	 and	 found	 that	 Gata3	 is	 required	 to	 prevent	 ectopic	metanephric	 kidney	 duct	 formation	 and	 premature	 cell	 differentiation.	Additionally,	 they	 have	 reported	 that	 Gata3	 haploinsufficincy	 resulted	 in	 renal	dysplasia	(Grote:	2008).	
Gata3	has	also	been	implicated	in	clear	cell	renal	cell	carcinoma	(cc-RCC),	the	most	common	subtype	of	RCC.	Cooper	et	al.	 (2010)	 found	that	when	Gata3	expression	 is	 downregulated	 by	 promoter	 hypermethylation,	 it	 results	 in	decreasing	 the	 expression	 of	 type	 III	 TGF-β	 receptor	 (TβRIII),	 which	 is	 a	betaglycan	protein	with	tumour	suppressor	features	(Cooper:	2010).	
Mammary	gland:	
Gata3	 is	 also	 crucial	 for	 mammary	 gland	 development.	 It	 is	 the	transcription	 factor	with	the	highest	expression	 in	 the	mammary	epithelium	as	shown	by	genome-wide	transcript	analysis	of	the	terminal	end	bud	and	mature	duct	 microenvironment	 (Kouros-Mehr	 and	 Werb:	 2006).	 When	 Gata3	 was	specifically	deleted	from	the	mammary	epithelium	at	the	onset	of	puberty,	using	
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the	murine	mammary	tumour	virus	(MMTV)	promoter-Cre	recombinase	(MMTV-Cre),	 the	 mammary	 glands	 failed	 to	 develop	 terminal	 end	 buds	 (TEBs)	 and	resulted	 in	 ductal	 abnormal	 structures.	 (Kouros-Mehr:	 2006,	 Asselin-Labat:	2007).	
GATA3	mutations	 have	 been	 detected	 in	 around	 10%	 of	 human	 breast	cancer.	While	the	range	of	somatic	mutations	was	varied,	they	clustered	mainly	in	the	highly	conserved	C-terminal	second	zinc	finger	(Koboldt:	2012).		
Data	suggest	that	GATA3	might	act	as	a	tumour	suppressor	gene.	Both	in	vitro	and	in	vivo	studies	have	indicated	a	potential	tumour	suppressor	role	since	the	 loss	of	Gata3	results	 in	 tumour	progression	and	 tumour	dissemination	 in	a	murine	luminal	breast	cancer	model	(Kouros-Mehr:	2008).	
GATA3	 expression	 inhibits	 breast	 cancer	 growth	 and	 pulmonary	metastasis	by	 repressing	metastasis-associated	genes	 such	as	 ID1/-3,	KRTHB1,	LY6E	and	RARRES3	(Dydensborg:	2009),	and	restoration	of	GATA3	expression	in	breast	cancer	cell	 lines	regulates	breast	cancer	differentiation	and	supresses	its	dissemination	(Kouros-Mehr:	2008).	
Moreover,	GATA3	was	found	to	promote	the	expression	of	microRNA-29b	(miR-29b),	 which	 in	 turn	 induces	 differentiation,	 supresses	 metastasis	 and	changes	 the	 tumour	 microenvironment	 (Chou:	 2013).	 In	 addition,	 low	expression	 of	 GATA3	 was	 associated	 with	 poor	 survival	 rate	 and	 a	 more	aggressive	 disease	 (Kouros-Mehr:	 2006),	 whereas	 GATA3-expressing	 breast	cancer	 patients	 had	 a	 better	 prognosis,	 were	 less	 likely	 to	 relapse,	 and	 had	 a	better	overall	survival	rate	(Oh:	2006).			
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1-6-2-Gata3	in	the	Haematopoietic	System:	
Within	 the	 haematopoietic	 system,	 Gata3	 is	 expressed	 in	 T-cells	 and	thymocytes,	and	in	the	NK	cell	lineage,	and	plays	a	crucial	role	in	the	regulation	of	 the	 immune	 system.	 It	 was	 found	 to	 be	 crucial	 for	 the	 development,	maintenance,	 survival	 and	 proliferation	 of	 early	 T-cell	 progenitors.	 	 Ting	 et	 al.	have	shown	in	chimera	studies	that	ES	cells	with	a	deleted	Gata3	gene	were	able	to	 contribute	 to	 the	 reconstitution	 of	 B-cell,	 myelomonocytic	 and	 erythroid	lineages	but	not	thymocytic	or	T-cell	lineages.		
Gata3	 is	 a	 master	 regulator	 of	 T	 helper	 type2	 cells.	 It	 regulates	 the	differentiation	 of	 Th2	 cells	 by	 controlling	 genes	 that	 encode	 Th2	 cytokines	interleukin-4	(IL4),	IL5,	and	IL13	(Lee:	2006).	
Gata3	levels	are	carefully	controlled	throughout	thymocyte	development	as	 levels	 that	 are	 too	 high	 are	 cytotoxic,	 and	 levels	 that	 are	 too	 low	 cause	developmental	failure	(Ho:	2009).		
GATA3	has	also	been	implicated	in	T-cell	acute	 lymphoblastic	 leukaemia	(T-ALL).	 Together,	 T-cell	 acute	 lymphocytic	 leukaemia	 1	 (TAL1),	 RUNX1,	 and	
GATA3	 form	 a	 positive	 interconnected	 auto-regulatory	 loop	 that	 directly	activates	MYB	oncogene,	thus,	reinforcing	and	stabilising	the	oncogenic	program	that	contributes	to	malignant	transformation	(Sanda:	2012).	
In	 addition,	 whole	 genome	 sequencing	 of	 patients	 with	 early	 T-cell	precursor	acute	 lymphoblastic	 leukaemia	 	 (ETP-ALL),	 an	aggressive	 subtype	of	
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T-ALL,	 has	 revealed	 GATA3	 inactivating	 lesions	 disrupting	 the	 haematopoietic	development	(Zhang:	2012).	
GATA3	has	also	been	linked	to	other	types	of	lymphoid	malignancies.	In	a	genomic	profiling	study,	a	GATA3	SNP	genotype	has	been	identified	in	a	subtype	of	 childhood	 acute	 lymphoblastic	 leukaemia	 (ALL),	 Philadelphia	 chromosome-positive	 ALL	 (Ph-like	 ALL)	 that	 has	 been	 associated	 with	 early	 treatment	response,	 higher	 risk	 of	 relapse	 and	 overall	 poor	 prognosis	 (Perez-Andreu:	2013).	And	 in	anaplastic	 large	cell	 lymphoma,	 the	absence	of	GATA3	protein	 in	addition	 to	 the	 presence	 of	 suppressive	 histone	 (H3K27)	 trimethylation	of	GATA3	suggests	 an	 epigenetical	 involvement	 of	 the	 disease	 pathogenesis	(Joosten:	2013).	
Gata3	 is	not	necessary	 for	 the	development	of	 classic	natural	killer	cells	(NK)	 (Vosshenrich:	 2006),	 but	 is	 crucial	 for	 a	 specialised	 subset	 of	 them.	 It	 is	important	for	the	terminal	differentiation	of	NK	cells	and	their	exit	from	the	bone	marrow,	and	is	crucial	for	the	maintenance	of	liver-resident	NK	cells	(Ali:	2016).		
Gata3	 is	 also	 highly	 expressed	 in	 the	 long	 term	 repopulating	 HSC	 (LT-HSC)	 population	 (Zhong:	 2005;	 Kent:	 2009;	 Benveniste:	 2009;	 Hosoya:	 2010)	and	 in	 embryonic	 HSC	 precursors	 (Bertrand:	 2005;	 Swiers:	 2013).	 Using	 null	
Gata3	mice,	a	Gata3	total	knockout	mouse	line,	Ku	et	al.	have	shown	that	Gata3	deletion	results	in	the	production	of	lower	numbers	of	adult	LT-HSCs,	and	that	a	lower	number	of	these	Gata3-null	LT-HSCs	are	in	cycle	(Ku:	2012).	This	indicates	that	Gata3	is	necessary	for	maintaining	normal	numbers	of	LT-HSCs,	and	that	it	regulates	their	entry	into	the	cell	cycle.		
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However,	 by	 using	 a	 conditional	Gata3	 knockout	mouse	 line,	 a	Vav-Cre	mediated	deletion,	Buza-Vidas	et	al.	have	shown	that	deleting	Gata3	expression	from	 HSCs	 after	 their	 emergence	 from	 HE	 in	 the	 embryo	 does	 not	 affect	 the	ability	of	HSCs	to	expand	normally	and	that	their	numbers	remain	unaffected	in	the	BM	after	birth.	Moreover,	 they	reported	that	Gata3	deletion	does	not	affect	the	ability	of	HSCs	to	self-renew	(Buza-Vidas:	2010).	It	should	be	noted	here	that	the	cells	used	for	this	study	were	BM	cells	isolated	from	mice	at	1-2	weeks	of	age	as	 donors,	 in	 contrast	 to	 Ku	 et	 al	 study	 (Ku:	 2012),	 where	 they	 used	 cells	obtained	from	E14.5	fetal	liver.		
More	 recently,	 by	 also	 using	 a	 conditional	 Gata3	 knockout	 mouse	 line,	
Mx1-Cre	 mediated,	 Frelin	 et	 al.	 have	 demonstrated	 that	 Gata3	 controls	 the	balance	of	LT-HSC	self-renewal	and	differentiation	by	regulating	their	transition	from	LT-HSC	to	Intermediate	term	HSCs	(IT-HSC).	The	IT-HSCs	are	important	in	maintaining	blood	counts	at	steady	state.	They	differ	from	LT-HSCs	in	that	they	are	able	 to	generate	myeloid	and	erythroid	progeny	 for	12	weeks	 (Benveniste:	2010),	 are	 more	 abundant	 than	 LT-HSCs	 (three	 times	 higher)	 (Foudi:	 2009;	Benveniste:	2010),	 are	more	proliferative,	 and	exit	quiescent	 state	of	 cell	 cycle	more	frequently	than	LT-HSCs;	every10-20	days	compared	to	50-100	days	in	LT-HSCs	 (Wilson:	 2008;	 Foudi:	 2009).	 In	 addition,	 they	 have	 reported	 that	 Gata3	relocation	from	the	cytoplasm	to	the	nucleus	is	associated	with	LT-	HSCs	exiting	quiescence	and	long-term	reconstitution	ability	reduction.	However,	the	precise	function	of	Gata3	in	adult	LT-HSCs	requires	further	dissection.		
Gata3	 is	 expressed	 in	 the	 sites	 of	 intraembryonic	 haematopoietic	 cell	generation	 in	 the	 mouse	 (Sp,	 P-Sp/AGM)	 (Manaia:	 2000),	 zebrafish	 (Neave:	
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1995),	 avian	 (Leonard:	 1993),	 human	 (Labastie:	 1998)	 and	 in	 Xenopus	(Bertwistle:	1996;	Turpen:	1997).		
In	 the	 mouse	 embryo,	 Gata3	 is	 expressed	 at	 low	 level	 at	 E8.5	 in	 the	splanchnic	mesoderm	(Manaia:	2000).	However,	by	E11.5	Gata3	is	expressed	at	high	 levels	 throughout	 the	 embryo.	 At	 this	 stage,	 Gata3	 deletion	 was	embryonically	lethal,	death	occurring	concomitantly	with	the	onset	of	definitive	haematopoiesis	 in	 the	 fetal	 liver	 (Pandolfi:	 1995).	 YS	 haematopoiesis	 was	normal,	which	corresponds	with	 the	 fact	 the	GATA3	 is	not	expressed	 in	 the	YS	(Manaia:	2000).		
Gata3	knockout	embryos	were	shown	to	have	growth	retardation,	along	with	severe	deformities	in	spinal	cord	and	brain,	massive	internal	haemorrhage,	anaemia,	 and	 defective	 liver	 haematopoiesis,	 i.e.	 definitive	 haematopoiesis,	suggesting	 that	 Gata3	 is	 essential	 for	 the	 development	 of	 various	 systems	(Pandolfi:	1995).		
In	 an	 in-vitro	 culture	 system,	 the	 colonies	 that	 resulted	 from	 the	 YS	 of	Gata3	 knockout	 embryos,	 compared	 to	 their	 wild-type	 and	 heterozygous	littermates	were	normal,	indicating	the	maintenance	of	primitive	erythropoiesis.	However,	the	colony	numbers	from	the	fetal	liver	of	the	knockout	embryos	was	low	compared	to	the	wild-type	and	heterozygous	littermates,	proving	that	Gata3	disruption	severely	affects	definitive	haematopoiesis	(Pandolfi:	1995).	
Using	Ly-6A	GFP	transgenic	embryos,	which	express	GFP	in	all	embryonic	HSCs	and	their	precursors,	a	microarray	expression	analysis	of	 the	AGM	region	aimed	 at	 identifying	 HSC	 regulators	 using	 a	 comparative	 gene	 expression	
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analysis	between:	(i)	HSC	containing	region	(middle	part	of	the	dorsal	aorta)	vs.	a	region	without	HSCs	(caudal	and	rostral	part);	 	 	 (ii)	 the	microenvironment	of	HSCs	 before	 and	 after	 their	 emergence;	 i.e.	 the	 aorta	 with	 the	 immediate	mesenchyme	 of	 E9-E10	 vs.	 E11	 (iii)	 HSC-enriched	 populations	 and	 their	precursors;	 intra-aortic	 clusters,	 haemogenic	 endothelium,	 and	 pre-HSCs/HSCs	(E9	Ly-6A	GFP+	cells	vs.	E11	Ly-6A	GFP+	cells).	 	 In	the	microarrays,	Gata3	was	found	 to	 be	 upregulated	 in	 2	 of	 the	 3	 comparisons	 (ii	 and	 iii),	 i.e.	 in	 tissues	surrounding	 the	 dorsal	 aorta	 specifically	 at	 the	 time	 of	 HSC	 emergence	 in	 the	AGM	 and	 in	 pre-HSCs/HSC-enriched	 populations;	 E11	 Ly-6A	 GFP+	 cells	(Mascarenhas:	2009).	
Gata3	plays	a	crucial	role	in	the	development	of	the	sympathetic	nervous	system	 (Lim:	 2000;	 Moriguchi:	 2006;	 Hong:	 2008;	 Zhao:	 2008;	 Jones	 and	Warchol:	2009).	 In	 fact,	 this	 is	 the	reason	why	Gata3	deletion	 is	embryonically	lethal.	 This	 lethality	 was	 attributed	 to	 the	 noradrenaline	 deficiency	 in	 the	sympathetic	 nervous	 system	 (SNS)	 and	 could	be	pharmacologically	 rescued	by	feeding	the	mothers	DOPS,	a	synthetic	catecholamine	intermediate	(Lim:	2000).		
It	was	subsequently	confirmed	that	Gata3	is	essential	 for	the	production	of	catecholamines,	the	sympathetic	nervous	system	(SNS)	mediators,	and	plays	a	major	 role	 in	 the	 survival	 of	 sympathetic	 neurons	 in	 both	 adults	 and	 embryos	(Tsarovina:	 2004,2010).	 Interestingly,	 Gata3	 was	 found	 to	 be	 regulating	 HSC	numbers	 through	 catecholamine	 production,	 with	 its	 absence	 impairing	 the	production	 of	 functional	 and	 phenotypic	 HSCs	 in	 the	 AGM	 (Fitch:	 2012).	Previously,	 it	 has	 been	 reported	 that	 the	 SNS	 plays	 a	 major	 role	 in	 the	mobilization	 (Katayama:	 2006),	 proliferation	 (Mendez-Ferrer:	 2008)	 and	
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repopulation	(Spiegel:	2007)	of	adult	HSCs	(as	discussed	above).	This	 indicates	the	 presence	 of	 a	 functional	 connection	 between	 the	 SNS	 and	 haematopoietic	system	development	and	that	HSC	emergence	in	the	AGM	should	be	investigated	as	a	part	of	 a	whole	developmental	process	 that	 is	 influenced	by	neighbouring	tissues	(Fitch:	2012).		
In	addition	to	its	role	in	the	AGM	HSC	microenvironment	described	above,	Gata3	was	also	found	to	be	expressed	at	higher	levels	in	23GFP+HE	than	in	non-haemogenic	endothelial	(NHE)	cells	(Swiers:	2013),	indicating	a	possible	role	of	its	involvement	in	HSC	and	progenitor	generation.	In	addition,	Gata3	expression	increased	 upon	 Notch1	 signaling	 induction,	 which	 expands	 the	 HE	 population	and	enhanced	their	haematopoietic	potential	(Jang:	2015).	
Manaia	 et	 al.	 analysed	 the	 expression	 of	 Gata3	 and	 Lmo2	 in	 mouse	embryonic	 development	 to	 understand	 the	 mechanisms	 involved	 in	 the	generation	 of	 definitive	 haematopoietic	 stem	 cells,	with	 a	 special	 emphasis	 on	intraembryonic	haemogenic	sites	(Manaia:	2000).	Interestingly,	they	found	that	Gata3	 and	 Lmo2	 are	 expressed	 concomitantly	 in	 the	 caudal	 embryonic	mesoderm	where	haematopoietic	cluster-bearing	vessels	develop,	suggesting	an	involvement	 in	 cell	 fate	determination.	Another	observation	of	 their	 study	was	that	Gata3	expression	is	restricted	to	sites	involved	in	definitive	haematopoiesis.	Gata3	 is	 expressed	 in	 the	 environment	 from	which	 intraembryonic	 precursors	emerge,	 and	 in	 the	 developing	 haematopoietic	 sites	 before	 their	 colonisation.	Gata3	was	 expressed	 in	 both	 thymic	 rudiment	 until	 the	 first	migrants	 arrived,	and	 inseptum	 transversum	 before	 it	 gives	 rise	 to	 the	 FL.	 However,	 no	 CD45+	
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haematopoietic	cells	were	present	within	those	sites	at	that	developmental	stage	(Manaia:	2000).	
Gata3	 expression	was	 restricted	 to	 the	 ventral	 side	 of	 the	 dorsal	 aorta,	where	 the	 haematopoietic	 clusters	 are	 found.	 Its	 expression	was	 at	 its	 highest	level	at	E10.5	(Swiers:	2013),	and	is	physically	located	below	the	haematopoietic	clusters	in	the	sub-aortic	mesenchyme	(Fitch:	2012).	This	expression	disappears	after	E12.5,	when	intraembryonic	clusters	cease	to	be	generated.	Thus,	Gata3	is	expressed	 in	 three	 different	 cell	 types	 in	 the	 AGM:	 the	 SNS,	 the	 sub-aortic	mesenchyme	and	the	HE,	and	its	involvement	in	the	production	of	the	first	HSCs	is	 therefore	 likely	 to	 be	 complex.	 The	 function	 of	 Gata3	 in	 these	 different	 cell	types	and	how	this	relates	to	haematopoietic	development	was	the	subject	of	this	PhD	thesis.	
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2-	Methods	
	
2-1-	Mice	and	Embryo	Generation:	
Timed	matings	were	set	up	using	the	following	mouse	strains:	wild-type	mice	 C57BL/6,	 Gata3-GFP	 knock	 in	 (Grote:	 2006),	 conditional	 Gata3	 knockout	(Zhu:	 2004),	 Gata3-LacZ	 knock	 in	 (van	 Doornick:	 1999)	 and	 Ve-Cadherin-Cre	(Speck:	2009).	Embryos	were	obtained	at	E9.5,	E10.5,	and	E11.5	where	the	date	of	vaginal	plug	detection	is	considered	as	day	0.	
	
2-2-	Genotyping	by	PCR:	
Embryo	 heads	 were	 cut	 off,	 and	 about	 1/5th	 of	 the	 head	 used	 for	genotyping.	 Genomic	 DNA	 was	 extracted	 using	 the	 HotSHOT	 method	 (Truett:	2000).	 A	 small	 part	 of	 the	 embryo	 head	was	 added	 to	 50	ml	 of	 Alkaline	 lysis	buffer	(0.04%	disodium	EDTA	and	0.25%	NaOH	in	water)	and	heated	to	95°C	at	280	×g	shaking	for	20	minutes.	Then,	50	ml	of	Neutralisation	Reagent	was	added	(4%	1M	Tris-HCl	in	water).		
The	 PCR	mastermix	 was	 comprised	 of	 12.5	 ml	 KAPA2G	 Fast	 ReadyMix	with	dye	(Anachem),	2.5	ml	of	the	primer	mix	(forward	and	reverse	primers),	1	ml	embryo	head	sample	and	9	ml	of	water	per	reaction.	
Primers	and	 conditions	of	PCR	are	detailed	 in	 table1.	Embryos	are	 then	processed	based	on	the	experiment	that	will	be	carried	out.	
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Mouse	Line	 Primer	 Sequence	 Program	
Gata3	GFP	 ASEQ	5408	ASEQ	5409	 CGCCGCCGGGATCACTCTCG	GATCCAGACATGATAAGATACA	 94oC	 2	minutes	94oC	 30	seconds	]	60oC	 30	seconds	]		x	30	cycles	 	72oC	 30	seconds	]	72oC	 30	seconds	
Conditional	 Gata3	
Knock	Out	
P13	P16	 CAGTCTCTGGTATTGATCTGCTTCTT	GTGCAGCAGAGCAGGAAACTCTCAC	 94oC	 5	minutes	94oC	 20	sec]	55oC	 20	sec]										x	30	cycles	72oC	 20	sec]	72oC	 5	minutes	
Gata3	LZ	 E2A2	913-931	NLS2	
CGTTGAGGACCGCGGGGTG	CAGGAGTCCGCGGACCTCC	CCAAGCTTGGACTCAAAAAACT	
94oC	 5	minutes	94oC	 30	sec]	55oC	 30	sec]										x	35	cycles	72oC	 30	sec]	72oC	 10	minutes	
Vec-Cre	 VECP-F-219	Cre-R107	 CCCAGGCTGACCAAGCTGAG		GCCTGGCGATCCCTGAACATG	 92oC	 2	minutes	95oC	 15	sec]	58oC	 15	sec]										x	30	cycles	72oC	 	5	sec]	72oC	 10	minutes	
Conditional	 Gata3	 –	
StellaCre	
P8	P16	 TCAGGGCACTAAGGGTTGTTAACTT	GTGCAGCAGAGCAGGAAACTCTCAC	 94oC	 5	minutes	94oC	 20	sec]	55oC	 20	sec]										x	30	cycles	72oC	 20	sec]	72oC	 5	minutes	
Table1:	Genotyping	primers	and	PCR	conditions	
	
2-3-	AGM	Dissection:	
On	 the	 desired	 gestation	 day,	 the	 embryos	 were	 harvested	 in	 sterile	complete	medium	 (10%	 FCS	 (Hyclone,	 Fisher	 Scientific)	 and	 1%	 pen/strep	 in	PBS	(Sigma)).	All	dissections	were	performed	under	a	Nikon	SMZ800	dissection	
		 60	
microscope	 (Nikon)	while	 the	 embryos	 and	 tissues	were	 in	 complete	medium.	After	embryos	extraction	from	the	uterine	 lumen,	 the	developmental	stage	was	specified	by	either	counting	somite	pairs	(E9.5-E10.5)	or	determining	the	stages	by	 the	 eye	 development	 (E11.5).	 Embryos	 smaller	 than	 their	 littermates	 or	lacking	a	heartbeat	were	excluded.	The	AGM	was	then	dissected,	and	the	planned	experiment	protocol	was	followed.	
	
2-4-	Flow	cytometry	and	cell	sorting:	
2-4-1-	AGM:	
AGMs	were	dissected	from	the	embryos	as	described	above,	added	to	PBS	supplemented	with	10%	FCS	(complete	medium)	and	1%	PenStrep	with	0.125%	collagenase	 (Alfa	 Aesar),	 incubated	 at	 37oC	 for	 45minutes,	 and	 mixed	 by	pipetting	 until	 the	 AGMs	were	 fully	 dissociated.	 The	 cell	 suspension	was	 then	washed	with	1	ml	of	complete	medium,	spun	down	at	4°C,	250	×g	for	5	minutes,	and	the	supernatant	discarded.		
	Antibody	staining	on	dissociated	cells	was	performed	for	30	minutes	on	ice	 in	 the	dark.	The	antibody	 fluorochrome	and	 concentrations	 are	 supplied	 in	table	2.		
After	the	staining,	the	cells	were	washed	with	1	ml	FACS	buffer	(2%	FCS	in	PBS),	spun	down	at	4°C,	250×g	for	5	minutes,	the	supernatant	discarded,	and	the	 cell	 pellet	 then	 resupended	 in	 300	 ml	 FACS	 buffer	 containing	 a	 dead	 cell	marker.	 Dead	 cells	 were	 excluded	 either	 via	 7-aminoactinomycin	 D	 staining	
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1:1000	(7AAD,	Invitrogen)	or	Sytox	7AAD	(1:5000)	(Invitrogen).	All	experiments	included	 the	 following	 controls:	 unstained	 cells,	 single	 stained	 sample	 for	 each	flurochrome.	 When	 sorting,	 additional	 fluorescent	 minus	 one	 (FMO)	 controls	were	also	used.Cells	were	analysed	using	LSRFortessa	(BD	Bioscience)	or	sorted	using	 MoFlo	 (Beckman	 Coulter),	 ARIA	 (BD	 Bioscience),	 and	 Fusion	 (BD	Bioscience).	
	
Antibody	 Fluorochrome	 Concentration		 Manufacturer		CD34	 PB	 1:100	 Biolegend	CD34	 PE	 1:100	 Biolegend	CD31	 APC	 1:100	 Biolegend	CD41	 BV421	 1:100	 BD	Bioscience	CD45	 BV421	 1:100	 BD	Bioscience	CD45	 APC-Cy7	 1:100	 BD	Bioscience	CD45	 A-700	 1:50	 Biolegend	CD43	 BV421	 1:100	 BD	Bioscience	TER-119	 V500	 1:00	 BD	Bioscience	PDGFR-b	 APC	 1:200	 Biolegend	PDGFR-b	 PE	 1:100	 Biolegend	Ve-cadherin	 PE-Cy7	 1:100	 Biolegend	Ve-cadherin	 Alexa	Fluor	647	 1:100	 BD	Bioscience	
Table	2:	Antibodies	Fluorochrome	and	concentration	for	FACS	
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2-4-2-	Blood	Samples:	
Around	 200	ml	were	 collected	 in	 EDTA	 tubes	 (Sarstedt,	 UK)	 from	 each	transplanted	mouse.	 Red	 Cell	 Lysis	 buffer	was	 prepared	 at	 RT	 by	 diluting	 the	stock	solution	(BD	Biosciences)	1:10	in	water.	700	ml	of	the	diluted	buffer	was	added	to	each	blood	sample,	and	incubated	in	the	dark	at	4°C	for	6	minutes.	The	tubes	were	 then	spun	down	at	4°C,	250	×g	 for	5	minutes,	 the	supernatant	was	discarded,	 and	 the	 pellet	 resupended	 in	 700	ml	 FACS	 buffer	 (2%	 FCS	 in	 PBS,	Sigma).	After	that,	the	samples	were	filtered	through	a	50mm	filter	(Partec)	into	5	ml	round-bottom	polystyrene	tubes	(SLS).	Another	700	ml	were	added	to	the	original	tube	and	filtered	to	ensure	all	cells	were	removed	from	both	the	blood	tube	 and	 the	 filter.	 The	 samples	 were	 spun	 again	 at	 the	 same	 conditions	 and	resuspended	in	staining	mastermix.		
The	 mastermix	 was	 prepared	 using	 the	 following	 antibodies:	 CD45.1	(Biolegend)	1:200	on	PE,	CD45.2	 (Biolegend)	1:100	on	A-700,	CD3	(Biolegend)	1:200	on	APC,	B220	(Biolegend)	1:200	on	APC,	MAC1	(Biolegend)	1:200	on	PB,	and	Gr1	(Biolegend)	1:200.	Dead	cells	were	excluded	via	7-aminoactinomycin	D	staining	1:1000	(7AAD,	Invitrogen).	Cells	were	analysed	using	LSRFortessa	(BD	Bioscience)			
	
2-5-	Cell	Cycle	Analysis:	
First,	DAPI	 staining	 solution	was	prepared	as	5ug/ml	DAPI	 (Sigma)	and	1%	 (v/v)	 	 Nonidet	 P40	 (Sigma)	 in	 dH2O.	 Sorted	 cells	 were	 stained	 for	 one	
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minute	(1:1)	at	room	temperature,	and	then	analysed	using	an	LSRFortessa	(BD	Bioscience).		
	
2-6-	AGM	explant	culture:	
AGMs	 from	E11.5	and	E10.5	embryos	were	cultured	on	Durapore	 filters	(Millipore)	at	the	air-liquid	interface	in	M5300	long-term	culture	medium	(Stem	Cell	Technologies)	supplemented	with	10-6	M	hydrocortisone	(Sigma).		
After	3	days,	AGMs	were	dissociated	with	collagenase	as	described	above	and	 single-cell	 suspensions	 were	 either	 processed	 using	 flow	 cytometry	 (see	above)	or	plated	in	in	methylcellulose	(see	above).	
	
	2-7-	Colony-Forming	Assays:	
Dissociated	AGM	cells	(either	 fresh	or	after	explant	culture)	were	added	to	 3.6ml	 methylcellulose	 (M3434:	 Stem	 cell	 technologies)	 and	 plated	 in	triplicates	 (65.000	 cells/plate).	 Plates	 were	 incubated	 at	 37oC	 and	haematopoietic	colonies	were	counted	and	scored	7	days	later.	
To	 determine	 the	 genotype	 of	 colonies	 when	 Gata3	 was	 deleted	 from	endothelium,	 each	 colony	 is	 picked	 from	 methylcellulose	 plate	 and	 added	 to	50ml	of	Alkaline	lysis	buffer	(0.04%	disodium	EDTA	and	0.25%	NaOH	in	water)	and	 heated	 to	 95°C	 at	 280	 ×g	 shaking	 for	 20	 minutes.	 Then,	 50	 ml	 of	Neutralisation	Reagent	was	added	(4%	1M	Tris-HCl	in	water).		
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The	 PCR	 mastermix	 was	 comprised	 of	 12.5	 µl	 KAPA2G	 Fast	 ReadyMix	with	dye	(Anachem),	2.5	µl	of	the	primer	mix	(forward	and	reverse	primers),	and	10	ml	colony	sample	per	reaction. 
	
2-8-OP9	cells	maintenance:		
OP9	 cells	were	maintained	 in	 aMEM	(Gibco)	with	20%	heat	deactivated	FCS	 (Hyclone)	 and	 0.22%	 sodium	 bicarbonate	 (Gibco)	 at	 37	 oC	 with	 5%	 CO2.	Cells	were	passaged	every	2-3	days	using	0.05%	Trypsin/EDTA	(Gibco)	at	37	oC.	For	co-culture	experiments,	cells	were	resuspended	in	aMEM	with	10%	FCS	and	0.01%	of	2-mercaptoethanol	and	plated	24	hours	before	the	experiment.	
	
2-9-	OP9	Co-cultures:	 	
OP9	 co	 cultures	 and	 maintenance	 were	 performed	 using	 the	 protocol	supplied	by	Swiers	et	al.	Briefly,	cells	were	sorted	and	plated	on	confluent	OP9	stroma.	 For	 	 	 haemogenic	 assays,	 cultures	were	 supplemented	with	 SCF,	 FLt-3	ligand	and	IL7	at	10ng/ml	concentration	(all	from	Pepro-Tech)	and	incubated	for	8–10	days	at	37o	C,	5%	CO2.	The	haematopoietic	nature	of	the	cells	generated	in	the	OP9	co	cultures	was	assessed	by	CFU-C	and	flow	cytometry.	
	
2-10-	OP9	Co-Aggregates:	
Cells	 from	E11.5	or	E10.5	embryos	were	 sorted	and	 co-aggregated	with	OP9	cells	according	to	the	protocol	supplied	by	Rybtsov	et	al	(2001).	
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Cell	suspensions	containing	1	embryo	equivalent	(e.e)		of	the	sorted	cells	and	 105	 OP9	 cells	 in	 30	 ml	 volume	 of	 media	 (Iscove’s	 modified	 Dulbecco’s	medium	 [IMDM],	 Invitrogen-GIBCO,	 20%	 of	 heat-inactivated	 FCS,	 L-glutamine,	penicillin/streptomycin)	 were	 centrifuged	 at	 450	 x	 g	 for	 12	 min	 in	 200	 ml	pipette	tips	sealed	with	parafilm	(Taoudi	et	al.,	2008).		The	IMDM	media	for	the	culture	steps	was	supplemented	with	SCF,	Flt3	and	IL3	at	a	concentration	of	100	ng/ml	 (all	 from	 Pepro-Tech).	 Coaggregates	 were	 cultured	 on	 floating	 0.8	 mm	AAWP	 25	 mm	 nitrocellulose	 membranes	 (Millipore)	 for	 4–5	 days.	 Cultured	aggregates	were	dissociated	using	 collagenase	and	either	processed	using	 flow	cytometry	(see	above),	or	plated	in	methylcellulose	(see	above),	or	transplanted	into	irradiated	mouse	recipients.		
	
2-11-	Transplantation	Experiments:		
The	 dissociated	 cell	 suspensions	 were	 spun	 down	 at	 4oC,	 250×g	 for	 5	minutes	and	then	resuspended	in	500	ml	PBS.	The	cell	suspensions	were	injected	intravenously	into	irradiated	recipients	together	with	2	x	105	spleen	cells	or	2	x	104	 	BM	cells	to	alleviate	the	 irradiation	effects.	The	irradiation	it	self	was	split	into	 two	 doses,	 each	 dose	 being	 460-475	 rad	 with	 three	 hours	 between	 each	dose.	The	congenic	CD45	system	was	used	with	allelic	variants	of	CD45	(CD45.1	and	 CD45.2)	 to	 track	 the	 donor	 contribution	 to	 the	 recipient	 haematopoietic	cells.	Recipients	were	CD45.1/.2	or	CD45.1/.1	and	the	donors	were	CD45.2/.2	on	a	C57BL6	background.	The	helper	cells	(spleen	or	BM)	were	either	CD45.1/.2	or	CD45.1/.1,	 to	 avoid	 contribution	 to	 the	donor	percentage.	Recipient	 blood	was	
		 66	
analysed	 at	 1	 and	 4	 months	 after	 the	 transplantation.	 The	 recipients	 were	considered	positive	if	the	donor	contribution	was	more	than	5%.		
	
2-12-	Tissue	preparation	for	Immunohistochemistry:	
Tissues	 and	 embryos	were	 fixed	 in	 2%	paraformaldehyde	 (PFA,	 Sigma)	and	 phosphate	 buffered	 saline	 (PBS;	 Cambrex	 or	 Sigma)	 for	 1.5	 hour	 at	 4°C,	while	rotating,	then	washed	three	times	in	PBS,	and	cryoprotected	overnight	in	30%	sucrose/PBS	at	4°C.			
Fixed	 tissues	 were	 then	 embedded	 in	 OCT	 TissueTek	 Compound	 and	quick-frozen	on	dry	ice,	before	being	transferred	to	-80°C.	10mm	sections	were	generated	on	a	cryostat	(Leica,	CM3050	S).		
	
2-13-	Immunohistochemistry	(IHC):	
For	 staining,	 either	 an	 Avidin/biotin	 system	 or	 fluorescent-labelled	secondary	antibodies	were	used.	PBS	with	1%	FCS	and	0.1%	Triton	was	used	for	washing	between	steps.	For	blocking,	PBS	with	0.05%	Tween	and	1%	BSA	was	used	(‘blocking	solution’).	Slides	were	allowed	to	dry	at	room	temperature	after	being	taken	out	from	-80oC	for	10	minutes.	They	were	then	washed	three	times	with	PBS	 for	 five	minutes,	blocked	with	200ml	of	 the	blocking	solution	or	with	the	Avidin/biotin	complex.	The	primary	antibody	was	then	added,	and	the	slides	were	 incubated	 for	 24	 hours	 at	 4oC	 in	 a	 dark	 humidified	 box.	 After	 the	incubation,	 the	 slides	were	 then	washed	with	PBS	and	 the	 secondary	 antibody	
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was	added,	incubated	for	45	minutes	at	room	temperature	in	a	dark	humidified	box.	 	 The	 slides	 were	 then	 washed	 with	 PBS,	 mounted	 with	 Vectashield	 with	DAPI	 (Vectorlabs),	 sealed	with	 nail	 varnish	 and	 placed	 in	 a	 dark	 box	 until	 the	time	of	analysis.	Antibody	concentrations	and	providers	are	detailed	in	Table	2.		
Antibody	 Concentration	TH	on	Mouse	(Millipore)	 1:300	GFP	on	Rabbit	(Lifetechnologies)	 1:500	P75	on	Goat	(Santa	Cruz)	 1:100	CD34	on	Rat	(BD-Pharmingen)	 1:100	Anti	rabbit	Alexa	555	(Invitrogen)	 1:500	Anti	mouse	Alexa	488	(Invitrogen)	 1:500	Biotin-conjugated	anti-rabbit	antibody	(DAKO)	 1:100	Streptavidin-Cy5	(Jackson	Immunoresearch)	 1:100	PDGFRb	on	Rabbit	(CellSignal)	 1:100	Anti	mouse	Alexa	546	(LifeTechnologies)	 1:200	Anti-donkey	488	Alexa	(LifeTechnologies)	 1:200	GFP	on	Chicken	(LifeTechnologies)	 1:400	Anti	chicken	647	Alexa	(Millipore)	 1:200	Anti	Rabbit	Alexa	647	(Lifetechnologies)	 1:200	Anti	goat	633	(Sigma)	 1:200	Runx1	on	Rabbit	(Abcam)	 1:100	
Table	3:	IHC	Antibodies	and	concentration	
	
2-14-	Statistical	Analysis:	
All	 graphs	 and	 statistical	 analysis	 were	 performed	 on	 GraphPad	 Prism.	The	 Mann-Whitney	 test	 was	 used	 to	 determine	 significance	 levels	 for	
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transplantation	 experiments,	 paired	 t-test	 was	 used	 to	 determine	 the	significance	 levels	 for	 colony	 forming	 assay	 following	 OP9	 co-culture	 and	coaggregates,	and	two	way	ANOVA	test	was	used	to	determine	significance	levels	for	colony	forming	assay.	
	
2-15-RNA	Sequencing:	
The	 protocol	 was	 provided	 by	 Nicola	 Wilson	 from	 Berthold	 Gottgens	group	(Picelli:	2014).	All	 steps	were	done	 in	a	UV-sterilised	hood	with	 laminar	flow.	To	ensure	that	all	surfaces	were	free	of	RNase	and	DNA,	all	surfaces	were	treated	with	DNase/RNase	Zap.		
	
2-15-1-Cell	lysis:	
Cells	 were	 sorted	 into	 eppendorf	 tubes	 based	 on	 their	 populations:	G3+EC,	 G3-EC,	 G3+HC,	 G3-HC,	 G3+MC,	 G3-MC,	 G3+SNS	 and	 G3-SNS.	 Each	population	was	 then	 sorted	 again	 into	96	wells	plate,	 20	 cells/well,	 containing	2.3 µl	of	lysis	buffer	comprised	of	0.2%	RNase	inhibitor	(Ambion,	Thermo	Fisher	Scientific)	 in	 Triton	 X-100	 (Sigma)	 in	 each	 well.	 Plates	 were	 spun	 down	 and	stored	at	-80°C	until	processed.	
Cells	were	collected	from	3	different	experiments	for	MC	and	SNS,	and	4	different	experiments	for	EC	and	HC.	
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2-15-2-Reverse	Transcription:	
The	annealing	mixture	was	made	up	of	5%	ERCC	RNA	spike-In	Mix	(pre-diluted	 at	 1:25,000;	 Invitrogen,	 Thermo	 Fisher	 Scientific),	 5%	 Oligo-dT	 (5′–AAGCAGTGGTATCAACGCAGAGTACT30VN-3′;	100	mM;	biomers.net),	50%	dNTP	10mM	(Fermentas,	Thermo	Fisher	Scientific)	and	40%	distilled	water.	Then,	2	µl		of	annealing	mix	were	added	to	each	well	,	and	the	plate	was	centrifuged	at	700	×	g	 for	 1	 minute.	 The	 samples	 were	 then	 incubated	 a	 72°C	 for	 3	 minutes	 and	immediately	placed	on	ice,	and	then	centrifuged	again	at	700	x	g	for	1	minute.		
The	 reverse	 transcription	 mixture	 was	 made	 up	 of:	 0.5	 µl	 	 (8.7%)	Superscript	 II	 RT	 (200	 U/ µl;	 Invitrogen,	 Thermo	 Fisher	 Scientific),	 0.25	 µl		(4.3%)	 RNase	 inhibitor	 (20	 U/ml),	 2	 µl	 	 (35%)	 5x	 Superscript	 II	 First	 Strand	Buffer	 (Invitrogen,	 Thermo	 Fisher	 Scientific),	 0.5	 µl	 	 (8.7%)	 DTT	 (Invitrogen,	Thermo	Fisher	Scientific),	2	µl		(35%)	100	mM	Betaine	(Sigma),	0.06	µl		(1%)	1	M	 MgCl2	 (Ambion,	 Thermo	 Fisher	 Scientific),	 0.1	 µl	 	 (1.7%)	 TSO	 Oligo	 (5′-AAGCAGTGGTATCAACGCAGAGTACATrGrG+G-3′;	 100	 mM;	 Exiqon)	 and	 0.29	 µl		(5%)	distilled	water	per	well.	5.7 µl	 	of	 the	reverse	transcription	mixture	were	added	per	well,	and	the	plate	was	centrifuged	at	700	×	g	for	1	minute.	The	plate	was	then	placed	in	a	PCR	cycler	with	the	following	settings:	42°C	for	90	minutes,	10	cycles	of:	50°C	for	2	minutes,	42°C	for	2	minutes,	then	at	the	end	70°C	for	15	minutes.	
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2-15-3-	PCR	Pre-Amplification:		
For	 the	 PCR	 Amplification,	 a	 PCR	mixture	was	 produced	 out	 of	 12.5	µl		(83%)	KAPA	HiFi	Hotstart	ReadyMix	(2x;	KAPA	Biosystems),	0.25	µl		(2%)	ISPCR	primer	(5′-AAGCAGTGGTATCAACGCAGAGT-3′;	10	mM;	biomers.net)	and	2.25	µl		(15%)	distilled	water	per	well.	 15	µl	 of	 the	PCR	mixture	were	 added	per	well,	and	the	plate	was	centrifuged	at	700	×	g	for	1	minute.	The	plate	was	placed	in	a	PCR	cycler	after	that	with	the	following	settings:	98°C	for	3	minutes,	21	cycles	of:	98°C	for	20	seconds,	67°C	for	15	seconds,	72°C	for	6	minutes,	and	then	at	the	end	72°C	for	5	minutes.	
Ampure	XP	beads	(Beckman	Coulter)	were	used	for	PCR	clean	up.	It	was			equilibrated	 at	 room	 temperature	 (RT)	 for	 15	 minutes	 and	 then	 vortexed	 for	several	seconds.	These	beads	were	then	added	to	each	sample	at	a	1:1	ratio	and	mixed	by	pipetting	until	the	solution	appeared	homogeneous.	The	sample/bead	mixture	was	left	to	incubate	at	RT	for	8	minutes	before	fitting	the	96-well	plate	on	a	plate	magnetic	stand.	The	plate	was	left	on	the	stand	for	5	minutes	until	all	beads	had	been	collected	at	one	well	corner.	The	supernatant	was	discarded,	and	the	beads	were	washed	 twice	with	200	µl	 of	 80%	ethanol	 after	 incubating	 the	ethanol/bead	mixture	 for	 30	 seconds	 each	 time.	 The	 last	 ethanol	 traces	 were	removed	with	yellow	tips,	leaving	the	beads	to	dry	completely	(approximately	3-7	minutes),	 indicated	 by	 a	 ‘cracked’	 appearance.	 Then,	 20	µl	 of	 Elution	 Buffer	(Qiagen)	 were	 added	 and	 mixed	 with	 the	 beads	 by	 pipetting.	 The	 plate	 was	incubated	 off	 the	magnet	 for	 2	minutes	 and	 then	placed	 back	 on	 the	magnetic	stand	 for	 2	minutes.	 Finally,	 the	 supernatant	was	 collected	without	 disturbing	the	beads	and	transferred	to	a	new	96-well	plate.			
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2-15-4-	Quality	Check	of	the	cDNA	Library:		
The	size	distribution	of	the	cDNA	library	was	checked	on	an	Agilent	high-sensitivity	 DNA	 chip	 (Agilent	 Technologies),	 according	 to	 the	 manufacturer	instructions.	This	was	done	for	11	random	wells	of	each	plate.	Briefly,	the	gel-dye	mix	 (composed	 of	 ‘High	 Sensitivity	DNA	dye	 concentrate’	 and	 ‘High	 Sensitivity	DNA	gel	matrix’)	was	allowed	to	equilibrate	 to	RT	 for	30	minutes.	A	new	 ‘High	Sensitivity	DNA	chip’	was	placed	on	the	chip	priming	station	and	9	µl		of	gel-dye	mix	were	pipetted	into	the	priming	station	and	distributed	across	the	chip	using	the	plunger.			Additional	9	µl		per	well	were	added	to	the	other	control	wells.	5	µl	of	a	marker	was	added	to	each	well	 in	addition	to	1	µl	of	 ‘High	Sensitivity	DNA	ladder’	or	sample,	depending	on	the	well	position	on	the	chip.	The	chip	was	then	vortexed	for	1	minute	at	2400	rpm	on	an	IKA	vortexer	and	loaded	on	the	Agilent	2100	Bioanalyser	instrument	(Agilent	Technologies).			
	
2-15-5-	Library	Preparation:			
To	 break	 up	 the	 DNA	 strands,	 transposon	 mediated	 fragmentation	(tagmentation)	 was	 carried	 out	 using	 the	 Illumina	 Nextera	 XT	 DNA	 sample	preparation	 kit	 (Illumina)	 according	 to	 an	 optimised	 Tagmentation	 protocol	(Fluidigm).	 NT	 buffer	 and	 Tagment	 DNA	 Buffer	 were	 equilibrated	 to	 RT	 and	vortexed	 until	 all	 precipitated	 particles	 were	 resuspended.	 Per	 cell,	 a	 pre-mix	was	made,	 the	volume	per	sample	consisted	of:	2.5µl	 tagmentation	DNA	buffer,	1.25µl	Amplification	Tagment	mix	 and	1.25µl	 of	 the	 eluted	 cDNA,	 and	 for	 each	cell	 a	 different	 well	 of	 a	 96-well	 plate	 was	 used.	 	 The	 plate	 was	 sealed	 and	centrifuged	at	4,000	rpm	for	5	minutes,	before	being	placed	in	a	thermal	cycler	
		 72	
for	 10	 minutes	 at	 55°C.	 Then,	 the	 NT	 buffer	 was	 added	 at	 20%	 ratio	 to	 the	original	volume	 in	each	well	and	 the	plate	was	sealed	and	centrifuged	again	at	4,000	rpm	for	5	minutes.	After	that,	Nextera	PCR	Master	Mix	(NMP)	was	added	at	a	 ratio	of	37.5%	to	 the	 initial	volume	and	 Index	Primers	1	 (N701-N712)	and	2	(S501-S508)	at	a	ratio	of	12.5%	(each)	were	combined	 in	a	way	that	each	well	was	 uniquely	 labelled	 and	 dual-indexing	metadata	 could	 be	 obtained	 (Nextera	XT	 96-Index	 kit;	 Illumina).	 The	 plate	 was	 centrifuged	 again	 at	 4000	 rpm	 for2	minutes,	 and	 PCR	 amplification	 was	 performed	 in	 a	 thermal	 cycler	 at	 these	settings:	 72°C	 for	 3	 minutes,	 95°C	 for	 30	 seconds,	 12	 cycles	 of:	 95°C	 for	 10	seconds,	55°C	for	30	seconds,	72°C	for	60	seconds	and	then	at	the	end	72°C	for	5	minutes.	
	
2-15-6-	Library	Pooling	and	Clean-up:	
Ampure	 XP	 beads	 were	 equilibrated	 at	 RT	 for	 15	 minutes	 and	 then	vortexed	for	several	seconds.	One	library	was	made	per	plate	by	pooling	1	µl		of	each	well	and	adding	beads	at	70%	of	the	total	pool	volume,	mixing	by	pipetting.	The	 tube	 containing	 the	 library	 mix	 was	 placed	 on	 a	 magnetic	 stand	 and	 the	supernatant	was	removed.	Two	washing	steps	were	performed	by	adding	1.2	ml	of	 freshly	prepared	80%	ethanol	and	 incubating	the	mixture	 for	30	seconds	on	the	magnetic	stand.	The	beads	were	allowed	to	air-dry	for	5-10	minutes,	then	the	sample	was	eluted	in	50	µl		of	elution	buffer.	
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2-15-7-	Library	Quality	Check:		
The	 library	 size	 distribution	was	 checked	 on	 an	 Agilent	 high-sensitivity	DNA	chip	as	described	above.			
	
2-15-8-	Library	Quantification:		
The	pooled	 library	was	quantified	using	 the	KAPA	 library	quantification	kit	 (KAPA	Biosystems).	 For	 each	 reaction,	 60%	 (6 µl)	 of	 ‘2X	KAPA	 SYBR	FAST	qPCR	Master	Mix	 +10X	Primer	Premix’	was	mixed	with	 20%	 (2 µl)	 PCR-grade	water	and	20%	(2	µl)of	diluted	library	solution.	Each	library	was	diluted	in	DNA	Dilution	Buffer	 (10	mM	Tris-HCl,	 pH	8.0	 and	 0.05%	Tween	 20)	 at	 1:2,000,000	and	 run	 in	 triplicates	 along	 with	 the	 provided	 DNA	 Standards	 (Standards	 3-6	were	used)	 and	No	Template	Controls.	 The	 following	 settings	were	used:	95°C	for	5	minutes,	35	cycles	of:	95°C	for	30	seconds,	60°C	for	45	seconds	and	65-95°C	for	a	melting	curve	step.	For	the	data	analysis,	a	standard	curve	was	generated	and	the	concentration	was	calculated	for	each	library.			
	
2-15-9-	Sequencing	&	Data	Analysis:		
Pooled	 libraries	 were	 sequenced	 on	 an	 Illumina	 Hi-Seq	 2500	 (Sanger,	Cambridge),	 as	 single-end	 125	 base	 pair	 reads.	 The	 samples	were	 run	 on	 two	lanes	 of	 a	 flowcell	 of	 8	 lanes.	 Each	 lane	 had	 4	 populations	 that	 were	 pooled	together.	 	This	was	achieved	 in	collaboration	with	Nicola	Wilson.	Lila	Diamanti	from	the	WT-MRC	Cambridge	Stem	Cell	Institute	performed	the	data	analysis.	
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The	threshold	for	the	quality	control	of	the	data	were:	
1- More	 than	 500,000	 reads	 mapped	 (either	 to	 ERCC	 spike-ins	 or	endogenous	mRNA)		
2- More	than	20%	of	total	reads	mapped	to	mRNA		
3- Less	than	20%	of	mapped	reads	allocated	to	mitochondrial	genes	
4- Less	than	20%	of	reads	mapped	to	ERCC	spike-ins		
5- More	than	8000	high	coverage	genes	
Gene	 Ontology	 (GO)	 analysis	 was	 done	 using	 the	 Gene	 Ontology	Consortium	 Enrichment	 Analysis,	 which	 utilise	 PANTHER	 Classification	System	for	biological	processes	in	mus	musculus.	
	
	
	
	
	
	
	
	
	
	
	
		 75	
3-	Gata3	expression	marks	haemogenic	endothelium	
	
3-1-	Background:	
Previously,	 the	 Ottersbach	 group	 carried	 out	 microarray	 expression	analyses	 of	 the	AGM	 region	 to	 identify	HSCs	 regulators.	 Among	 the	 genes	 that	were	 upregulated	 at	 the	 time	 of	 HSCs	 emergence	 was	 Gata3	 (Mascarenhas:	2009).	
Subsequently,	 the	Ottersbach	group	has	 identified	 that	GATA3	 regulates	HSCs	 generation	 indirectly	 by	 the	 means	 of	 the	 SNS.	 Gata3-deficient	 embryos	could	 not	 develop	 a	 functional	 SNS,	 and	 as	 a	 result	 could	 not	 produce	catecholamines	 the	 SNS	 mediators,	 which	 caused	 a	 marked	 reduction	 in	 both	HSCs	and	haematopoietic	progenitors	in	these	embryos	(Fitch:	2012).	
However,	 a	 more	 direct	 role	 of	 Gata3	 in	 haematopoiesis	 is	 yet	 to	 be	investigated.	Gata3	was	previously	reported	to	be	expressed	in	endothelial	cells,	mesenchymal	 cells	 and	 sympathoadrenal	 cells	 within	 the	 AGM	 region	 (Fitch	2012;	 Manaia:	 2000)	 and	 has	 subsequently	 been	 shown	 to	 be	 enriched	 in	haemogenic	endothelial	cells	(Swiers:	2013),	where	 it	was	reported	to	enhance	the	haematopoietic	potential	of	those	cells	(Jang:	2015).		
Given	 the	 correspondence	 of	 both	 temporal	 and	 spatial	 expression	 of	Gata3	with	the	activity	of	HE	and	the	generation	of	HSCs	and	progenitor	cells,	we	therefore	 hypothesised	 that	 Gata3	 could	 potentially	 mark	 haemogenic	endothelium	 and	 have	 a	 distinct	 and	 more	 direct	 role	 in	 HSC	 and	 progenitor	formation.	
To	enable	us	to	further	investigate	and	isolate	Gata3-expressing	cells,	we	used	 a	G3-GFP	 reporter	mouse	 (G3-GFP)	 line	 (Grote:	 2005)	 in	 order	 to	 isolate	those	Gata3-expressing	cells	and	to	characterise	them.		
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3-2-	Aims:	
- Characterise	 Gata3-expressing	 cells	 using	 the	 G3-GFP	 reporter	mouse	line	
- Investigate	 the	 haematopoietic	 potential	 of	 Gata3-expressing	endothelial	and	haematopoietic	cells.	
- Determining	 the	 type	 and	place	of	G3+	HC	 in	 the	haematopoietic	differentiation	pathway		
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3-3-GATA-3	is	expressed	in	various	cell	types	in	the	E10.5	and	E11.5	
AGM:	
3-3-1	E11.5:	
Initially,	we	wanted	to	confirm	if	the	GFP	in	our	mouse	line	was	a	faithful	reporter	 to	 the	 indigenous	 expression	 of	 Gata3.	 For	 that	 reason,	 I	 stained	 a	section	 from	 an	 E11.5	G3-GFP+	 embryo	 and	 used	 both	 an	 anti-Gata3	 antibody	along	with	 an	 anti-GFP	 antibody.	 	 The	 staining	 showed	 that	 indeed	 Gata3	 and	GFP	 stained	 the	 same	 cells.	 However,	 the	 staining	 patterns	 were	 different	 in	those	cells,	as	Gata3	 is	 intranuclear	while	GFP	 is	extranuclear	 in	 the	cytoplasm	(Figure	3-1).	
In	 flow	 cytometry	 analysis,	 only	 cells	 from	embryos	 that	were	G3-GFP+	have	shown	a	definitive	spike	in	the	G3-GFP	region,	which	was	confirmed	by	RT-PCR	(Figure	3-2	and	data	not	shown).			
Figure	 3-1:	 A	 section	 from	 a	 G3-GFP+	 E11.5	 embryo	 showing	 the	 co-staining	
between	Gata3	(green)	and	GFP	(red).	(A)	merged	image,	(B)	antibody	to	GFP,	(C)	
antibody	 to	Gata3.	 (D-G)	Magnification	 of	 cells	 indicated	 by	 yellow	box	 in	 image	
showing	 the	 costaining	 between	 Gata3	 and	 GFP.	 Ao:	 dorsal	 aorta,	 AG:	 	 adrenal	
anlage,	SG:	sympathetic	ganglia,	DS:	dorsal	side,	VS:	ventral	side.		
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Figure	3-2:	FACS	analysis	showing	a	definitive	spike	in	the	GFP	region	in	the	AGM	
obtained	 from	 a	 G3-GFP	 E11.5	 embryo	 compared	 to	 unstained	 AGM	 sample	
obtained	from	a	wild-type	littermate.		
		 Using	 these	 markers,	 several	 populations	 that	 were	 G3-GFP+	 were	identified.	 It	 should	 be	 noted	 that	 all	 G3-GFP+	 cells	 at	 this	 stage	 are	 CD45-	(Figure	3-3).		G3-GFP+	cells	were	found	both	in	the	positive	and	negative	CD34,	PDGFRb,	and	P75	subfractions.	Most	of	the	GFP+	cells	at	this	stage	are	SNS	which	compromise	15%	of	the	total	GFP+	cells,	followed	by	mesenchymal	cells	(2.6%),	and	 lastly	 endothelial	 cells	 (1%).	 The	 rest	 of	 the	GFP+	 cells	 are	more	 likely	 to	belong	to	the	mesonephros	duct.	
G3-GFP+CD34+	 cells	 were	 designated	 as	 G3+ECs,	 G3-GFP+PDGFRb+	 as	mesenchymal	 cells	 (G3+MC),	 G3-GFP+P75+	 as	 SNS	 cells	 (G3+SNS),	 G3-GFP-CD34+	as	G3-EC,	and	G3-GFP-PDGFRb-	as	G3-MC.	
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Figure	3-3:	Flow	cytometry	analysis	of	G3-GFP+	samples	from	E11.5	AGMs,	stained	
for	 CD45,	 CD34,	 PDGFRb	 and	 P75.	 No	 Gata3-GFP	 was	 expressed	 in	 the	 HC	 (A).	
Three	populations	were	expressing	Gata3-GFP:	(B)	EC,	(C)	MC,	and	(D)	SNS.	
	
To	characterise	the	spatial	distribution	of	G3-GFP+	cells	within	the	AGM	region,	 embryo	 sections	of	G3-GFP+	E11.5	embryos	were	 stained	with	an	anti-GFP	antibody	in	combination	with	antibodies	to	tyrosine	hydroxylase	(Th),	a	rate	limiting	 enzyme	 for	 catecholamine	 synthesis	 that	 is	 expressed	 in	sympathoadrenal	cells;	CD34,	a	cell	surface	marker	for	endothelial	cells	in	order	to	 identify	 the	 location	 of	 HECs	 within	 the	 wall	 of	 the	 aorta;	 Runx1,	 a	transcription	 factor	 expressed	 in	 haemogenic	 endothelium	 cells;	 P75,	 a	 cell	surface	marker	for	SNS	cells;	and	PDGFRb,	a	marker	for	mesenchymal	cells.		Here	we	wanted	 determine	 the	 expression	 and	 overlap	 between	Gata3-GFP	 and	 the	
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different	cell	populations	of	 interest;	Th,	CD34,	and	PDGFRb,	P75	and	Runx1	in	more	detail	(Figures	3-4,	3-5,	3-6,	3-7,	3-8).			
Figure	3-4:	 (A)	section	 from	a	Gata3-GFP+	E11.5	embryo	stained	with	(B)	Gata3-
GFP	 (red),	 (C)	 Th	 (green)	 and	 (D)	 CD34	 (white).	 White	 arrows	 shows	 the	 co-
staining	between	Gata3	and	CD34.	(E-G)	Magnification	of	cells	 indicated	by	white	
arrow	in	 image	(A)	shows	the	co-staining	between	CD34	(G)	and	Gata3	(F).	 (H-I)	
Magnification	of	cells	 indicated	by	yellow	box	 in	 image	(A)	 shows	 the	co-staining	
between	 Gata3	 (I)	 and	 Th	 (J).Yellow	 arrow	 highlight	 the	 staining	 of	 Gata3	 in	
subaortic	 mesenchyme.	 .	 Ao:	 dorsal	 aorta,	 AG:	 	 adrenal	 anlage,	 SG:	 sympathetic	
ganglia,	DS:	dorsal	side,	VS:	ventral	side		
	 The	endothelial	cells	in	the	walls	of	the	dorsal	aorta	have	been	established	as	the	source	of	progenitors	and	the	first	definitive	HSCs.	Gata3	is	expressed	in	some	of	 those	 cells	 (Figure	 3-4	A,	 E-G).	 Gata3	 regulates	HSC	numbers	 through	catecholamine	production	and	 is	 thus	also	expressed	 in	SNS	cells	as	previously	observed	 (Fitch:	 2012	 Tsarovina:2004	 ,Moriguchi:2006	 )	 (Figure	 3-4	 A,	 H-J).	Gata3	 is	 also	 expressed	 in	 some	 cells	 of	 the	mesenchyme	ventral	 to	 the	dorsal	aorta,	 i.e.	 the	 sub-aortic	 mesenchyme	 region,	 highlighted	 by	 the	 yellow	 arrow	(Figure	3-4	A).			
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Figure	(3-4	A)	demonstrates	an	obvious	overlap	between	Th	and	Gata3	in	the	adrenal	anlage	region,	where	the	neural	crest	cells	differentiate	to	form	the	SNS.	However,	only	 few	cells	were	expressing	both	Gata3	and	CD34	among	the	CD34+	 cells	 that	 form	 the	 endothelial	 lining	 of	 the	 dorsal	 aorta,	 where	 HSCs	emerge	(Figure	3-4	A,	E-G).		
More	stainings	were	performed	to	determine	the	expression	and	overlap	between	 G3-GFP	 and	 the	 different	 cell	 populations	 of	 interest;	 Th,	 CD34,	PDGFRb,	P75	and	Runx1	in	more	detail.		
To	look	at	the	supportive	microenvironment	of	the	HSCs	(specifically	the	sub-aortic	mesenchyme),	sections	were	obtained	 from	E11.5	G3-GFP+	embryos	and	 stained	 for	 PDGFRb,	 CD34,	 Th	 and	 GFP.	 The	 staining	 showed	 a	subpopulation	 of	 the	 mesenchymal	 cells,	 PDGFRb+	 cells,	 that	 co-expressed	Gata3.	These	cells,	G3-GFP+PDGFRb+	were	CD34-	(Figure	3-4	B)	and	Th-	(Figure	3-5).	 	 PDGFRb,	 and	 Th	 showed	 to	 be	 mutually	 exclusive,	 with	 Gata3	 being	expressed	within	a	subpopulation	of	each	(Figure	3-4,	3-5,	3-6).	
	
Figure	3-5:	(A)	section	from	a	Gata3-GFP+	E11.5	embryo	stained	with	(B,F)	Gata3-
GFP	 (white),	 (C,G)	PDGFRb	 (red)	and	 (D,H)	CD34	 (green).	 (E-H)	Magnification	of	
cells	indicated	by	yellow	box	in	image	(A)	shows	the	co-staining	between	Gata3	and	
CD34,	Gata3	and	PDGFRb.	There	was	no	 co-staining	between	CD34	and	PDGFRb.	
Ao:	dorsal	aorta,	AG:		adrenal	anlage,	SG:	sympathetic	ganglia,	,	DS:	dorsal	side,	VS:	
ventral	side.	
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	Figure	3-6:	(A)	section	from	a	Gata3-GFP+	E11.5	embryo	stained	with	(B)	Gata3-
GFP	(white),	 (C)	Th	(green),	and	(D)	PDGFRb	(red).	Yellow	box	shows	co-staining	
between	Gata3	and	Th,	Gata3,	but	there	was	no	co-staining	between	PDGFRb	and	
Th.	Ao:	dorsal	aorta,	AG:		adrenal	anlage,	SG:	sympathetic	ganglia,	DS:	dorsal	side,	
VS:	ventral	side.		 To	further	investigate	the	co-staining	between	G3-GFP	and	Th-expressing	cells,	 especially	 since	 the	 overlap	 does	 not	 seem	 to	 be	 complete	 and	 may	represent	different	stages	 in	 the	maturation	of	neural	crest	cells	 to	SNS	cells,	a	marker	 for	 neural	 crest	 cells,	 P75	 (Ngfr),	 was	 used	 (Stemple	 and	 Anderson:	1992).	Neural	 crest	 cells,	 the	 precursors	 of	 sympathoadrenal	 neurons,	migrate	from	 the	 neural	 tube	 to	 the	 aorta,	 where	 they	 differentiate	 into	 the	sympathoadrenal	 cells.	 They	 continue	 to	 express	 P75	 throughout	 this	 entire	process	(Stemple	and	Anderson:	1992).	
The	 IHC	 stains	 confirm	 that	 P75	 expression	 persists	 through	 the	migration	of	these	cells	and	is	still	expressed	in	the	more	differentiated	cells	of	the	 SNS,	where	 it	 co-stains	with	both	G3-GFP	 and	Th	 (Figure	3-7).	All	 the	 SNS	cells	(Th+	cells),	including	G3-GFP+	cells	within	the	SNS,	express	p75.	Thus,	P75,	a	membrane	protein,	 can	be	used	as	a	marker	 for	SNS	cells	of	 the	AGM,	which	makes	it	possible	to	isolate	this	cell	population	by	flow	sorting.	
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	Figure	3-7:	(A)	section	from	a	Gata3-GFP+	E11.5	embryo	stained	with	(B,E)	Gata3-
GFP	(white),	(C,F)	Th	(red),	and	(D,G)	P75	(green).	The	yellow	box	highlights	one	of	
the	areas	where	there	is	co-staining	between	all	three	markers.	(E-G)	Magnification	
of	cells	indicated	by	yellow	box	in	image	(A).	All	Th	expressing	cells	are	Gata3+	and	
P75+.	 Ao:	 dorsal	 aorta,	 AG:	 	 adrenal	 anlage,	 SG:	 sympathetic	 ganglia,	 DS:	 dorsal	
side,	VS:	ventral	side.	Then,	we	wanted	to	confirm	if	Gata3	is	co-expressed	with	Runx1,	a	known	marker	 for	 haemogenic	 endothelium	 cells	 and	 haematopoietic	 clusters.	 CD34	was	also	included	to	mark	the	endothelium	(Figure	3-8).	Gata3,	CD34	and	Runx1	were	 co-expressed	 in	 some	 cells,	 in	 particular	 at	 the	 ventral	 side	 of	 the	dorsal	aorta,	marked	with	a	yellow	box.	 In	addition	to	that,	both	Runx1	and	Gata3	co-stained	some	cells	in	the	subaortic	mesenchyme	that	were	CD34-.	
Figure	3-8:	 (A)	section	 from	a	Gata3-GFP+	E11.5	embryo	stained	with	(B)	Gata3-
GFP	 (yellow),	 (C)	 CD34	 (Cyan	 blue),	 (D)	 and	 Runx1	 (purple).	 The	 yellow	 box	
highlights	one	of	 the	areas	where	 there	 is	 co-staining	between	all	 three	markers.	
(E-G)	Magnification	of	cells	indicated	by	yellow	box	in	image	(A).	Ao:	dorsal	aorta,	
AG:		adrenal	anlage,	SG:	sympathetic	ganglia,	DS:	dorsal	side,	VS:	ventral	side.	
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3-3-2	E10.5:	
To	 further	 investigate	 HECs,	 the	 expression	 of	 CD34	 and	 G3-GFP	 were	analysed	in	E10.5	AGMs,	at	which	point	these	cells,	in	contrast	to	E11.5,	are	more	numerous	 (Swiers:	 2013).	 The	 same	 populations	 of	 G3-GFP+	 cells	 were	identified	 (Figure	 3-9	 A,B).	 However,	 when	 we	 looked	 at	 the	 literature	 to	 see	how	 the	 HE	 cells	 were	 isolated,	 Ve-Cad	 was	 an	 established	 marker	 for	haemogenic	endothelium,	so	at	this	point	we	switched	to	Ve-Cad	as	a	marker	for	our	endothelial	 cell	population,	 especially	 since	 it	 gave	a	more	 robust	 signal	 in	flow	cytometry	(Figure	3-9	C).	 In	contrast	 to	E11.5,	around	3%	of	 the	total	G3-GFP+	 cells	 were	 mesenchymal	 cells,	 1.4%	 were	 SNS	 cells,	 2%	 were	haematopoietic	cells	(CD41/45),	and	3-4%	were	endothelial	cells,	the	rest	of	the	GFP+	cells	are	more	likely	to	be	a	part	of	the	developing	nephric	duct.	
Interestingly,	 looking	 at	 IHC,	 G3-GFP	 expression	 was	 higher	 in	 the	endothelium	at	this	stage	(Figure	3-9	B,	C).	What	was	even	more	intriguing	was	the	presence	of	a	transient	haematopoietic	population	(CD41/45+)	that	was	G3-GFP+	 and	 was	 present	 at	 E10.5	 but	 disappeared	 at	 E11.5	 (Figure	 3-9	 C).	 The	majority	of	these	cells	did	not	express	VE-Cad.	
To	test	whether	Gata3	expression	in	the	endothelium	marks	haemogenic	endothelial	cells,	we	employed	the	OP9	co-culture	system.	
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Figure	3-9:	 (A)	Flow	cytometry	analysis	of	G3-GFP	and	CD34	on	 cells	 from	E10.5	
AGMs.	GATA3	was	expressed	in	endothelial	cells.	(B)	section	from	a	G3-GFP+	E10.5	
embryo	stained	for	GFP	(red)	and	CD34	(green).	(C)	Flow	cytometry	analysis	of	G3-
GFP,	Ve-Cad	and	CD41/45	on	cells	from	E10.5	AGMs,	(D)	FMO	for	CD41/43/45	on	
BV421	and	(E)	FMO	for	Ve-Cad	on	PE-CY7.	FMO:	Fluorescence	minus	one.	
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3-4-	 The	 haemogenic	 endothelium	 activity	 is	 enriched	 in	 the	 G3+	
compartment:	
OP9	is	a	stromal	cell	 line	that	was	obtained	from	an	osteoporotic	OP/OP	mouse	calavaria	(Kodama:1994).	
These	 cells	 are	 used	widely	 in	 developmental	 biology	 as	 a	 tool	 as	 they	provide	 an	 easy,	 versatile	 and	 efficient	 culture	 system	 to	 support	 the	 growth,	differentiation	and	proliferation	of	haematopoietic	cells	from	different	sources	of	stem	cells	based	on	the	growth	factors	supplied.		
Cells	 were	 obtained	 from	 E9.5-E10.5	 G3-GFP	 embryos,	 since	 the	haemogenic	 endothelium	 activity	 is	 higher	 at	 that	 stage	 compared	with	 E11.5.	Cells	were	then	cultured	on	top	of	OP9	in	media	supplemented	with	IL7,	SCF	and	Flt3.	 Cells	 were	 harvested	 after	 3	 weeks	 and	 analysed	 using	 either	 flow	cytometry	analysis	or	CFU-C	assays	(Figure	3-10).	
Figure	 3-10:	 Schematic	 diagram	 for	 experimental	 approach	 for	 OP9	 co-culture.	
AGMs	are	dissected	 from	E9.5-E10.5	G3-GFP+	 embryos,	 and	made	 into	 single	 cell	
suspension.	Cells	are	then	sorted	into	four	populations,	and	plated	on	top	of	OP9	in	
conditions	 that	 support	 the	 production	 of	 haematopoietic	 progeny.	 Cells	 are	
collected	 after	 three	 weeks	 to	 be	 analysed	 by	 flow	 cytometry	 and	 plated	 in	
methylcellulose	for	CFU-C	assays.	
	
Colony	Forming	Unit-Cells	 (CFU-C)	 is	 an	 in-vitro	 culture	assay,	 aimed	at	identifying	 the	 haematopoietic	 potential	 of	 a	 tissue;	 i.e.	 the	 ability	 of	haematopoietic	progenitors	to	proliferate	and	differentiate,	as	detected	through	the	 formation	 of	 haematopoietic	 colonies	 in	 methylcellulose	 medium	 in	 the	
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presence	of	cytokines.	The	number	of	colonies	relates	to	the	frequency	of	these	cells	within	a	haematopoietic	tissue.		
Haematopoietic	progenitors	can	give	rise	to	different	types	of	identifiable	colonies	in	CFU-C	assays.	CFU-Mix	colonies	are	derived	from	the	most	immature	and	 stem	 cell-like	 multipotent	 progenitor	 and	 contain	 granulocytes,	macrophages	 and	 erythrocytes.	 Next,	 there	 are	 CFU-GM	 colonies,	 which	 are	derived	 from	more	mature	progenitors	 than	CFU-Mix	and	contain	granulocytes	and	 macrophages	 only.	 CFU-G	 colonies	 are	 derived	 from	 the	 precursors	 for	granulocytes,	 CFU-M	 from	 the	 precursors	 for	macrophages	 and	 BFU-E	 are	 the	burst-forming	unit	for	erythrocytes.	
Initially,	 we	 sorted	 the	 AGM	 cells	 into	 4	 populations:	 G3+EC:	 GFP+Ve-Cad+CD41/45-,	G3-EC:	GFP-Ve-Cad+CD41/45-,	and	used	Mesenchymal	and	SNS	cells	 (GFP+Ve-Cad-CD41/45-)	 for	negative	 control	 and	CD45+	cells	 for	positive	control.	 We	 plated	 1000	 cells	 per	 well	 and	 the	 following	 CFU-C	 readout	 was	obtained	(Figure	3-11).	The	G3+EC	output	was	five	fold	higher	than	that	of	G3-EC.	 As	 expected,	 the	 highest	 colony	 count	 came	 from	 the	 haematopoietic	 cells,	which	 served	 as	 our	 positive	 control	 here,	 and	 no	 colonies	 grew	 from	 the	MC/SNS	compartment,	which	served	as	a	negative	control	in	this	experiment.		
Then,	 given	 that	 1000	 cells	 from	 G3+EC	 population	 were	 about	 8-12	embryo	 equivalent	 (ee),	 depending	 on	 the	 embryonic	 age	 and	 the	 variation	 of	G3+EC	count	 in	each	embryonic	stage	E9.5-E10.5,	whereas	1000	cells	 from	G3-EC	were	 less	than	0.5	ee,	we	changed	our	strategy	to	make	 it	more	biologically	representative.	However,	plating	less	than	a	1000	cells	of	G3+EC	did	not	give	any	read-out.	
	
Figure	3-11:	CFU-C	assay	representing	the	progenitor	counts	of	G3+EC,	G3-EC,	HC	
and	MC/SNS	cells	plated	into	methylcellulose	after	OP9	co-culture.	n=1.	
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So	we	choose	to	plate	1000	cells	of	G3+EC	and	their	ee	of	G3-EC.	Here	we	introduced	 a	 new	 sorting	 strategy	 to	 also	 include	G3+HC	 in	order	 to	 test	 their	haematopoietic	 potential.	 The	 new	 sorting	 strategy	 was:	 G3+EC:	 GFP+Ve-Cad+CD41/45-,	G3-EC:	GFP-Ve-Cad+CD41/45-,	G3+HC:	GFP+CD41/45+,	and	G3-HC:	GFP-CD41/45+	(Figure	3-12).	At	the	end	of	the	co-culture,	we	analysed	the	harvested	cells	using	flow	cytometry	and	CFU-C	assays	(Figure	3-13	and	3-14).		
The	 haematopoietic	 potential	 in	 the	 G3+	 endothelial	 compartment	 was	significantly	higher	 than	 that	 of	 the	G3-EC	as	was	 revealed	by	both	CFU-C	 and	flow	cytometry	analysis.	
	
Figure	3-12:	 Sorting	Strategy	 for	 the	OP9	 co-culture:	 combining	GFP,	Ve-Cad	 (on	
PE	Cy7),	CD41/45	(BV421)	has	enabled	us	to	sort	four	distinct	populations	from	the	
AGM.	Gating	strategy	of	representative	AGM	sample	on	a	BD	ARIA	sorter	operating	
on	BD	FACSDIVA	Software.	P1:	Morphology	gate,	P2:	single	cells,	P3:	Live	cells,	P4:	
CD41/45-	cells,	P5:	CD41/45+	cells,	P6:	G3-EC:	CD41/45-GFP-Ve-Cad+,	P7:	G3+EC:	
CD41/45-GFP+Ve-Cad+,	 P8:	 G3-HC:	 CD41/45+GFP-,	 and	 P9:	 G3+HC:	
CD41/45+GFP+		
In	the	flow	cytometry	analysis,	both	G3+EC	and	G3-EC	were	shown	to	be	able	 to	 produce	 haematopoietic	 progeny	 (CD45+	 cells)	 that	 expressed	mature	myeloid	 markers	 (CD11b	 and	 Gr1),	 although	 the	 haematopoietic	 output	 from	G3+EC	was	more	robust	(Figure	3-13).	
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The	 CFU-C	 results	 were	 consistent	 with	 those	 of	 the	 flow	 cytometry	analysis,	 and	 G3+EC	 produced	 significantly	 higher	 numbers	 of	 colonies	 in	contrast	to	G3-EC	(Figure	3-14).	
It	should	be	noted	here,	while	the	plating	of	the	OP9	co-culture	was	based	on	ee	count,	the	amount	of	cells	of	the	G3-EC	were	consistently	higher	by	a	factor	of	ten	than	G3+ECs.	
	
Figure	 3-13:	 (A)	 FACS	 analysis	 of	 the	 haematopoietic	 progeny	 produced	 by	 both	
G3+EC	and	G3-EC	after	OP9	 co-culture.	 CD45	marks	all	 the	haematopoietic	 cells,	
CD11b	and	Gr1	mark	 cells	 of	 the	myeloid	 lineage.	 (B)	Total	 percentage	 of	 CD45,	
CD11b	and	Gr1	cells	in	FACS	analysis	represented	by	bar	graph.	Statistical	analysis	
were	done	using	two-way	ANOVA,	n=4.		
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Figure	3-14:	CFU-C	assay	representing	the	progenitor	counts	of	G3+EC	and	G3-EC	
after	OP9	co-culture.	Statistical	analysis	were	done	using	paired	t	test,	n=4.	
	
3-5-	 G3+	 progenitors	 are	 enriched	 for	 CFU-Mix	 potential,	 the	most	
immature	and	stem	cell-like	progenitor:	
To	 further	 investigate	 the	 haematopoietic	 potential	 of	 the	 previously	identified	 G3+	 haematopoietic	 cells	 (3-3),	 we	 collected	 those	 cells,	 along	 with	their	G3-HC	counterparts	and	cultured	them	on	OP9	cells	as	above.	
Flow	 cytometry	 analysis	 revealed	 that	 both	 G3+HC	 and	 G3-HC	 can	produce	haematopoietic	progeny	(Figure	3-15	A,B).	It	also	should	be	noted	here	that	 the	 G3+HC	 population	 comprised	 0.5-1.5%	 of	 the	 present	 total	haematopoietic	population	in	the	AGM,	whereas	G3-HC	make	up	the	rest	of	that	population.	
Intriguingly,	while	G3-HC	produced	over	5x	the	colonies	that	 the	G3+HC	produced,	 the	 colonies	 that	 were	 generated	 were	mostly	 CFU-M,	 CFU-GM	 and	some	CFU-Mix	(Figure	3-15	C-F).	However,	around	90%	of	the	colonies	produced	by	 G3+HC	were	 CFU-Mix	 colonies,	 generated	 by	 the	most	 immature	 and	 stem	cell-like	progenitor	(Figure	3-15	C-G).	
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Figure	 3-15:	 G3+	 progenitors	 are	 enriched	 for	 CFU-Mix	 potential,	 the	 most	
immature	and	stem	cell	like	progenitor:	G3+HC	and	G3-HC	were	sorted	from	E9.5-
10.5	G3-GFP	embryos	and	cultured	on	OP9	cells	as	ee.	(A)	Flow	cytometry	analysis	
of	 the	haematopoietic	progeny	produced	by	both	G3+HC	and	G3-HC.	CD45	marks	
all	 the	haematopoietic	 cells,	CD11b	and	Gr1	mark	mature	myeloid	 cells.(B)	Total	
percentage	 of	 CD45,	 CD11b	 and	 Gr1	 cells	 in	 FACS	 analysis	 represented	 by	 bar	
graph	(D-F):	CFU-C	assay	representing	the	progenitor	counts	of	G3+HC	and	G3-HC	
after	OP9	co-culture;	(B)	represents	the	total	count	of	progenitors.	Separate	panels	
show	 bar	 graphs	 representing	 different	 types	 of	 colonies	 produced	 in	 the	 CFU-C	
assay	where	(D)	CFU-M,	(E)	CFU-GM,	and	(F)	CFU-Mix.	(G):	picture	of	CFU-C	plates,	
showing	a	higher	number	of	CFU-Mix	colonies,	marked	by	arrows,	produced	by	the	
G3+HC	in	contrast	to	G3-HC.	Statistical	analysis	were	done	using	two-way	ANOVA	
for	B	and	C,	and	paired	t-test	for	D-F.		n=3,***:	P=	0.0003,	****:	P	<	0.0001	
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3-6-	 Haematopoietic	 progenitors	 are	 restricted	 to	 the	 G3-HC	
compartment:	
We	 then	 wanted	 to	 determine	 the	 origin	 of	 both	 G3+HC	 and	 G3-HC,	 so	 we	performed	CFU-Cs	with	directly	sorted	cells	from	G3-GFP	E10.5	AGMs	(Figure	3-12).	Interestingly,	the	only	population	that	produced	haematopoietic	progenitors	was	the	G3-HC,	while	G3+HC	did	not	produce	any,	indicating	either	the	absence	of	 haematopoietic	 progenitors	 in	 this	 compartment,	 or	 that	 the	 frequency	 of	haematopoietic	progenitors	in	the	sorted	cells	is	too	low	to	give	a	read-out	at	this	point.	As	expected,	neither	endothelial	population	(G3+EC	and	G3-EC)	produced	any	colonies	when	plated	directly	in	methylcellulose	(Figure	3-16).	
	
	
Figure	 3-16:	 CFU-C	 assay	 representing	 the	 progenitor	 counts	 of	 freshly	 sorted	
G3+EC,	 G3-EC,	 G3+HC	 and	 G3-HC	 that	 were	 directly	 plated	 uncultured	 into	
methylcellulose.	 The	 only	 population	 that	 was	 able	 to	 generate	 colonies	 directly	
was	that	of	G3-HC.	n=1.	
	
3-7-	 G3	 marks	 specific	 stages	 along	 the	 developmental	 pathway	
towards	the	generation	of	dHSCs:	
As	our	results	suggested	that	Gata3	is	expressed	in	haemogenic	cells,	we	wanted	to	determine	more	precisely	the	type	of	HSC	precursor	that	is	marked	by	Gata3.	The	OP9	co-aggregates	is	a	system	developed	by	Rybtsov	et	al	(2011)	to	support	 the	maturation	of	pre-HSCs	 into	definitive	HSCs	 in	culture.	The	system	co-aggregates	 sorted	 cells	 from	 the	AGMs	with	OP9	 stromal	 cells	 in	 conditions	
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that	favour	the	maturation	of	pre-HSCs	into	definitive	HSCs.	In	contrast	to	AGM	explants,	 this	 system	 allows	 more	 cell	 manipulation	 and	 further	 support.	Moreover,	additional	studies	by	the	authors	have	demonstrated	the	superiority	of	 OP9	 cell	 co-aggregates	 to	 AGM	 re-aggregates	 in	 terms	 of	 supporting	 HSCs	production.	Most	importantly,	based	on	the	developmental	stage	and	specific	cell	surface	markers,	distinct	steps	in	HSC	maturation	can	be	distinguished	(Rybtsov:	2011;	2014).	
AGMs	were	 obtained	 from	 E9.5-10.5	 and	 E11.5	 G3-GFP	 embryos,	made	into	 single	 cell	 suspensions	 and	 sorted	 into	 four	 populations	 (G3+EC,	 G3-EC,	G3+HC	and	G3-HC;	Figure	3-17,	3-18).	We	changed	the	sorting	strategy	here	and	added	two	more	markers:	Ter119	a	marker	for	erythrocytes	(exclusion	marker)	and	CD43	which	is	another	marker	for	Pre-HSCs	(Figure	3-18).		Cells	are	then	co-aggregated	with	OP9	stromal	cells	in	media	supplemented	with	Flt3,	IL6	and	SCF,	which	 are	 conditions	 that	 are	 known	 to	 promote	 pre-HSC	 maturation.	 Co-aggregates	are	then	harvested	and	either	transplanted	into	irradiated	recipients,	plated	 into	methylcellulose	 for	CFU-C	assays,	or	analysed	using	 flow	cytometry	(Figure	3-17).		
Figure	3-17:	Schematic	diagram	for	experimental	approach	for	OP9	co-aggregates.	
AGMs	are	dissected	 from	E9.5-E10.5	and	E11.5	G3-GFP+	embryos,	 and	made	 into	
single	 cell	 suspension.	 Cells	 are	 then	 sorted	 into	 four	 populations,	 co-aggregated	
with	 OP9	 cells	 and	 the	 aggregates	 cultured	 in	 conditions	 that	 favour	 HSC	
production.	 Cells	 are	 collected	 after	 4	 days	 to	 be	 transplanted,	 analysed	 by	 flow	
cytometry,	or	plated	in	methylcellulose	for	CFU-C.	
	 We	 looked	 for	 the	 presence	 of	 haematopoietic	 cells	 by	 flow	 cytometry	analysis	after	co-aggregations.	The	results	were	mostly	consistent	with	those	of	
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the	 CFU-C	 assays,	 referring	 to	 section	 3-6,	 however,	 it	 revealed	 that	 the	 G3+	compartments	 tended	 to	 generate	 a	 higher	 percentage	 of	 haematopoietic	 cells	(Figure	3-19	A).	
Figure	3-18:	Sorting	Strategy	 for	 the	OP9	co-aggregates:	combining	Ter119,	GFP,	
Ve-Cad,	CD41/43/45	has	enabled	us	to	sort	four	distinct	populations	from	the	AGM.	
Gating	 strategy	of	 representative	AGM	sample	on	a	BD	ARIA	 sorter	operating	on	
BD	 FACSDIVA	 Software	where;	 P1:	morphology,	 P2:	 single	 cells,	 P3:	 Ter119-	 live	
cells,	 P4:	 Ter119-Ve-Cad+CD41/43/45-,	 P5:	 Ter119-CD41/43/45+,	 P6:	 G3-EC:	
Ter119-Ve-Cad+GFP-CD41/43/45-,	P7:	G3+EC:	Ter119-Ve-Cad+GFP+CD41/43/45-,	
P8:	 G3-HC:	 Ter119-Ve-cad+/-GFP-CD41/43/45+,	 and	 P9	 :G3+HC:	 Ter119-Ve-
Cad+/-GFP+CD41/43/45+.	
	
In	 CFU-C	 assays	 after	 the	 co-aggregation,	 the	 G3-HC	 progenitor	 counts	have	 increased	by	a	 two	 fold	change	 in	contrast	 to	G3-HC	after	 the	plating	of	a	fresh	 sorted	 cells	 (3-16).	 Interestingly,	 the	 G3+HC	 have	 actually	 expanded	 to	comparable	 levels	 to	 that	 of	 G3-HC.	 Both	 G3+EC	 and	 G3-EC	 produced	 a	 small	number	of	colonies	with	the	G3-EC	being	the	lower	of	the	two	(Figure	3-19	B).	
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In	transplantation	assays,	only	two	mice	highly	repopulated	in	the	G3+HC	compartment	 for	 cells	 obtained	 from	 E9-5-E10.5	 AGMs	 at	 the	 one-month	analysis.	However,	before	the	four-month	bleed	and	flow	cytometry	analysis,	one	of	 those	 two	mice	died.	The	arrow	denotes	 the	 flow	cytometry	 result	obtained	after	1	month	following	the	transplantation.	However,	given	its	high	levels,	 it	 is	highly	 likely	 that	 this	 mouse	 would	 have	 remained	 highly	 repopulated	 in	 the	ensuing	three	months	(Figure	3-20	A).	
	
		 	
Figure	3-19:	(A)	Flow	cytometry	analysis	of	the	haematopoietic	progeny	produced	
by	 G3+EC,	 G3-EC	 G3+HC	 and	 G3-HC	 obtained	 from	 E9.5-E10.5	 G3-GFP	 embryos	
after	OP9	co-aggregates.	CD45	marks	all	the	haematopoietic	cells,	CD11b	and	Gr1	
mark	 cells	 of	 the	myeloid	 lineage.	 (B)	Total	 percentage	 of	 CD45,	 CD11b	and	Gr1	
cells	 in	FACS	analysis	represented	by	bar	graph	(C)	CFU-C	assay	representing	the	
progenitor	counts	of	G3+EC,	G3-EC,	G3+HC	and	G3-HC	plated	into	methylcellulose	
after	co-aggregate	culture.	n=1	
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We	also	performed	transplantation	assays	after	co-aggregates	 from	cells	obtained	from	E11.5	AGMs.	Interestingly,	at	this	stage,	 the	only	population	that	had	repopulated	 the	 irradiated	recipients	was	 that	of	G3-HC,	where	 three	mice	repopulated	(Figure	3-20	B).	
Figure	 3-20:	 (A)	 Chimerism	 levels	 in	 transplanted	 animals	 from	 sorted	 cells	
(G3+EC,	G3-EC,	G3+HC	and	G3-HC)	obtained	from	E9.5-E10.5	G3-GFP	AGMs	and	co-
aggregated	 with	 OP9-cells.	 Horizontal	 solid	 line	 represents	 the	 mean,	 and	 the	
arrow	 represents	 the	 1	 month	 result	 for	 one	 mouse.	 (B)	 Chimerism	 levels	 in	
transplanted	animals	from	sorted	cells	(G3+EC,	G3-EC,	G3+HC	and	G3-HC)	obtained	
from	E11.5	G3-GFP	AGMs	and	co-aggregated	with	OP9-cells	in	ee.	Horizontal	solid	
line	 represents	 the	mean.	Chimerism	of	5%	or	higher	was	 set	as	 the	 threshold	at	
which	mice	are	considered	positive	for	repopulation.	E9.5-10.5	n=	28,	E11.5	n=	18.	
	
3-8-Discussion:	
Flow	 cytometry	 analysis	 showed	 that	 G3-GFP	 is	 expressed	 in	 CD34+	endothelial	 cells,	 p75+	 SNS	 cells	 and	 PDGFRb+	 mesenchymal	 cells	 at	 E11.5	within	the	AGM	region	of	the	embryo.	However,	 it	was	not	expressed	in	CD45+	haematopoietic	cells	at	 that	stage.	This	 indicates	 that	Gata3	 is	not	expressed	 in	haematopoietic	 cells	of	 the	AGM	region,	 including	HSCs.	This	 corresponds	with	what	was	suggested	before	by	Fitch	et	al.	(2012)	and	implicates	Gata3	as	a	factor	influencing	the	haematopoietic	environment.		
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Interestingly,	 Gata3	was	 expressed	within	 a	 subgroup	 of	 hematopoietic	cells	 at	 E10.5.	 This	 population	 proved	 to	 be	 a	 transient	 population,	 starting	 to	appear	 at	 late	 E9,	 with	 its	 highest	 levels	 at	 E10.5	 and	 declining	 the	 older	 the	embryo	gets	until	it	finally	disappears	at	E11.5.	This	corresponds	with	what	was	reported	 before	 by	 Swiers	 et	 al.	 (2013),	 and	 suggests	 a	 role	 for	 Gata3	 in	haematopoietic	progenitor	development.			
The	flow	cytometry	analysis	and	IHC	staining	has	also	revealed	that	Gata3	is	 expressed	 in	 a	 subpopulation	 of	mesenchymal	 cells	 (Figure	 3-2,	 3-4	 B,C,E,).	Other	 key	 regulators	 of	 HSCs	 are	 also	 expressed	 in	 the	 mesenchyme	 such	 as	Runx1	 (North:	 1999)	 and	 Bmp4	 (Durand:	 2007).	 However,	 the	 identity	 and	function	of	these	cells	is	still	unknown.	The	G3-GFP	mouse	line	now	presents	me	with	a	tool	to	isolate	and	further	characterise	these	mesenchymal	cells.	
Gata3	 is	 expressed	 in	 a	 subgroup	of	 endothelial	 cells,	where	 it	 co-stains	with	Runx1.		It	has	been	reported	that	Gata3	expression	is	elevated	in	HE,	along	with	 other	 transcription	 factors	 that	 have	 been	 associated	 with	 early	specification	of	the	haematopoietic	system	such	as	Gata2,	Meis1	and	Runx1.	This	upregulation	was	obvious	from	E8.5	(Swiers:	2013).	Gata3	expression	was	found	in	 endothelial	 cells	 in	 flow	 cytometry	 analysis	 at	 E10.5	which	 is	 followed	by	 a	rapid	 reduction	 the	 older	 the	 embryos	 get	 (Figure	 3-2,	 3-4	 A,C).	 This	 timeline	also	 corresponds	 with	 the	 function	 of	 haemogenic	 endothelium	 and	 HSC	 and	progenitor	generation.		
To	 examine	 the	 spatial	 distribution	 of	 the	G3-GFP+CD34+	population	 in	the	 walls	 of	 the	 dorsal	 aorta,	 IHC	 on	 G3-GFP-expressing	 embryo	 sections	 was	performed.	 Few	Gata3-GFP+	 cells	were	 found	within	 the	 endothelial	 layer	 that	forms	 the	walls	 of	 the	 dorsal	 aorta	within	 the	 AGM	 region	 at	 E11.5.	 This	was	consistent	with	 the	AGM	being	considered	one	of	 the	haemogenic	endothelium	sites,	 where	 Gata3	 is	 upregulated	 in	 the	 AGM	 at	 the	 time	 of	 HSC	 emergence	(Mascarenhas:	 2009)	 and	 Gata3	 was	 reported	 to	 be	 enriched	 in	 HE	 (Swiers:	2013).	 Its	 upregulation	 seems	 to	 start	 already	 at	 E8.5	 at	 the	 time	 of	haematopoietic	specification	in	HE	(Swiers:	2013).	Together,	these	data	suggest	
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that	 Gata3	 plays	 an	 additional	 role	 in	 HSC	 development	 independent	 of	 its	expression	in	the	SNS	(Fitch:	2012).			
G3-GFP	is	also	expressed	in	SNS	cells,	identified	here	by	flow	cytometry	as	G3-GFP+P75+	 cells,	 in	 the	 AGM.	 Immunohistochemistry	 on	 G3-GFP	 E11.5	embryo	 sections	 showed	 that	Gata3	expression	overlapped	with	Th	 staining	 in	the	SNS	cells	surrounding	the	AGM	region	(Figure	3-4	A,H,I,J),	and	that	staining	overlapped	with	P75,	indicating	that	P75	can	act	as	a	membrane	marker	to	FACS	sort	SNS	cells	more	directly	(Figure	3-7	A-G).			
Gata3	 is	 a	 member	 of	 a	 transcription	 factor	 network	 that	 controls	sympathetic	 neuron	 development	 from	 their	 precursors	 in	 the	 neural	 crest.	 In	fact,	 Gata3	 is	 essential	 for	 the	 generation	 and	 differentiation	 of	 sympathetic	neurons	 and	 the	 production	 of	 catecholamines	 (Tsarovina:	 2010).	 It	 was	previously	reported	that	Gata3’s	role	in	HSC	development	is	secondary	to	its	role	in	the	SNS;	i.e.	Gata3	influences	HSC	through	the	SNS	and	catecholamine	release	(Fitch:	2012).	However,	the	findings	presented	here	suggest	that	Gata3	may	also	impact	on	HSC	development	through	its	expression	in	HE,	MCs	and	HCs.	
In	 OP9	 co-cultures,	 supplemented	 with	 factors	 that	 support	 HSPC	generation,	 G3+EC	 and	 G3-EC	 obtained	 from	 the	 AGM	 of	 E9.5-E10.5	 G3-GFP	embryos	 gave	 rise	 to	 haematopoietic	 progeny,	 including	mature	myeloid	 cells.	This	confirms	the	presence	of	HE	cells	within	the	AGM	region	of	embryos	which	was	 reported	 previously	 (Boisset:	 2010,	 Bertrand	 2010,	 Kissa	 2010,	 Swiers:	2013).	 	However,	 a	 single	 cell	OP9	co-culture	would	 still	 be	needed	 to	 confirm	that.		
Here	 we	 have	 shown	 that	 G3+EC	 are	 haemogenic,	 and	 that	 G3+EC	haemogenic	potential	is	more	robust	than	that	of	G3-EC,	which	corresponds	with	our	previous	findings	from	IHC	of	Gata3	being	co-expressed	with	both	Runx1	and	CD34	in	the	walls	of	the	dorsal	aorta.	
In	 addition,	 here	 we	 have	 shown	 that	 G3+HC	 not	 only	 are	 capable	 of	generating	robust	haematopoietic	progeny	in	OP9	co-cultures,	but	also	that	they	mainly	 generate	 CFU-C	Mix	 in	 CFU-C	 assays,	 the	most	 immature	 stem-cell	 like	
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colony.	Therefore,	we	wanted	investigate	these	cells	in	more	detail	and	identify	their	place	within	the	HSC	developmental	hierarchy.	
We	performed	CFU-Cs	directly	for	our	sorted	populations,	which	revealed	that	 the	 G3+HC	 could	 not	 produce	 progenitors	 when	 plated	 directly	 into	methylcellulose,	unlike	G3-HC.	We	then	performed	OP9	co-aggregates	which	is	a	method	that	was	optimised	to	facilitate	the	maturation	of	pre-HSCs	into	dHSCs.	After	the	co-aggregates,	G3+HC	produced	colonies	that	were	one	fold	higher	than	those	 produced	 by	G3-HC	prior	 to	 the	 co-aggregates	 (their	 levels	were	 similar	after	the	co-aggregates),	and	was	able	to	produce	more	haematopoietic	cells	(as	shown	by	flow	cytometry)	than	those	produced	by	G3-HC.	Furthermore,	the	only	population	of	AGMs	obtained	from	E9.5-E10.5	G3-GFP	embryos	that	repopulated	irradiated	recipient	mice	was	that	of	G3+HC.		
All	 of	 that	 suggests	 that	 the	G3+HC	could	 contain	a	pre-HSC	population,	corresponding	to	the	ones	described	by	Rybtsov	et	al	(2011,	2014).	However,	as	all	haematopoietic	markers	(CD41/43/45)	were	combined	in	a	single	colour,	we	do	not	currently	know	if	it	is	type	I	or	II,	or	if	it	is	even	pro-HSCs.	
We	 also	wanted	 to	 confirm	 that	HSCs	 are	 not	 in	 the	 G3+,	 as	 previously	suggested	(Fitch:	2012).	We	therefore	sorted	AGMs	from	E11.5	G3-GFP	embryos	into	two	populations:	GFP+	and	GFP-	in	order	to	minimise	the	cell	loss.	We	tried	injecting	mice	with	1ee,	2	ee,	3	ee	and	4	ee.	However,	there	was	no	repopulation	from	either	 compartment,	 suggesting	 technical	 problems	 in	 the	 assay,	 possibly	due	to	low	HSC	numbers	in	the	AGMs	as	they	were	haploinsufficient	(due	to	the	GFP	 knockin).	 Reduced	 HSC	 numbers	 in	 Gata3	 heterozygous	 AGMs	 were	previously	demonstrated	(Fitch:2012).	
To	circumvent	this	problem,	we	used	the	co-aggregate	system	for	our	four	populations	obtained	 from	E11.5	G3-GFP	AGMs.	 Interestingly,	unlike	E10.5,	 the	only	 group	 that	 showed	 repopulation	 was	 that	 of	 G3-HC.	 This	 suggests	 the	presence	 of	 dHSCs	 in	 that	 compartment,	 which	 corresponds	 with	 what	 was	reported	before	by	Fitch	et	al	(2012)	that	Gata3	is	not	expressed	in	dHSCs	in	the	AGM.		
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The	 fact	 that	 there	 were	 only	 low	 numbers	 of	 haematopoietic	 progeny	produced	by	either	G3+EC	or	G3-EC	in	the	co-aggregate	system,	even	though	this	is	similar	to	co-cultures	to	some	extent	in	terms	of	growth	factors	and	OP9	cells,	could	be	contributed	to	the	duration	of	the	co-aggregates	(4	days)	and	that	there	is	 not	 sufficient	 time	 for	 the	 EHT	 to	 take	 place,	 compared	 to	 that	 of	 OP9	 co-cultures	(3	weeks).	
In	the	next	chapter,	we	will	focus	more	on	the	HE	and	Gata3	and	whether	Gata3	 actually	 performs	 a	 functional	 role	 in	 the	 HE.	 We	 will	 investigate	 the	conditional	deletion	of	Gata3	from	the	endothelium	and	the	effect	it	has	on	HSCs	and	progenitors.		
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4-	GATA3	plays	an	important	role	in	the	haemogenic	endothelium	
	
4-1-	Background:	
Gata3	 was	 previously	 reported	 to	 be	 expressed	 in	 endothelial	 cells,	mesenchymal	 cells	 (Manaia:	 2000)	 and	 sympathoadrenal	 cells	within	 the	AGM	region	 (Fitch:	 2012)	 and	 has	 subsequently	 been	 shown	 to	 be	 enriched	 in	haemogenic	endothelial	cells	and	is	expressed	in	haematopoietic	progenitor	cells	(Swiers	2013).	This	was	also	confirmed	using	our	Gata3-GFP	reporter	mouse	line	in	chapter	3.	
It	was	established	that	Gata3	regulates	HSC	and	progenitor	production	by	means	 of	 the	 SNS	 (Fitch:	 2012).	 However,	 its	 function	 in	 the	 other	 cell	populations	is	still	to	be	investigated.	
Previously,	 it	was	 reported	by	 the	Ottersbach	group	 that	Gata3	 deletion	causes	 a	 significant	 reduction	 in	HSCs	and	CFU-S	progenitor	 cells	 in	E11.5	and	E10.5	 AGMs.	 When	 AGMs	 from	 E11-E11.5	 embryos	 of	 wild-type	 embryos	(G3+/+),	Gata3	heterozygous	embryos	(G3+/-),	and	total	knockout	embryos	(G3-/-),	 were	 transplanted	 into	 irradiated	 recipients,	 there	 was	 a	 noticeable	reduction	in	the	repopulating	ability	of	both	G3+/-	and	G3-/-	AGMs.	Around	60%	of	G3+/+	embryos	showed	a	donor	contribution,	compared	to	17%	in	G3+/-	and	14%	in	G3-/-.		Interestingly,	when	adding	an	explant	step	prior	to	the	transplant,	the	repopulating	ability	of	G3+/-	AGMs	was	restored	to	that	of	a	G3+/+;	however,	the	observed	reduction	persisted	in	G3-/-	AGMs.	The	effect	of	Gata3	deletion	on	more	mature	haematopoietic	progenitor	cells	is	yet	to	be	investigated.	
The	 findings	described	above	had	all	been	made	using	germline	deleted	Gata3	embryos,	 and	 the	haematopoietic	phenotype	had	been	 largely	attributed	to	 the	 failure	 of	 the	 defective	 SNS	 to	 secrete	 catecholamines	 (Fitch:	 2012).	However,	 given	 that	 HSCs	 and	 progenitors	 emerge	 from	 vascular	 endothelial	cells	 through	 the	 formation	 of	 intra-aortic	 clusters	 (Jaffredo:	 1998),	 and	 that	Gata3	is	expressed	within	those	cells	at	the	time	of	haemogenic	activity	of	those	
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cells,	 it	 is	 possible	 that	 the	 haematopoietic	 defect	 is	 caused	 by	 the	 absence	 of	Gata3	 in	more	than	one	cell	 type.	We,	 therefore,	wanted	to	 look	at	 the	effect	of	the	 conditional	 deletion	 of	 Gata3	 from	 the	 vascular	 endothelium	 on	 HSC	 and	progenitor	formation,	using	Vec-Cre-mediated	deletion	(Chen:	2009).		
Vec	 is	 a	 transmembrane	 protein	 that	 is	 involved	 in	 endothelial	 cell	adhesion	 (Lampugnani:	 1995)	 and,	 from	 E9.5,	 it	 is	 expressed	 in	 the	 vascular	endothelium	 throughout	 the	 embryo	 (Drake:	 2000),	 and	 also	 marks	haematopoietic	cells	at	that	stage	(North:	2002;	Taoudi:	2004).	This	expression	pattern	 persists	 at	 later	 developmental	 stages,	 and	 Vec	 has	 been	 reported	 to	mark	 haemogenic	 endothelial	 cells,	 pre-HSCs	 and	 definitive	HSCs	 at	 E10.5	 and	E11.5	 (Ivanovs:	 2014;	 North:	 2002;	 Taoudi:	 2005;	 Rybtsov:	 2011;	 Rybtsov:	2013).	
Using	 a	 Vec-Cre	 transgenic	 mouse	 line	 (Chen:	 2009)	 we	 were	 able	 to	excise	Gata3	from	the	endothelium	and	investigate	the	effect	of	that	deletion	on	HSC	and	haematopoietic	progenitor	generation.		
	
4-2-	Aims:	
- Investigate	 the	 effect	 of	 Gata3	 deletion	 on	 haematopoietic	progenitors	- Identify	 the	 effect	 of	 the	 conditional	 deletion	 of	 Gata3	 from	endothelium	on	haematopoietic	progenitors	- Identify	 the	 effect	 of	 the	 conditional	 deletion	 of	 Gata3	 from	endothelium	on	haematopoietic	repopulation	
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4-3-	Gata3	deletion	causes	a	reduction	in	haematopoietic	progenitor	
cell	counts	in	E10.5	and	E11.5	AGMs	in	a	dose-dependent	manner:	
Our	 group	 has	 previously	 reported	 a	 requirement	 for	 Gata3	 in	 HSC	production	 in	 the	 AGM	 (Fitch:	 2012);	 however,	 its	 role	 in	 haematopoietic	progenitors	 in	 the	 AGM	 was	 unknown.	 As	 we	 had	 detected	 Gata3-GFP+	haematopoietic	cells	 in	 the	E10.5	AGM	(Figure	3-5C),	we	wanted	 to	 investigate	whether	Gata3	deletion	has	an	effect	on	HSPCs.	AGMs	were	collected	from	Gata3	wild-type	 (G3+/+),	 Gata3	 heterozygous	 (G3+/-),	 and	 total	 knockout	 embryos	(G3-/-),	 dissociated	 and	 plated	 in	 methylcellulose.	 In	 some	 cases,	 AGMs	 were	placed	 into	 explant	 culture	 prior	 to	 plating	 in	methylcellulose	medium,	 as	 this	had	previously	been	shown	to	rescue	HSC	numbers	in	G3+/-	AGMs	(Fitch:	2012)	(Figure	4-1).	The	number	and	types	of	colonies	were	scored	after	7	days	for	each	genotype	and	compared	 to	 the	control	condition;	 i.e.	 the	wild-type	genotype.	 It	should	be	noted	here	that	some	of	the	knockout	embryos	were	smaller	in	size	in	contrast	to	their	wild-type	and	heterozygous	littermates.	However,	as	they	were	harder	to	obtain,	only	one	knockout	embryo	would	survive	 in	every	2-3	 litters,	those	smaller	embryos	were	used.	
Figure	 4-1:	 Representative	 schematic	 of	 the	 experimental	 design	 of	 the	 CFU-C	
assay.	AGMs	are	dissected	 from	E10.5	or	E11.5	G3+/+,	G3+/-,	G3-/-	 embryos,	and	
either	dissociated	and	plated	 into	methylcellulose	medium	directly,	or	cultured	 in	
explant	 cultures	 at	 the	 air/liquid	 interface,	 before	 plating	 in	 methylcellulose	
medium.	
	
In	contrast	to	wild-type	embryos	(G3+/+),	the	haematopoietic	progenitor	count	was	lower	by	22%	in	heterozygous	embryos	(G3+/-)	in	E11.5	AGMs.	This	
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reduction	was	more	pronounced	in	the	AGMs	of	knockout	embryos	(G3-/-)	by	a	significant	35.7%	(Figure	4-2:A).		
	
	
Figure	4-2:	Bar	graph	 shows	 total	 number	of	 colonies	and	 colony	 types	 obtained	
per	 1x105	 directly	 cultured	 E11.5	 AGM	 cells.	 (A)	 Graph	 shows	 total	 number	 of	
colonies	obtained	per	1x105	directly	cultured	AGM	cells.	Bar	graph	shows	numbers	
of	BFU-E	(B),	CFU-M	(C),	CFU-GM	(D)	and	CFU-Mix	(E)	colonies	per	1x105	cultured	
AGM	cells	obtained	for	each	genotype.	Error	bars	indicate	standard	deviation.	WT:	
wild-type	 (G3+/+),	 HET:	 heterozygous	 (G3+/-),	 KO:	 knock-out	 (G3-/-).	 Statistical	
analysis	were	done	using	two-way	ANOVA.	n=3-4.			
Specifically,	 this	 reduction	was	more	noticeable	 in	 certain	 colony	 types:	BFU-E	 and	CFU-GM	 counts	 for	 the	 heterozygous	 embryos,	 although	 the	 colony	count	 for	 the	CFU-M	showed	a	 significant	 increase,	whereas	 the	 reduction	was	significantly	 lower	 in	 the	BFU-E	and	CFU-GM	counts	 for	 the	knockout	embryos	(Figure	4-2:B-E)	
The	 same	 trend	 was	 observed	 in	 AGMs	 obtained	 from	 E10.5	 embryos,	albeit	 at	 a	more	 significant	 level.	 In	 contrast	 to	 wild-type	 embryos,	 when	 one	allele	 of	 Gata3	 was	 deleted	 (G3+/-),	 the	 progenitor	 counts	 were	 significantly	reduced	by	40%,	 and	when	both	 alleles	were	deleted,	 the	 reduction	was	more	severe,	reaching	64%	(Figure	4-3:A).			
Colonies	 that	 were	 significantly	 affected	 were	 CFU-GM	 for	 the	heterozygous,	and	CFU-M	and	CFU-GM	for	the	knockout	(Figure	4-3	B-E).	
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Figure	4-3:	Bar	graph	 shows	 total	 number	of	 colonies	and	 colony	 types	 obtained	
per	 1x105	 directly	 cultured	 E10.5	 AGM	 cells.	 (A)	 Graph	 shows	 total	 number	 of	
colonies	obtained	per	1x105	directly	cultured	AGM	cells.	Bar	graph	shows	numbers	
of	BFU-E	(B),	CFU-M	(C),	CFU-GM	(D)	and	CFU-Mix	(E)	colonies	per	1x105	cultured	
AGM	cells	obtained	for	each	genotype.	Error	bars	indicate	standard	deviation.	WT:	
wild-type	 (G3+/+),	 HET:	 heterozygous	 (G3+/-),	 KO:	 knock-out	 (G3-/-).	 Statistical	
analysis	were	done	using	two-way	ANOVA.	n=3-4	
	
4-4-	 G3+/-	 and	 G3-/-	 progenitors	 are	 unable	 to	 expand	 during	
explant	culture:	
Given	the	migratory	nature	of	haematopoietic	cells,	the	direct	evaluation	of	CFU-C	content	in	the	AGM	may	not	give	an	accurate	indication	of	their	origin	when	measured	directly,	 as	a	 significant	proportion	will	have	arrived	 from	 the	yolk	sac	via	the	circulation.	Hence,	an	additional	explant	culture	step	was	added	to	enumerate	AGM-born	progenitor	numbers.	
This	 model	 utilises	 a	 gas/liquid	 interface	 created	 by	 placing	 the	 whole	AGM	 on	 top	 of	 a	membrane	 instead	 of	 being	 submerged	 in	 a	 culture	medium,	which	 maintains	 the	 whole	 tissue	 structure,	 and	 gives	 a	 modest	 in	 vivo	expansion	of	CFU-Cs	within	the	AGM	(Taoudi	and	Medvinsky:	2007).		
Therefore,	we	investigated	the	potential	of	AGMs	from	all	three	genotypes	from	both	E11.5	and	E10.5	to	develop	and	expand	CFU-Cs	 independently	using	an	explant	culture	system	followed	by	methylcellulose	cultures	as	above.		
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As	expected,	this	additional	explant	step	expanded	the	number	of	colonies	obtained	 from	 wild-type	 AGMs	 (compare	 Figure	 4-2:A	 with	 Figure	 4-4:A).	 In	addition,	it	heightened	the	difference	between	wild-type	AGMs	and	heterozygous	and	knockout	AGMs,	as	the	reduction	in	progenitor	counts	was	more	significant	and	consistent	between	different	genotypes	after	the	explant	step	(Figure	4-4:A	and	 Figure	 4-5:A).	 In	 contrast	 to	 the	 wild-type	 control,	 the	 heterozygous	embryos	produced	fewer	colonies	by	noticeable	34%,	and	the	knockout	embryos	by	69%	at	E11.5	 (Figure	4-4:A).	There	was	also	a	 significant	 reduction	of	53%	when	 the	 knockout	 embryos	 were	 compared	 to	 the	 heterozygous	 embryos.	(Figure	4-4:A).			
	 	
Figure	4-4:	Bar	graph	 shows	 total	 number	of	 colonies	and	 colony	 types	 obtained	
per	 1x105	cultured	 E11.5	 AGM	 cells	 after	 an	 explant	 step.	 (A)	 Graph	 shows	 total	
number	 of	 colonies	 obtained	 per	 1x105	 cultured	 AGM	 cells.	 Bar	 graph	 shows	
numbers	of	BFU-E	(B),	CFU-M	(C),	CFU-GM	(D)	and	CFU-Mix	(E)	colonies	per	1x105	
cultured	 AGM	 cells	 obtained	 for	 each	 genotype.	 Error	 bars	 indicate	 standard	
deviation.	WT:	wild-type	(G3+/+),	HET:	heterozygous	(G3+/-),	KO:	knock-out	(G3-/-
).	Statistical	analysis	were	done	using	two-way	ANOVA	n=3-4.			
The	colony	types	that	were	significantly	affected	by	this	were	CFU-GM	for	both	 heterozygous	 embryos	 and	 knockout	 embryos	 by	 two	 and	 four	 fold	reduction,	respectively	(Figure	4-4:B-E).	
At	 E10.5,	 the	 reduction	 after	 the	 explant	 step	 in	 the	 heterozygous	embryos	 was	 elevated	 to	 74%	 (Figure	 4-5:A)	 compared	 to	 40%	 reduction	without	 explant	 (Figure	 4-3:A),	 while	 in	 the	 knockout	 embryos,	 the	 reduction	
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observed	was	that	of	90%	compared	to	the	wild-type	AGM,	and	60%	lower	than	the	heterozygous	embryos.	
This	 reduction	 was	 particularly	 noticeable	 in	 specific	 colony	 types	 for	both	 genotypes:	 	 CFU-M	 and	 CFU-GM	 in	 comparison	 to	 the	 wild-type	 control.	Between	the	G3+/-	and	G3-/-,	there	was	a	significant	reduction	in	BFU-E,	CFU-M,	CFU-GM	and	CFU-Mix	(Figure	4-5:B-E).	
It	 thus	 appears	 that	 G3+/-	 and	 G3-/-	 progenitors	 are	 unable	 to	 expand	under	these	conditions.	
	 	
Figure	4-5:	 	Bar	graph	shows	total	number	of	colonies	and	colony	types	obtained	
per	 1x105	cultured	 E10.5	 AGM	 cells	 after	 an	 explant	 step.	 (A)	 Graph	 shows	 total	
number	 of	 colonies	 obtained	 per	 1x105	 directly	 cultured	 AGM	 cells.	 Bar	 graph	
shows	numbers	of	BFU-E	(B),	CFU-M	(C),	CFU-GM	(D)	and	CFU-Mix	(E)	colonies	per	
1x105	cultured	AGM	cells	obtained	for	each	genotype.	Error	bars	indicate	standard	
deviation.	WT:	wild-type	(G3	+/+),	HET:	heterozygous	(G3+/-),	KO:	knock-out	(G3-
/-).		Statistical	analysis	were	done	using	two-way	ANOVA.	n=3-4.		
	
4-5-	 Gata3	 within	 the	 HE	 plays	 a	 major	 role	 in	 haematopoietic	
progenitor	formation:	
To	gain	further	insight	into	the	role	of	Gata3	in	progenitor	formation,	we	looked	at	the	effect	of	Gata3	deletion	specifically	from	the	vascular	endothelium	on	haematopoietic	progenitor	counts	using	the	Vec-Cre	system	(Chen:	2009).	By	crossing	 conG3	 f/f	 	 (Zhu:	 2004)	 with	 conG3	 f/+:+/cre	 we	 generated	 three	genotypes:	Gata3	f/f:+/cre	 	(f/f:+/cre),	which	represents	Gata3	deletion	from	the	endothelium;	Gata3	f/+:+/cre	(f/+:+/cre),	which	represents	a	partial	deletion	or	a	
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heterozygous;	and	Gata3	f/f:+/+	or	Gata3	f/+:+/+	(	f/f	or	f/+),	which	is	the	control	and	our	equivalent	to	a	wild-type	in	this	experiment.		
	 E10.5	and	E11.5	AGMs	of	these	genotypes	were	obtained	and	were	either	 directly	 plated	 into	methylcellulose	 for	 CFU-Cs,	 or	 explant	 cultured	 and	then	plated	into	methylcellulose	for	CFU-Cs	(Figure	4-6).	
Strikingly,	 the	 results	 were	 similar	 to	 those	 obtained	 from	 the	 global	Gata3	 deletions	 (4-2).	 With	 AGMs	 obtained	 from	 E11.5	 embryos	 and	 directly	plated	in	methylcellulose,	the	heterozygous	AGM	progenitor	counts	were	44.7%	lower	than	those	of	the	control,	whereas	the	Gata3	f/f:+/cre	were	52.6%	lower	than	those	of	the	control	(Figure	4-7A).	
Figure	 4-6:	 Representative	 schematic	 of	 the	 experimental	 design	 of	 CFU-C	 assay.	
AGMs	are	dissected	 from	E10.5	or	E11.5	 f/f:+/+,	 f/+:+/cre,	and	f/f:+/cre	embryos,	
and	either	dissociated	and	plated	into	methylcellulose	medium	directly,	or	cultured	
at	 the	 air/liquid	 interface	 for	 three	 days,	 harvested,	 dissociated	 and	 plated	 into	
methylcellulose	medium.		
The	 colonies	 that	 were	 mostly	 affected	 by	 Gata3	 deletion	 from	 the	endothelium	 were	 CFU-M,	 CFU-GM	 and	 CFU-Mix	 in	 both	 Gata3	 f/+:+/cre	 and	Gata3	f/f:+/cre	(Figure	4-7	B-E).	BFU-E	showed	an	expected	gradual	reduction	in	colony	counts	with	the	highest	numbers	being	in	the	control,	followed	by	Gata3	f/+:+/cre,	and	at	 last	Gata3	 f/f:+/cre	where	there	were	no	colonies	(Figure	4-7	B).	
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CFU-GM	 had	 a	 somewhat	 different	 count;	 the	 control	 genotype	 had	 the	highest	colony	count,	and	both	Gata3	 f/+:+/cre	and	Gata3	 f/f:+/cre	had	similar	colony	counts	(Figure	4-7	D).	
However,	 in	 CFU-M	 there	 was	 a	 significant	 increase	 in	 both	 Gata3	f/+:+/cre	 and	 Gata3	 f/f:+/cre	 with	 Gata3	 f/+:+/cre	 having	 the	 highest	 colony	count,	 followed	 by	 Gata3	 f/f:+/cre	 and	 at	 last	 Gata3	 f/f	 or	 f/+	 (Figure	 4-7	 C).	Furthermore,	 in	 the	CFU-Mix,	 the	highest	 colony	 count	was	 that	of	 the	 control,	followed	 by	 the	 knockout	 (Gata3	 f/f:+/cre),	 and	 the	 lowest	 count	 was	 that	 of	Gata3	f/+:+/cre	(Figure	4-7	E).			
	 	
Figure	4-7:	Bar	graph	 shows	 total	 number	of	 colonies	and	 colony	 types	 obtained	
per	 1x105	 directly	 cultured	 E11.5	 AGM	 cells.	 (A)	 Graph	 shows	 total	 number	 of	
colonies	obtained	per	1x105	directly	cultured	AGM	cells.	Bar	graph	shows	numbers	
of	BFU-E	(B),	CFU-M	(C),	CFU-GM	(D)	and	CFU-Mix	(E)	colonies	per	1x105	cultured	
AGM	 cells	 obtained	 for	 each	 genotype:	 f/f	 or	 f/+,	 f/+:	 +/cre,	 and	 f/f:	 +/cre..	
Statistical	analysis	were	done	using	two-way	ANOVA.	n=3-4			
Then	 we	 directly	 plated	 E10.5	 AGM	 cells,	 and,	 similar	 to	 those	 in	 the	global	 knockout,	 there	 was	 a	 reduction	 in	 both	 Gata3	 f/+:+/cre	 and	 Gata3	
f/f:+/cre	progenitor	numbers,	which	was	70%	and	67%	 lower	 than	 the	control	numbers,	respectively	(Figure	4-8	A-E).			
E11.5-Direct
f/f 
or
 f/+
f/+
:+/
Cr
e
f/f:
+/c
re
0
20
40
60
BFU-E
CFU-M
CFU-GM
C
ol
on
ie
s/
A
G
M CFU-G
CFU-Mix****
**
A
E11.5-Direct
f/f 
or
 f/+
f/+
:+/
Cr
e
f/f:
+/C
re
0.0
0.5
1.0
1.5
BFU-E
C
ol
on
ie
s/
A
G
M
***
E11.5-Direct
f/f 
or
 f/+
f/+
:+/
Cr
e
f/f:
+/C
re
0
10
20
30
40
CFU-GM
C
ol
on
ie
s/
A
G
M
*** ***
E11.5-Direct
f/f 
or
 f/+
f/+
:+/
Cr
e
f/f:
+/C
re
0
2
4
6
8
10
CFU-M
C
ol
on
ie
s/
A
G
M
***
****
E11.5-Direct
f/f 
or
 f/+
f/+
:+/
Cr
e
f/f:
+/C
re
0
2
4
6
8
C
ol
on
ie
s/
A
G
M
CFU-Mix
***
**
   B                                                               C
  D                                                                E   
		 110	
		 	
Figure	4-8:	Bar	graph	 shows	 total	 number	of	 colonies	and	 colony	 types	 obtained	
per	 1x105	 directly	 cultured	 E10.5	 AGM	 cells.	 (A)	 Graph	 shows	 total	 number	 of	
colonies	obtained	per	1x105	directly	cultured	AGM	cells.	Bar	graph	shows	numbers	
of	BFU-E	(B),	CFU-M	(C),	CFU-GM	(D)	and	CFU-Mix	(E)	colonies	per	1x105	cultured	
AGM	cells	obtained	for	each	genotype:	f/f	or	f/+,	f/+:+/cre,	and	f/f:+/cre.	Statistical	
analysis	were	done	using	two-way	ANOVA.	n=3-4.			
Finally,	 we	 examined	 both	 stages	 after	 explant	 culture,	 given	 that	 it	reflects	the	actual	progenitor	counts.	At	E11.5,	progenitor	numbers	were	similar	to	 those	 following	 global	 Gata3	 deletion	 and	 direct	 CFU-C	 assays	 from	 the	conditionally	deleted	embryos,	with	Gata3	f/+:+/cre	and	Gata3	f/f:+/cre	numbers	35.5%	and	60%	lower	than	the	control,	respectively	(Figure	4-9	A).	Moreover,	it	also	 emphasized	 the	 difference	 between	 the	 different	 genotypes.	 The	 colonies	that	 were	 mostly	 affected	 were	 CFU-M,	 CFU-GM	 and	 CFU-Mix	 in	 both	 Gata3	
f/+:+/cre	 and	Gata3	 f/f:+/cre	 (Figure	 4-9	 B-E).	While	 there	was	 a	 reduction	 in	BFU-E,	CFU-M	and	CFU-GM,	the	CFU-Mix	on	the	other	hand	showed	a	significant	increase	 in	 Gata3	 f/+:+/cre	 compared	 to	 Gata3	 f/+	 or	 Gata3	 f/f	 and	 Gata3	
f/f:+/cre	genotypes.	
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Figure	4-9:	Bar	graph	 shows	 total	 number	of	 colonies	and	 colony	 types	 obtained	
per	 1x105	cultured	 E11.5	 AGM	 cells	 after	 an	 explant	 step.	 (A)	 Graph	 shows	 total	
number	 of	 colonies	 obtained	 per	 1x105	 directly	 cultured	 AGM	 cells.	 Bar	 graph	
shows	numbers	of	BFU-E	(B),	CFU-M	(C),	CFU-GM	(D)	and	CFU-Mix	(E)	colonies	per	
1x105	cultured	AGM	cells	obtained	for	each	genotype:	f/f	or	f/+,	f/+:	+/cre,	and	f/f:	
+/cre.	Statistical	analysis	were	done	using	two-way	ANOVA.	n=3-4.			
When	 the	explant	 culture	was	performed	with	E10.5	AGMs,	 followed	by	CFU-Cs,	the	results	were	also	similar	to	those	of	global	knockout	and	direct	CFU-Cs.	The	Gata3	f/+:+/cre	colony	count	was	33%	lower	than	the	control,	whereas	
Gata3	f/f:+/cre	was	63%	 lower	 (Figure	4-10	A).	The	 colonies	 that	were	mostly	affected	were	CFU-mix	in	both	genotypes	(Figure	4-10	B-E).	
	 		
Figure	 4-10:	 (A)	 Bar	 graph	 shows	 total	 number	 of	 colonies	 and	 colony	 types	
obtained	per	1x105	cultured	E10.5	AGM	cells	after	an	explant	step.	Bar	graph	shows	
numbers	of	BFU-E	(B),	CFU-M	(C),	CFU-GM	(D)	and	CFU-Mix	(E)	colonies	per	1x105	
cultured	AGM	cells	obtained	for	each	genotype:	f/f	or	f/+,	f/+:	+/cre,	and	f/f:	+/cre.	
Statistical	analysis	were	done	using	two-way	ANOVA.	n=3-4.		
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To	confirm	Cre-mediated	Gata3	deletion,	we	performed	PCR	to	determine	the	 genotypes	 of	 the	 knockout	 colonies	 by	 picking	 them	 from	 the	 E10.5	Gata3	
f/f:+/cre	plates	at	the	end	of	the	CFU-C	assay.	20	CFU-GM	colonies	were	picked	and	 out	 of	 those	 colonies,	 6	 colonies	 seemed	 to	 have	 escaped	 Gata3	 deletion,	suggesting	 that	 the	 effect	 of	 endothelial-specific	 Gata3	 deletion	 is	 even	 more	severe	(Figure	4-11).		
	Figure	4-11:	PCR	for	colonies	picked	from	CFU-C	assays	derived	from	E10.5	explant	
cultured	AGM	cells.	Six	colonies	out	of	20	(25%)	have	escaped	the	deletion.	
	
4-6-	 The	 effect	 of	 Gata3	 deletion	 from	 endothelium	 on	
haematopoietic	repopulation:	
In	 order	 to	 investigate	 the	 effect	 of	 Gata3	 conditional	 deletion	 on	haematopoietic	 repopulation	 and	HSCs,	we	 performed	 a	 transplantation	 assay.	AGMs	 from	 E11.5	 embryos	 of	 the	 various	 genotypes	 were	 transplanted	 into	irradiated	mouse	recipients,	and	the	repopulation	was	examined	4	months	after	the	transplants	(Figure	4-12).	
These	 in	 vivo	 repopulation	 assays	 revealed	 that	 E11.5	 AGMs	 of	 Gata3	
f/f:+/cre	can	repopulate	irradiated	recipients,	but	at	a	much	lower	rate,	with	only	1	mouse	repopulated	out	of	12	transplanted	(8.5%)	in	contrast	to	the	wild-type	control	 where	 5	 out	 of	 13	 mice	 repopulated	 (38.5%),	 and	 to	 Gata3	 f/+:+/cre	where	5	out	of	10	recipients	engrafted		(50%)	(Figure	4-13).		
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Figure	 4-12:	 Representative	 schematic	 of	 the	 experimental	 design	 of	 the	
transplantation	assays.	AGMs	are	dissected	from	E11.5	embryos	with	the	following	
genotypes:	 f/f	 or	 f/+,	 f/+:+/cre,	 and	 f/f:+/cre	 and	 transplanted	 into	 irradiated	
recipients.	Mice	are	then	bleed	at	4	months	and	the	donor	cell	contribution	to	the	
peripheral	 blood	 of	 the	 recipient	 is	 measured	 by	 flow	 cytometry	 analysis.	
Chimerism	of	5%	or	higher	was	set	as	the	threshold	at	which	mice	are	considered	
positive	for	repopulation.	
	
Figure	 4-13:	 Levels	 of	 chimerism	 from	 transplanted	 AGMs	 of	 the	 following	
genotypes:	f/f	or	f/+,	f/+:+/cre,	and	f/f:+/cre.	1	ee	was	injected	per	mouse.	Statistics	
were	 performed	 on	 GraphPad	 Prism	 and	 the	 Mann-Whitney	 test	 was	 used	 to	
determine	significance	levels.	Chimerism	of	5%	or	higher	was	set	as	the	threshold	
at	which	mice	are	 considered	positive	 for	 repopulation.	 f/f	 or	 f/+	n=13,	 	 f/+:+cre	
n=10,		f/f:+/cre	n=	11	
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4-7-	Discussion:	
HSCs	 and	 haematopoietic	 progenitors	 emerge	 from	 the	 vascular	endothelium	within	 the	 AGM	 (Jaffredo:	 1998;	 Bertrand:	 2010;	 Chen:	 2009;	 de	Bruijn:	2002;	Kissa	and	Herbomel:	2010;	Zovein:	2008).	Our	results	demonstrate	here	 that	Gata3	 in	 the	endothelium	 is	necessary	 for	haematopoietic	progenitor	formation,	and	that	it	plays	a	role	in	HSC	generation.	
Previously,	 it	was	 reported	by	 the	Ottersbach	group	 that	Gata3	 deletion	causes	a	significant	reduction	in	HSCs	and	progenitor	cells	(CFU-S)	in	E11.5	and	E10.5	 AGMs,	 using	 a	 germline-deleted	 Gata3	 knockout	 line.	 Here,	 we	 have	demonstrated	 that	 Gata3	 is	 also	 important	 for	 maintaining	 normal	 counts	 of	other,	 more	 mature,	 haematopoietic	 progenitor	 cell,	 as	 enumerated	 in	 CFU-C	assays.	In	fact,	Gata3	reduction	lowered	haematopoietic	progenitor	cell	numbers	in	both	heterozygous	and	knockout	embryos,	which	corresponds	with	what	was	reported	before	by	Fitch	et	al	 (2012)	of	Gata3	haploinsufficiency	reducing	HSC	activity.	
Our	findings	here	have	revealed	that	the	effect	of	Gata3	on	progenitors	is	both	 dose-dependent	 and	 stage-dependent:	 i.e.	 haploinsufficient	 vs.	 knockout	and	E10.5	vs.	E11.5.	The	reduction	in	the	CFU-C	counts	seems	to	follow	the	same	pattern	 at	 both	 E11.5	 and	 E10.5;	 however,	 it	 is	 much	 more	 severe	 and	pronounced	 at	 E10.5.	 Given	 the	 variation	 in	 the	 counts	 between	 embryos,	 and	considering	the	migratory	nature	of	haematopoietic	cells,	we	added	an	explant-culture	 step	 to	 ensure	 that	 these	 progenitors	 originated	 from	 the	 AGM	(Medvinsky	 and	 Dzierzak:	 1996;	 Kumaravelu:	 2002;	 Taoudi:	 2005;	 de	 Bruijn	2000).	 Interestingly,	 adding	 the	 explant	 step	 not	 only	 reduced	 the	 variation	between	embryos,	reflecting	a	more	accurate	representation	of	the	total	number	of	 progenitors	 in	 each	 AGM,	 but	 also	 revealed	 that	 Gata3+/-	 and	 Gata3-/-	progenitors	 are	 unable	 to	 expand	 during	 the	 explant	 culture,	 unlike	wild-type	progenitors.	The	reduction	in	both	heterozygous	and	knockout	AGMs	compared	to	 the	 wild-type	 control	 after	 the	 explant	 was	 elevated	 from	 22%	 to	 34%	 in	E11.5	heterozygous	AGMs,	and	56%	to	69%	in	knockout	AGMs.	The	reduction	in	CFU-Cs	of	E10.5	AGMs	was	from	40%	to	74%	in	heterozygous,	and	from	64%	to	
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90%	 in	 knockout	 embryos.	 This	 reduction	 following	 explant	 culture	 could	 be	attributed	to	Gata3	involvement	in	regulating	cell	cycle	entry,	which	corresponds	with	what	was	reported	for	HSCs	by	Ku	et	al.	(2007).	
It	should	be	noted	here	that	among	the	colonies,	CFU-M	seemed	to	be	the	least	affected	by	Gata3	reduction	and/or	absence.	This	could	contributed	to	the	fact	 that	 these	 colonies	 are	 produced	 by	 the	 EMPs,	which	 are	 produced	 in	 the	yolk	 sac	 during	 the	 primitive	 haematopoiesis,	 a	 process	 that	 has	 shown	 to	 be	
Gata3	independent	(Pandolfi:	1995).		
The	fact	that	the	reduction	at	E10.5	was	more	pronounced	than	at	E11.5	could	 be	 explained	 by	 the	 presence	 of	 a	 transient	 Gata3+	 haematopoietic	 cell	population	 that	 appears	 around	E10	 and	disappears	 by	E11.5.	 This	 population	was	 identified	 during	 the	 Gata3	 expression	 analysis	 (section	 3-3-2),	 and	 the	absence	of	one	or	both	alleles	of	Gata3	may	have	affected	that	population.			
Another	explanation	for	this	could	also	be	the	involvement	of	Gata3	in	HE	function,	 and	 that	 its	 absence	 or	 haploinsufficiency	 could	 impair	 its	haematopoietic	 potential,	 and	 resulting	 in	 lower	 output	 of	 haematopoietic	progenitors	from	endothelial	precursors.			
The	latter	interpretation	receives	support	from	the	experiments	with	the	conditional	Gata3	knockout	line.	When	Gata3	was	conditionally	deleted	from	the	vascular	endothelium,	 it	 caused	a	 significant	drop	 in	progenitor	 counts	 in	both	
Gata3	f/+:+/cre	 and	Gata3	 f/f:+/cre.	 Similar	 to	 the	global	deletion	of	Gata3,	 the	effect	was	more	pronounced	at	E10.5	and	even	more	so	after	adding	an	explant	culture	 step.	 This	 demonstrates	 that	Gata3	 is	 essential	 in	 the	 endothelium	 for	haematopoietic	progenitor	formation.		
Gata3	has	been	previously	implicated	in	cell	cycle	regulation	(Ku:	2012).	When	Gata3	was	deleted;	fewer	HSCs	were	produced,	they	were	more	quiescent,	and	 failed	 to	 enter	 the	 cell	 cycle	 after	myelosupression	 to	 recover.	 	 This	 could	explain	the	more	pronounced	effect	on	CFU-C	counts	after	the	additional	explant	step,	during	which	progenitors	are	thought	to	undergo	an	expansion.		
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Gata3	 in	 the	 vascular	 endothelium	 also	 plays	 a	 role	 in	 HSC	 generation.	Transplantation	 assays	 have	 revealed	 here	 that	when	Gata3	 was	 deleted	 from	the	endothelium,	 it	almost	completely	abrogated	engraftment	potential	 in	AGM	cells.	 Some	 residual	 HSC	 activity	 remained	 in	 Gata3-null	 AGMs,	 which	may	 be	due	to	some	haemogenic	endothelial	cells	having	escaped	Cre-mediated	deletion.	However,	 previous	 transplant	 experiments	 with	 germline-deleted	 Gata3	knockout	 AGMs	 have	 also	 detected	 some,	 albeit	 greatly	 reduced,	 repopulating	activity	 (Fitch	 2012),	 which	 may	 indicate	 that	 Gata3	 is	 important,	 but	 not	essential,	for	EHT.	
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5-	Gata3	expression	in	the	HSC	microenvironment	
	
5-1-	Background:	
Gata3	 is	 expressed	 in	 various	 cell	 types	 in	 the	 AGM,	 and	 our	 previous	findings	 (chapter	 3)	 have	 shown	 that	 expression	 to	 be	 stage	 dependent.	 It	 is	expressed	 in	 sympathoadrenal	 cells	 (Fitch:	 2012),	mesenchymal	 cells	 (Manaia:	2000),	 endothelial	 cells	 (Manaia:	 2000;	 Swiers:	 2013),	 and	 in	 haematopoietic	cells	(Swiers:	2013),	all	of	which	we	confirmed	in	chapter	3.	
Previously,	we	have	confirmed	the	expression	of	Gata3	in	a	subset	of	each	of	 those	 4	 populations,	 and	 performed	 functional	 assays	 to	 confirm	 a	 role	 of	Gata3	 in	 the	 haematopoietic	 and	 endothelial	 populations.	 However,	 how	 these	four	populations	interact	with	one	another	and	how	they	affect	HSC	emergence	is	still	 to	 be	 investigated.	 Furthermore,	 how	 the	 Gata3-expressing	 subpopulation	differs	 from	 the	 Gata3-negative	 one	 has	 not	 been	 fully	 investigated	 for	 all	 of	these.	
Gata3	 has	 been	 implicated	 in	 cell	 cycle	 regulation.	 Previously,	 Ku	 et	 al.	(2012)	demonstrated	 that	Gata3	 is	 required	 for	 both	promoting	HSC	 cell	 cycle	entry	and	maintaining	normal	numbers	of	adult	HSCs.	Gata3	involvement	in	cell	cycle	regulation	could	also	explain	the	increased	reduction	in	progenitor	counts	from	Gata3-deficient	AGMs	after	the	explant	culture	step	in	the	CFU-C	assays	in	chapter	4.	
Here,	 we	 use	 a	 highly	 sensitive	 RNA-seq	method	 to	 examine	 the	whole	transcriptome	of	small	numbers	of	Gata3-expressing	subpopulations	within	the	immediate	environment	of	HSCs	 (HC,	MC,	 SNS,	 and	EC)	and	compared	 them	 to	their	 non-Gata3	 expressing	 counterparts.	 Given	 the	 limited	 number	 of	 Gata3	expressing	cells	 these	populations,	RNA	sequencing	provides	 the	most	efficient	and	sensitive	method	 for	analysis	of	 these	cells.	A	possible	 link	of	Gata3	 to	cell	cycle	regulation	will	also	be	investigated	in	these	data	sets.	
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5-2-	Aims:	
- Identify	 key	 genes	 and	 processes	 that	 correlate	 with	 Gata3	expression	in	the	HSC	immediate	microenvironment.	- Investigate	 the	 effect	 of	 Gata3	 expression	 on	 cell	 cycle	 in	 HSC	immediate	microenvironment	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
		 119	
5-3-	Gata3+	and	Gata3-	cells	segregate	into	distinct	clusters:	
To	analyse	gene	expression	in	our	identified	populations	form	chapter	3;	G3+HC,	 G3+EC,	 G3+SNS	 and	 G3+MC,	 in	 parallel	 to	 non-Gata3	 expressing	counterparts;	 G3-HC,	 G3-EC,	 G3-SNS,	 and	G3-MC,	we	 dissected	AGMs	 from	G3-GFP	embryos	of	E10.5	for	haematopoietic	and	endothelial	populations,	and	E11.5	for	 mesenchymal	 and	 SNS	 populations	 since	 these	 stages	 reflect	 the	 peak	 of	Gata3	 expression	 in	 each	 population	 (Swiers:	 2013;	 Manaia:	 2000;	 Pandolfi:	1995;	 Fitch:	 2012;	 and	 chapter	 3	 of	 this	 thesis).	 The	 cells	 were	 then	 sorted	according	 to	Figure	5-1,	 and	 the	 transcriptome	of	 each	population	analyzed	by	RNA-Seq.	
Figure	 5-1:	 RNA-Sequencing	 sorting	 strategy.	 Cells	 are	 obtained	 from	 G3-GFP	
embryos,	 E10.5	 for	 haematopoietic	 and	 endothelial	 cells,	 and	 E11.5	 for	 SNS	 and	
mesenchymal	 cells.	 Cells	 were	 double	 sorted;	 the	 first	 sort	 was	 to	 isolate	 the	
populations	 in	E10.5	G3+EC,	G3-EC,	G3+HC	and	G3-HC,	and	 in	E11.5	G3+SNS,	G3-
SNS,	G3+MC,	and	G3-MC.	Each	of	 these	populations	was	 then	 sorted	again	 into	a	
96well	 plate	 into	20	wells;	 20	 cells/	well	 and	a	400	 cells	were	 collected	 for	 each	
population.	Cells	were	obtained	from	3-5	independent	biological	replicates.	
	 The	 principal	 component	 analysis	 (PCA)	 shows	 a	 clear	 separation	between	all	eight	populations.	While	cells	of	 the	same	population	cluster	 in	the	same	 region	 i.e.	 HC,	 EC,	 SNS	 and	MC,	 each	 of	 the	 Gata3-expressing	 population	nevertheless	 shows	 a	 clear	 distinct	 cluster	 from	 its	 non-Gata3	 expressing	population	(Figure	5-2).	
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Figure	 5-2:	 PCA	 showing	 the	 distribution	 of	 all	 Gata3-expressing	 populations	
G3+EC	(GFP+Ve-Cad+),	G3+HC	(GFP+CD41/45+),	G3+SNS	(GFP+P75+),	and	G3+MC	
(GFP+PDGFRb+)	compared	to	non-G3	expressing	cells	of	same	populations:	G3-EC	
(GFP-Ve-Cad+),	 G3-HC	 (GFP-CD41/45+),	 G3-SNS	 (GFP-P75+),	 and	 G3-MC	 (GFP-
PDGFRb+).	n=400	cells	per	population	distributed	equally	over	20	wells.		
	
Next	we	 studied	 each	 population	 individually	 and	 compared	 the	 Gata3-expressing	 subfraction	 to	 the	 Gata3-	 population.	 This	 again	 showed	 that	 each	group	formed	a	distinct	cluster	based	on	Gata3	expression	or	absence	(Figure	5-3	A-D).		
While	 all	 of	 the	 cell	 types	 show	 a	 clear	 separation	 between	 each	 of	 its	subpopulations,	 the	 SNS	 seemed	 to	 have	 a	 transitional	 shape,	 which	 could	 be	contributed	 to	 the	on-going	development	of	 the	SNS	 following	 the	migration	of	
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neural	 crest	 cells	 to	 the	 neural	 patches	 in	 order	 to	 form	 the	 SNS	 with	 Gata3	marking	later	stages	of	maturation	(Figure	5-3	B).		
A																																																																																B	
	C																																																																															D	
		
Figure	5-3:	PCA	showing	the	clustering	of	Gata3	expressing	populations	in	contrast	
to	their	G3-	counterpart.	 Individual	panels	represent	each	population:	(A)	G3+MC	
(GFP+PDGFRb+)	 vs.	 G3-MC	 (GFP-PDGFRb+),	 (B)	 G3+SNS	 (GFP+P75+)	 vs.	 G3-SNS	
(GFP-P75+),	(C)	G3+HC	(GFP+CD41/5+)	vs.	G3-HC	(GFP-CD41/45+)	and	(D)	G3+EC	
(GFP+Ve-Cad+)	 vs.	 G3-EC	 (GFP-Ve-Cad+).	 n=400	 cells	 for	 each	 population	
distributed	equally	between	20	wells.	
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Furthermore,	 endothelial	 cells	 seemed	 to	 be	 intermingled	 in	 the	middle	before	they	separate,	which	could	be	attributed	to	EHT	taking	place	 in	some	of	these	 cells	 before	 forming	 haematopoietic	 cells,	 and	 then	 forming	 distinct	clusters	 that	 separate	 endothelial	 cells	 from	 haemogenic	 endothelium,	 with	Gata3	marking	haemogenic	endothelium	(Figure	5-3	D).	
Compared	with	the	G3-populations,	the	expression	of	Gata3	results	in	the	downregulation	 of	 232	 genes	 in	 the	 haematopoietic	 cells,	 254	 genes	 in	 the	endothelial	 cells,	 74	 genes	 in	 the	mesenchymal	 cells	 and	226	genes	 in	 the	 SNS	cells	 (Figure	5-4	A).	 In	contrast,	 the	upregulated	genes	were	much	higher	 than	the	downregulated	ones	in	the	HC	compartment	(1528),	in	the	ECs	(558)	and	in	the	MCs	(252).	However,	the	upregulated	genes	in	the	SNS	were	slightly	 lower:	217	(Figure	5-4	A	and	B).	
We	next	performed	differential	gene	expression	analysis	of	each	of	those	populations	 in	 order	 to	 identify	how	Gata3	 expression	 affects	 each	population,	and	to	identify	the	similarities	and	differences	between	these	populations.		
Within	 the	 downregulated	 genes,	 there	 was	 little	 overlap	 between	 the	different	cell	populations,	EC	and	HC	overlapped	in	7	genes,	EC	and	MC	had	two	genes	in	common,	EC	and	SNS	had	only	two	genes	in	common,	MC	and	HC	had	2	genes	in	common,	HC	and	SNS	had	also	two	genes	in	common	between	them,	and	SNS	 and	 MC	 which	 had	 one	 gene	 in	 common	 between	 them	 and	 EC	 as	 well	(Figure	5-4	A).	
The	 upregulated	 genes	 showed	 more	 overlap	 between	 the	 different	populations:	EC	and	HC	had	160	genes	in	common,	EC	and	MC	had	45	genes	in	common,	 EC	 and	 SNS	 had	 9	 genes	 in	 common,	 MC	 and	 HC	 had	 69	 genes	 in	common,	HC	and	SNS	had	46	genes	in	common,	and	similar	to	the	downregulated	genes,	MC	and	SNS	had	one	gene	in	common	(Figure	5-4	B).			
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A																																																																														B	
	 		Figure	5-4:	Venn	diagrams	 showing	 the	overlapping	genes	between	 the	different	
Gata3-expressing	 populations	 where	 (A)	 represents	 the	 downregulated	 genes	 in	
Gata3-expressing	populations	and	(B)	represents	the	upregulated	genes	in	Gata3-
expressing	 populations.	 EC:	 endothelial	 cells,	 MC:	 mesenchymal	 cells,	 HC:	
haematopoietic	 cells,	 and	SNS:	 sympathetic	nervous	 system.	The	differential	gene	
analysis	 was	 done	 on	 DE-Seq	 using	 the	 adjusted	 P	 value	 of	 0.01	 and	 log2	 fold	
change	of	0.1.		
	
5-4-	The	downregulated	genes	are	associated	with	development	and	
differentiation	of	various	cells	and	systems:			
To	learn	more	about	the	differentially	expressed	genes	and	the	biological	processes	 they	are	 involved	 in,	we	performed	Gene	Ontology	(GO),	 first	 for	 the	downregulated	 genes.	 Given	 the	 amount	 of	 genes	 that	 were	 identified,	 I	 have	only	 selected	 the	GO	 for	biological	 processes	 that	 are	 relevant	 to	 this	 thesis	 in	each	population	(Figure	5.5).	
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Figure	 5-5:	 GO	 terms	 enriched	 in	 the	 downregulated	 genes	 in	 Gata3+	 cells	 in	
contrast	to	Gata3-	cells.	(A)	MC:	mesenchymal	cells,	(B)	SNS:	Sympathetic	nervous	
system,	 (C)	 HC:	 haematopoietic	 cells,	 and	 (D)	 EC:	 endothelial	 cells.	 .	 Gene	
enrichment	 for	 biological	 processes	 analysis	 was	 done	 on	 Gene	 Ontology	
Consortium	website	using	the	PANTHER	classification	system.		
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Of	 note,	 most	 of	 the	 gene	 enrichments	 for	 biological	 processes	 in	 all	populations	were	 involved	with	development	and	differentiation	of	several	cell	types	 and	 tissues	 whether	 its	 central	 nervous	 system	 neuron	 development	(Wnt2,	 Wnt5a,	 and	 Cbln1),	 and	 mesenchyme	 development	 (Cbln1,	 Ptch1,	 and	Epha4)	in	MC	compartment;	or	stem	cell	differentiation	(Sfrp1,	Ntf4,	and	Gdnf),	nervous	 system	 development	 (Fgf20,	 Chl1,	 and	 Sdc4),	 gonad	 development	(Dmrt1,	 Lhx9,	 Nr5a1,	 Kitlg,	 Gata4,	 and	 Bcl2),	 and	 mesenchyme	 development	(Bmp7,	 Smad6,	 Gdnf,	 Has2	 and	 Fgf10)	 in	 SNS	 compartment;	 myeloid	 cell,	lymphocytes,	 and	 leukocytes	 development	 and	 activation	 (Nfam1,	 and	 Spi1),	immune	 system	development	 (Icos,	 Stap1,	Myb,	 and	 Irf8),	 cytokine	 production	(Casp1,	Ccl3,	Cybb,	and	 Il6ra	 ),	 and	haematopoiesis	 (Gpr183,	Klf4,	Cdk6,	Stap1,	and	Anxa1)	in	HC;	and	myeloid	and	leukocytes	differentiation	in	ECs	in	addition	to	 the	 regulation	 of	motility,	 cell	 cycle	 and	 homeostasis	 (Myc,	 Cd36,	Mif,	 Gnl3,	and	Mafb)	(Figure	5-5).	
	
5-5-	 The	 upregulated	 genes	 are	 associated	 with	 migration,	
proliferation,	development	and	apoptosis:	
			The	 upregulated	 genes	 were	 found	 to	 be	 mostly	 enriched	 for	 the	following	GO	terms;	development,	migration,	proliferation	and	apoptosis	(Figure	5-6).			
In	 the	 MC	 population,	 the	 gene	 enrichment	 was	 mostly	 for	 apoptosis	regulation	 (Gadd45b),	 regulation	 of	 cell	 proliferation	 (Btc,	 Ctgf,	 Figf,	 and	 Pgf),	adhesion	(Fn1,	Smad6,	Cntn4,	and	Postn),	differentiation	(Gdnf,	Fn1,	Gata6,	Frzb	and	 Lama2),	 and	 migration	 (Fn1	 and	 Angpt2),	 as	 well	 as	 development	 of	 the	urogenital	 system	 (Lama5,	 Myocd,	 and	 Col4a1),	 muscle	 processes	 (Smad7,	Dmpk,	 Dsg2	 and	 Ctgf),	 circulatory	 system	 and	 angiogenesis	 (Hif3a,	 Figf,	 and	Mcam)	(Figure	5-6	A).	
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Figure	5-6:	GO	terms	enriched	in	the	upregulated	genes	in	Gata3+	cells	in	contrast	
to	Gata3-	cells.	 (A)	MC:	mesenchymal	cells,	 (B)	SNS:	Sympathetic	nervous	 system,	
(C)	HC:	haematopoietic	cells,	and	(D)	EC:	endothelial	cells.	+).	Gene	enrichment	for	
biological	processes	analysis	was	done	on	Gene	Ontology	Consortium	website	using	
the	PANTHER	classification	system.			
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In	the	SNS,	most	of	the	gene	enrichment	was	associated	with	the	GO	terms	of	 cell	 differentiation	 (Sox7,	 Nefl,	 and	 Ngf),	 nervous	 system	 development	(Map1b,	CD9,	and	Tlx,),	catecholamine	metabolic	and	biosynthetic	processes	(Th,	Gch1,	 and	 Agtr2),	 norepinephrine	 synthesis	 (Dbh,	 and	 Insm1),	 and	 neuron	apoptotic	process	(Crlf1,	Kcnip3,	Ascl1,	Agtr2,	Mt3	and	Sct)	(Figure	5-6	B).		
The	HCs	were	mainly	enriched	for	genes	that	are	involved	in	chemotaxis,	locomotion,	cell	migration,	cell	adhesion	(Esam,	Bcam,	and	Kitlg),	stem	cell	and	cell	differentiation	(Sox10,	Sox11,	Hand2,	Isl1,	Jag1,	and	Sox8),	cell	proliferation	and	 blood	 vessel	 development	 (Mmp2,	 Fn1,	 Pdgfra,	 Lef1,	 Endra,	 Bmp4,	 Cdh5,	Cdh13,	Fgfr1,	Hand1,	Pecam1,	and	Angpt1)	(Figure	5-6	C).		
The	gene	enrichment	in	the	ECs	was	associated	with	the	development	of	cells	 and	 stem	 cells	 (Jag1,	Nrp1,	 Fn1	 and	 Lama5),	 blood	 vessels	 (Mmp2,	 Cdh5,	Bmpr2,	 Smad7,	 and	Cxcl12),	haematopoietic	or	 lymphoid	organ	 (CD34,	Mapk3,	Jag2,	Vegfa,	and	Sox4),	nervous	system	(Bmpr2,	Cxcl12,	and	Sox6),	and	immune	system	(Tek,	Pbx1,	and	Gata2).	It	was	also	enriched	for	genes	associated	with	cell	motility	 (Fn1,	 Tie2,	 Cxcl16	 and	 Bcr),	 cell	 proliferation	 (Pbx1,	 and	 Gata6),	 cell	death	 (Fas,	 Pdcd4,	 and	 Notch1),	 cell	 differentiation	 (Meis2,	 Cdh5,	 Smad7,	 and	Emp2),	and	blood	circulation	(Foxc2,	Vegfc,	Emp2	and	Cav1)	(Figure	5-6	D).	
Of	note,	the	Gata3+	ECs	were	enriched	for	genes	that	were	involved	in	the	regulation	of	transforming	growth	factor	beta	receptor	signalling	pathway	and	in	the	regulation	of	Wnt	signalling	pathway.	
The	overall	picture	of	GO	 terms	and	differential	 gene	expression,	where	cyclin	dependent	kinases	(Cdk)	were	identified	in	the	downregulated	genes	(HC	and	 EC),	 and	 in	 the	 upregulated	 genes	 (HC,	 EC	 and	 SNS),	 suggested	 an	involvement	 of	 Gata3	 in	 cell	 cycle	 regulation.	 I	 therefore	 decided	 to	 further	analyse	 the	 cell	 cycle	 status	 of	 Gata3-expressing	 populations	 compared	 with	their	Gata3-	counterparts.	Strikingly,	we	found	only	pro-proliferation	Cdks	in	the	downregulated	 genes,	 whereas	 it	 is	 almost	 only	 cell	 cycle	 inhibitors	 in	 the	upregulated	genes	(Table	5-1).	
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Cell	Type	 Upregulated	Cdks	 Downregulated	Cdks		
HC	 Cdkn1c		Cdkn2d	 Cdk6	
EC	 Cdkn1c		Cdk19	 Cdk1		Cdkl1	
SNS	 Cdkn1c	 -	
Table	4:	 	List	of	cyclin	dependent	kinases	(Cdk)	and	their	 inhibitors	(Cdkn)	 found	
amongst	 upregulated	genes	 and	downregulated	genes	 in	 different	 populations	 of	
G3+	cells.		
	
5-6-	Gata3	expression	is	associated	with	a	more	quiescent	cell	state:	
Cell	cycle	refers	to	the	process	by	which	a	cell	duplicates	its	DNA	in	order	to	produce	two	daughter	cells.	The	cell	cycle	 is	divided	 into	4	stages:	G1,	S,	G2,	and	M.	The	G1	stage	stands	for	the	Gap	1	stage,	where	cells	can	either	go	to	G0	and	are	not	consider	 in	cell	cycle	anymore,	or	go	 into	stage	S.	Stage	S	refers	 to	synthesis	 of	 the	DNA,	 or	 the	DNA	 replication	which	 is	 followed	by	 stage	G2	or	Gap	2.	This	is	stage	is	then	followed	by	M	stage,	which	stands	for	mitosis	where	nuclear	and	cytoplasmic	division	happens,	forming	the	two	daughter	cells.	These	cells	then	can	either	go	into	phase	G1	again	to	start	a	new	cycle	or	exit	the	cell	cycle.		
HSCs	 function	 and	 phenotype	 varies	 according	 to	 the	 time	 and	 tissue	during	 ontogeny;	 In	 the	 AGM,	 the	 pre-HSCs	 are	 associated	 more	 with	 a	proliferative	 status.	 However,	 once	 these	 cells	 start	 to	 acquire	 definitive	 HSCs	state,	they	slow	down	cycling	(Batsivari:	2017).	In	fetal	liver,	the	HSCs	are	highly	
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proliferative	 and	 are	 in	 cycle	 (Morrison:	 1995),	 whereas	 the	 HSCs	 in	 the	 BM,	cycle	infrequently	and	are	mostly	quiescent	(Wilson:	2008).		
Considering	 that,	 we	 performed	 cell	 cycle	 analysis	 on	 the	 sorted	populations	obtained	 from	G3-GFP	embryos,	E10.5	 for	HCs	and	ECs,	 and	E11.5	for	SNS	cells	and	MCs,	and	found	that	Gata3	expression	affected	each	population	differently.	
	
	
Figure	5-7:	Cell	cycle	phase	distribution	of	Gata3+	and	Gata3-	cells	in	the	different	
cell	 populations	 in	 the	 AGM,	 where:	 (A)	 G3+EC:	 Gata3+	 endothelial	 cells,	 G3-EC:	
Gata3-	 endothelial	 cells,	 G3+HC:	 Gata3+	 haematopoietic	 cells,	 G3-HC:	 Gata3-	
haematopoietic	 cells,	 (B)	 G3+SNS:	 Gata3+	 sympathetic	 nervous	 system,	 G3-SNS:	
Gata3-	 sympathetic	 nervous	 system,	 G3+MC:	 Gata3+	 mesenchymal	 cells,	 G3-MC:	
Gata3-	mesenchymal	cells	C:	.	n=	3-4	independent	experiments,	Statistical	analysis	
were	done	using	Mann-Whitney	test.		
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In	 the	 EC	 compartment,	 Gata3	 expression	 was	 found	 to	 be	 associated	mainly	with	 cells	 in	 the	 G0/G1	 phase,	 around	 75%,	while	 11%	 of	 Gata3+	 ECs	were	in	the	S	phase,	and	11%	were	in	the	G2/M	phase.	G3-	ECs	had	fewer	cells	in	the	G0/G1	phase,	around	64%,	with	20.5%	of	the	cells	in	the	S	phase	and	14.4%	in	the	G2/M	phase	(Figure	5-7	A).	
Within	the	HCs,	Gata3	expression	was	associated	with	61%	of	the	cells	in	the	G0/G1	phase,	around	20%	in	the	S	phase	and	19.4%	in	the	G2/M	phase.	 In	G3-HCs,	 on	 the	 other	 hand,	 55%	were	 found	 in	 the	 G0/G1	 phase	 (which	 was	significantly	 lower	 than	 the	G0/G1	phase	 in	G3+HC),	27.7%	 in	 the	S	phase	and	16.5%	were	in	the	G2/M	phase	(Figure	5-7A).	
In	SNS	cells	77.7%	Gata3+	cells	were	found	in	the	G0/G1	phase,	12.2%	in	the	S	phase,	and	10%	in	the	G2/M	phase,	while,	in	contrast,	70%	of	the	G3-SNS	was	 in	 the	G0/G1	phase,	17%	were	 in	 the	S	phase,	and	12%	were	 in	 the	G2/M	phase	(Figure	5-7	B).	Finally,	the	cell	cycle	distribution	of	Gata3+	and	Gata3-	MCs	was	more	 or	 less	 equal.	 68.9%	 of	 G3+MCs	were	 found	 to	 reside	 in	 the	 G0/G1	phase,	15.9%	in	the	S	phase,	and	14.6%	in	the	G2/M	phase,	which	 is	similar	 to	Gata3-	 cells,	 where	 68.8%	 are	 in	 the	 G0/G1	 phase,	 18.2%	 in	 the	 S	 phase	 and	12.6%	in	the	G2/M	phase.				
However,	 it	 should	 be	 noted	 here	 that	 while	 the	 cells	 in	 the	 Gata3-	compartment	were	more	abundant	and	formed	a	clear	consistent	profile	 in	 the	cell	cycle	analysis,	as	it	requires	over	10,000	cells,	Gata3-expressing	populations	were	much	more	scarce;	around	1000	cells	for	G3+ECs	and	less	than	400	cells	for	G3+HC.		
	
5-7-	Discussion:	
In	this	chapter,	we	performed	RNA-Seq	analysis	to	gain	more	insight	into	what	distinguishes	Gata3-expressing	 cells	 from	non-expressing	 cells	within	 the	EC,	HC,	MC	and	SNS	compartments.	When	we	 looked	at	 the	PCA,	each	of	our	8	populations	formed	a	clear	cluster.	As	one	would	expect,	the	clustering	was	more	
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prominent	when	we	looked	at	each	population	individually:	HC,	EC,	SNS,	and	MC,	where	 Gata3-expressing	 cells	 formed	 a	 subpopulation	 distinct	 from	 the	 G3-	populations.	
Most	 of	 the	 GO	 terms	 associated	with	 the	 genes	 that	 were	 found	 to	 be	enriched	in	these	populations	were	related	to	general	developmental	processes,	migration,	and	differentiation	of	various	cells	and	systems.	This	is	to	be	expected	given	 the	nature	of	 the	developing	embryo	and	highlights	 the	 fact	 that	most	of	these	 cells	 will	 go	 through	 various	 changes	 whether	 it	 is	 epithelial	 to	mesenchymal	 transition,	 endothelial	 to	 haematopoietic	 transition,	 or	 the	migration	of	neural	crest	cells	to	form	the	SNS.		
For	example,	the	cell	migration	and	motility	genes	enriched	in	ECs	could	participate	 in	 the	 EHT	 that	 the	 cells	 must	 undergo	 before	 forming	haematopoietic	cells,	which	involves	major	morphological	changes.	Cells	start	to	bud	from	the	endothelial	cells	lining	the	walls	of	the	dorsal	aorta,	forming	intra-aortic	clusters	before	being	released	as	HCs.		
Also	 enriched	 in	 the	 GO	 terms	 associated	 with	 Gata3-expressing	endothelial	cells	were	the	regulation	of	the	transforming	growth	factor	b	(TGF-b)	pathway	and	Wnt	signalling.	Both	have	been	 implicated	before	as	regulators	of	haematopoietic	cell	emergence	(Challan:	2010;	Nostro:	2008).	
Of	 note,	 the	 upregulated	 genes	 expressed	 in	 the	 G3+	 ECs	 were	 most	significantly	enriched	with	genes	that	are	associated	with	blood	vessel	formation	and	 angiogenesis.	 These	 findings	 were	 similar	 to	 the	 findings	 in	 (Solaimani	Kartalaei:	 2015),	 where	 they	 reported	 that	 angiogenesis-related	 receptors,	 as	
Plxnd1,	 Eltd1,	 Calcrl,	 Ramp2,	 and	 S1pr1,	 play	 a	 role	 in	 activation	 of	 the	haematopoietic	potential	in	endothelial	cells	and	the	generation	of	HE.		
Furthermore,	among	the	upregulated	genes	in	the	G3+EC	were	genes	that	were	 associated	 with	 the	 early	 specification	 of	 the	 haematopoietic	 system	 as	
Gata2,	which	is	a	master	regulator	of	haematopoiesis	(Ling:	2004),	Sox17	which	is	 an	 intrinsic	 regulators	 of	 haemogenic	 endothelium	 specification	 and	 EHT	(Clarke:	 2013),	 BMP	 which	 is	 essential	 for	 the	 haemogenic	 endothelium	 cell	
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formation	 and	 HSCs	 initiation	 (Zhang:	 2014),	 and	 Meis1	 which	 regulates	 the	haemogenic	 endothelium	 generation	 (Wang:	 2018).	 Taken	 together,	 this	confirming	that	G3+	ECs	are	part	of	the	HE.		
Amongst	the	differentially	expressed	genes,	we	found	members	of	the	Cdk	family	and	the	Cdkn	family	expressed	in	HC,	SNS	and	EC.	We	therefore	decided	to	investigate	if	Gata3	plays	a	role	in	regulating	the	cell	cycle	of	these	cell	types.	
Except	for	MCs,	where	there	was	no	major	difference	in	the	cell	cycle	state	between	the	G3+	and	G3-	compartment,	all	of	the	other	populations	displayed	a	slight	 change	 in	 their	 proliferative	 status	 based	 on	 the	 Gata3	 expression.	 In	endothelial	 cells,	 the	 G3+	 subpopulation	 was	 more	 highly	 represented	 in	 the	non-proliferative	stage	(75%)	as	compared	with	the	G3-EC	compartment	(64%).		
Similarly,	 in	 the	 HC	 population,	 G3+	 cells	 were	 mainly	 in	 the	 non-proliferative	stage	(61%),	which	was	slightly	higher	than	the	55%	of	the	G3-HCs.	Interestingly,	 it	 was	 reported	 recently	 by	 Batsivari	 et	 al.	 (2017),	 that	 the	 Pre-HSCs	of	E10.5	AGMs	were	mainly	in	the	non-proliferative	stage.		
Similarly,	 in	 the	SNS,	 the	percentage	of	G3+	cells	 that	were	 found	 in	 the	quiescent	 stage	 was	 slightly	 higher	 than	 that	 of	 the	 G3-SNS,	 77.7%	 and	 70%,	respectively,	which	corresponds	with	what	was	reported	by	Chan	et	al.	(2016),	of	most	of	the	sympathoadrenal	cells	being	found	in	the	quiescent	stage	prior	to	the	specification	of	those	cells.	
Given	that	there	were	no	Cdks	expressed	in	the	MCs	in	both	G3+	and	G3-	compartments,	 we	 did	 not	 expect	 any	 major	 differences	 between	 the	 two	populations.	 Therefore,	 as	 expected,	 the	 smallest	 difference	 between	 all	populations	 was	 found	 in	 the	 MC.	 G3+MC	 had	 68.9%	 in	 the	 non-proliferative	stage	whereas	G3-MC	had	68.8%.		
The	 fact	 that	 we	 found	 75%	 of	 the	 G3+EC	 in	 the	 G0/G1	 phase	 is	interesting	as	previous	studies	have	shown	that	the	duration	of	the	G1	phase	is	a	determinant	of	 stem	cell	 fate	 (Hindley:	2013;	Kueh:	2013;	Pauklin:	2013).	This	agrees	with	what	was	proposed	before	by	Gritz	et	al.	(2016)	in	their	review,	that	
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the	 endothelial	 cells	 must	 be	 arrested	 in	 G1	 phase	 in	 order	 to	 undergo	haemogenic	specification	(Gritz:	2016).	
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6-	Discussion	and	future	directions	
	
Haematopoietic	 stem	 and	 progenitor	 cells	 emerge	 from	 a	 subset	 of	endothelial	 cells,	 termed	 haemogenic	 endothelium,	 which	 is	 found	 lining	 the	walls	 of	 the	 dorsal	 aorta	 from	 about	 E9.5	 until	 E11.5.	 The	 immediate	microenvironment	that	provides	a	niche	for	HSCs	and	regulates	the	endothelial	to	 haematopoietic	 transition	 also	 harbours	 a	 network	 of	 signals	 coming	 from	various	 tissues,	 where	 these	 are	 controlled	 by	 transcription	 factors.	 One	 such	transcription	factor	that	is	expressed	in	various	tissues	within	the	AGM	is	Gata3.	Corresponding	with	what	was	reported	before,	we	have	confirmed	that	Gata3	is	expressed	 in	 the	 SNS	 (Fitch:	 2012),	 mesenchymal	 cells	 (Manaia:	 2000),	endothelial	and	haematopoietic	cells	(Swiers:	2013).	
Here,	we	 have	 further	 characterised	 the	 expression	 of	 Gata3	 and	 found	that	it	varied	between	different	cells	based	on	the	embryonic	age.	At	E11.5	Gata3	is	 expressed	 highly	 in	 the	 SNS	 and	 mesenchymal	 cells,	 to	 a	 lower	 extent	 in	endothelial	 cells,	 and	 not	 expressed	 in	 haematopoietic	 cells.	 At	 E10.5,	 Gata3	 is	expressed	 in	 more	 endothelial	 cells,	 but	 to	 a	 lesser	 extent	 in	 SNS	 and	mesenchymal	 cells.	 At	 this	 stage,	 Gata3	 was	 also	 expressed	 in	 a	 transient	haematopoietic	population	that	disappeared	at	E11.5.	
In	 order	 to	 investigate	 the	 haematopoietic	 potential	 of	 endothelial	 and	haematopoietic	 populations,	 we	 used	 the	 OP9	 co-culture	 system	 in	 conditions	that	support	the	formation	of	haematopoietic	progenies.	Within	the	endothelial	compartment,	 we	 found	 that	 Gata3-expressing	 cells	 were	 enriched	 for	haemogenic	 endothelium,	 and	 produced	 a	 higher	 number	 of	 haematopoietic	progenitors	when	the	cultured	cells	were	plated	into	methylcellulose	culture.	
Within	 the	 haematopoietic	 compartments,	 we	 have	 found	 that	 Gata3-expressing	haematopoietic	 cells	had	a	 significant	haematopoietic	potential	 that	paralleled	 that	of	 the	non-Gata3	expressing	 cells.	 In	 addition,	when	plated	 into	methylcellulose,	albeit	the	colonies	that	were	produced	were	significantly	fewer	than	 those	 produced	 by	 G3-HC,	 the	 progenitors	 produced	 by	 G3+HC	 were	
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enriched	 in	 CFU-Mix,	 derived	 from	 the	 most	 primitive	 and	 stem	 cell-like	progenitor.	 In	 fact,	 with	 the	 exception	 of	 a	 few	 CFU-GM	 colonies,	 most	 of	 the	progenitors	produced	by	these	cells	were	CFU-Mix.	
Given	the	transient	nature	of	G3+HC	and	their	intriguing	output	in	CFU-C	after	OP9	co-culture,	we	wanted	to	further	investigate	the	origins	and	function	of	these	 cells.	 We	 performed	 CFU-C	 on	 freshly	 sorted	 uncultured	 cells	 obtained	from	 E10.5	 G3-GFP	 embryos.	 The	 only	 compartment	 that	 produced	haematopoietic	 progenitors	was	 that	 of	 the	G3-HC.	 As	 expected,	 neither	 of	 the	endothelial	 cell	 populations	 (G3+EC	 and	 G3-EC)	 produced	 any	 colonies.	 In	contrast	 to	 both	 co-aggregates	 and	 co-culture,	 G3+HC	 did	 not	 produce	 any	colonies	suggesting	that	these	progenitors	are	at	such	a	rare	frequency	that	they	require	a	few	days	in	culture	in	order	to	expand,	mature,	and	give	a	read-out	in	CFU-C	assays.		
To	 further	 investigate	 these	 cells	 and	 their	 place	 within	 the	developmental	 pathway	 towards	 the	 generation	 of	 dHSCs	 we	 used	 the	 co-aggregate	 system;	 a	 system	 that	 was	 developed	 by	 the	 Medvinsky	 group	 to	promote	the	development	of	pro/pre-HSCs	to	dHSCs.	Haematopoietic	cell	output	from	this	system	is	much	higher	than	that	produced	by	OP9	co-culture;	however,	the	progenitors	produced	by	Gata3+	cells	had	 fewer	CFU-Mix	amongst	 them	 in	contrast	 to	 the	 colonies	 produced	 after	 OP9	 co-culture.	 Yet	 overall	 the	 colony	count	was	similar	to	that	obtained	from	G3-HC.		
As	one	would	suspect	that	neither	G3+	nor	G3-	endothelial	cells	produced	any	 colonies	 in	methylcellulose	 after	 plating	 them	directly	 from	 freshly	 sorted	AGMs,	and	the	haematopoietic	colonies	produced	in	methylcellulose	after	the	co-aggregates	 were	 few	 in	 contrast	 to	 those	 produced	 after	 OP9	 co-culture.	Considering	 the	 difference	 in	 the	 duration	 of	 OP9	 co-culture	 (2-3	 weeks)	compared	with	the	co-aggregates	(4-5	days),	this	suggests	that	the	endothelial	to	haematopoietic	transition	is	still	at	its	early	stages	and	that	only	few	cells	were	produced.		
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To	study	HSC	maturation,	we	transplanted	cells	obtained	from	E11.5	and	E10.5	AGM	co-aggregates.	At	both	stages,	there	was	no	repopulation	from	either	G3+EC	or	G3-EC.	However,	that	was	not	the	case	for	the	haematopoietic	cells.	For	haematopoietic	 cells	 harvested	 from	 E11.5	 co-aggregates,	 only	 the	 G3-HC	compartment	 repopulated	 the	 recipients.	 This	was	 in	 contrast	 to	 E10.5,	where	only	 G3+HC	 could	 engraft	 irradiated	 mice.	 A	 number	 of	 conclusions	 can	 be	drawn	 from	 this	 experiment:	 (A)	 that	 there	 are	 no	 Gata3-expressing	 HSCs	 in	E11.5	 embryos;	 (B)	 the	 presence	 of	 either	 pro/pre-HSCs	within	 E10.5	G3+HCs	that	matured	into	HSCs	after	the	co-aggregates,	(3)	the	presence	of	dHSCs	and/or	pre-HSCs	(I/II)	 in	G3-HCs.	However,	given	that	the	markers	were	pooled	 in	the	same	channel	(CD41/43/45)	we	could	not	specify	at	which	stages	those	cells	are.	Therefore,	more	experiments	are	needed	in	the	future	to	investigate	the	different	subpopulations	 of	 Gata3+HC,	 and	 also	 identify	 the	 stages	 of	 these	 G3+HC	 and	place	them	in	the	dHSCs	developmental	lineage.		
These	 results	 implicated	 Gata3	 in	 haematopoietic	 progenitor	 formation.	Taken	together	with	the	previously	reported	effect	of	Gata3	germline	deletion	on	HSCs	(Fitch:	2012),	we	wanted	to	 look	at	 the	effect	of	Gata3	global	deletion	on	haematopoietic	 progenitor	 formation.	 Interestingly,	 we	 found	 that	 Gata3	deletion	 affects	 progenitor	 counts	 in	 a	 dose-	 and	 stage-dependent	manner:	 i.e.	heterozygous	 AGMs	 produced	 a	 lower	 count,	 which	 was	 significantly	 further	reduced	 in	 knockout	 AGMs,	 and	 the	 effect	 of	 the	 deletion	was	more	 severe	 at	E10.5.	This	dose-dependent	effect	of	Gata3	was	also	reported	in	other	systems;	in	thymocyte	development	(Ho:	2009),	in	kidney	development	(Grote:	2008),	in	SNS	 development	 (Pandolfi:	 1995	 ;	 Lim:	 2000	 ),	 in	 hair	 and	 skin	 development	(Kaufman:	2003;	de	Guzman	Strong:	2006;	Kurek:	2007)	and	in	mammary	gland	development	(Kouros-Mehr:	2006;	Asselin-Labat:	2007).	
	We	 then	 added	 an	 explant	 step	 in	 order	 to	 eliminate	 the	 variation	between	 different	 biological	 replicates,	 thus	 giving	 a	 more	 accurate	representation	 of	 progenitor	 numbers	 in	 the	 AGM.	 The	 effect	 of	 deletion	 was	maintained,	 yet	 appeared	more	 pronounced,	 since	wild-type	 progenitors	were	able	 to	 expand	 during	 the	 explant	 culture	 step.	 The	 inability	 of	 both	haploinsufficient	and	knockout	progenitors	to	expand	could	be	contributed	to	an	
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involvement	of	Gata3	in	cell	cycle	regulation,	which	corresponds	with	what	was	reported	by	Ku	et	al.	of	Gata3	knock-out	HSCs	failing	to	enter	the	cell	cycle	(Ku:	2007).	
In	 order	 to	 investigate	 if	 Gata3	 plays	 a	more	 direct	 role	 in	 haemogenic	endothelium	 and	 HSC	 and	 progenitor	 formation,	 we	 used	 the	 Vec-Cre	 system	(Chen:	2009)	to	delete	Gata3	from	the	vascular	endothelium.	The	results	we	got	from	conditional	deletion	of	Gata3	from	endothelium	were	strikingly	similar	 to	those	 we	 got	 from	 germline	 deletion:	 Gata3	 deletion	 affected	 progenitor	numbers	in	a	dose-dependent	and	stage-dependent	manner;	thus,	showing	that	Gata3	within	the	haemogenic	endothelium	plays	a	major	role	in	haematopoietic	progenitor	formation.	
Given	 that	 both	 haematopoietic	 progenitors	 and	 HSCs	 emerge	 from	haemogenic	 endothelium,	 we	 also	 investigated	 the	 effect	 of	 Gata3	 conditional	deletion	 from	 endothelial	 cells	 on	 haematopoietic	 repopulation	 via	transplantation	 assay	 and	 found	 that	 indeed	 Gata3	 plays	 a	 role	 in	 HSC	generation.	When	Gata3	was	deleted	from	the	endothelium,	there	was	almost	no	HSC	engraftment	in	irradiated	recipients.	There	was	some	repopulation	in	some	of	 the	mice,	which	 could	 be	 attributed	 to	 a	 few	HSCs	 that	might	 have	 escaped	Gata3	deletion	in	those	AGMs,	as	we	observed	in	some	colonies	in	CFU-C	assays.	However,	this	retained	activity	in	some	of	the	HSCs	in	Gata3-null	AGMs	was	also	reported	by	Fitch	et	 al.	 (2012),	 suggesting	 that	while	Gata3	plays	a	key	 role	 in	HSC	 and	 progenitor	 formation,	 its	 role	 in	 EHT	 does	 not	 seem	 to	 be	 absolutely	essential.		
It	 is	 interesting	 that	 the	 effect	 of	 endothelial-specific	Gata3	 deletion	 on	progenitor	and	HSC	numbers	is	very	similar	to	the	effect	observed	with	a	global	knockout,	 suggesting	 the	 function	 of	 Gata3	 in	 the	HE	 is	more	 relevant	 to	AGM	haematopoiesis	than	its	function	in	the	SNS.	It	may	also	indicate	that	the	role	of	Gata3	in	the	HE	is	temporally	upstream	of	the	role	of	Gata3	in	the	SNS,	with	the	former	 regulating	 HSC	 formation	 and	 the	 latter	 HSC	 maintenance	 and/or	function	after	these	have	been	generated.	The	rescue	effect	we	have	previously	observed	with	catecholamine	addition	(Fitch:	2012)	may	stem	from	an	increased	
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survival	 or	 expansion	 of	 those	 few	 HSCs	 that	 are	 detected	 in	 Vec-Cre	 deleted	embryos.	
To	 gain	 further	 insight	 into	 the	 role	 of	 Gata3	 in	 the	 different	 AGM	 cell	populations,	we	preformed	a	whole	transcriptome	analysis	for	small	numbers	of	each	 of	 the	 Gata3-expressing	 subpopulations	 (EC,	 HC,	 MC	 and	 SNS),	 and	compared	them	to	their	Gata3-negative	counterparts.	RNA-Seq	analysis	revealed	that	Gata3+	and	Gata3-	cells	segregated	into	distinct	clusters	in	the	PCA	analysis,	thus	 revealing	 that	Gata3-expressing	 cells	 share	 a	 common	genetic	profile	 that	differentiates	them	from	Gata3-non	expressing	cells.	
The	genes	that	differentiate	between	the	Gata3+	and	Gata3-	fractions	within	each	cell	population	were	classified	according	to	the	biological	processes	they	are	involved	in	using	Gene	Ontology	analysis.	All	Gata3-expressing	populations	shared	a	common	theme	in	the	gene	enrichment	analysis	in	both	upregulated	and	downregulated	genes.	Mainly,	the	downregulated	genes	were	associated	with	cell	development,	differentiation	and	specification	of	various	cells	and	systems,	whereas	the	upregulated	genes	were	mostly	associated	with	migration,	proliferation,	development	and	apoptosis.	Of	note,	genes	that	were	associated	with	blood	vessel	formation	and	angiogenesis	such	as	Hey1,	Efnb2,	and	Nrp1	(Zhou:2016;	Solaimani	Kartalaei:	2015)	were	found	in	G3+EC	in	the	upregulated	genes.	These	genes	have	been	reported	before	to	be	enriched	in	the	haemogenic	endothelium	and	are	associated	with	EHT.	Other	genes	upregulated	in	G3+ECs	that	have	previously	been	reported	to	be	enriched	in	HEC	included	Mecom,	Notch4,	Notch1,	Mapk3,	Sox17,	Epas1,	Hey2,	Sox7,	Sox17,	Nkx2-3,	Tsc22d1,	Nfic,	and	Pdlim1	(Solaimani	Kartalaei:	2015).	This	implicates	Gata3	as	a	key	regulator	for	HE	and	EHT.	However,	given	that	G3-EC	are	still	capable	of	producing	haematopoietic	progeny,	it	would	be	interesting	to	see	if	Gata3	marks	a	subtype	of	HE,	and	if	that	subfraction	is	responsible	for	a	certain	type	of	haematopoietic	cells	or	may	represent	HECs	at	different	stages	of	the	cell	cycle.	
In	 addition,	 we	 found	 that	 all	 Gata3-expressing	 cell	 populations,	 except	mesenchymal	 cells,	 had	 amongst	 their	 differentially	 expressed	 genes	 cyclin-dependent	 kinases	 or	 their	 inhibitor,	 known	 regulators	 of	 the	 cell	 cycle.	 Given	
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what	 was	 reported	 before	 of	 Gata3	 involvement	 in	 cell	 cycle	 regulation	 (Ku:	2007),	we	wanted	to	further	explore	a	possible	link	of	Gata3	with	the	cell	cycle	within	 the	 different	 AGM	 populations.	 We	 found	 that	 Gata3	 expression	 is	associated	with	more	quiescent	cells	 in	 the	AGM,	which	goes	with	 the	 fact	 that	almost	 all	 of	 the	 upregulated	 cell	 cycle	 genes	 were	 cyclin-dependent	 kinase	inhibitors,	whereas	cyclin	dependent-kinases	were	amongst	 the	downregulated	genes.		
The	cell	cycle	status	of	AGM	HSCs	and	their	precursors	has	recently	been	analysed	 by	 the	 Medvinsky	 group.	 They	 found	 that	 pre-HSCs	 could	 be	 either	quiescent	 or	 proliferating,	 depending	 on	 the	 developmental	 time	 point	 and	whether	 it	 was	 pre-HSCs	 I	 or	 II	 (Batsivari:	 2017).	 It	 will	 be	 interesting	 to	determine	whether	Gata3	 is	 one	of	 the	 factors	 controlling	 the	 cycling	 status	of	these	cells.		
Within	 the	 haemogenic	 endothelium,	 we	 found	 that	 Gata3	 is	 also	associated	 with	 more	 quiescent	 cells.	 The	 specification	 of	 haemogenic	endothelium	was	suggested	 to	happen	during	an	arrest	 in	 the	G1	phase	 (Gritz:	2016),	 and	 some	 studies	 have	 shown	 that	 the	 length	 of	 the	 G1	 phase	 is	 a	determinant	 of	 stem	 cell	 fate	 (Hindley:	 2013;	 Kueh:	 2013;	 Pauklin:	 2013).	 In	addition,	 gene	 transcriptome	 analysis	 has	 also	 revealed	 that	 several	haematopoietic	 transcriptional	 regulators	 were	 expressed	 in	 the	 G1	 phase	(Aggarwal:	 2012).	 Along	 with	 our	 functional	 studies,	 this	 further	 implicates	Gata3	as	an	EHT	regulator.	
Within	 the	 sympathoadrenal	 cells,	 similar	 to	 both	 HC	 and	 EC,	 Gata3-expressing	cells	were	associated	with	the	quiescent	phase,	though	the	effect	was	more	 pronounced	 in	 this	 population,	 which	 corresponds	 with	 the	 findings	 of	Chan	et	al.	(2016)	of	sympathoadrenal	cells	exiting	the	cell	cycle	at	E11.5	prior	to	their	specification	and	differentiation.		
In	 mesenchymal	 cells,	 there	 was	 no	 significant	 difference	 in	 cell	 cycle	status	 between	 Gata3-expressing	 cells	 and	 Gata3	 negative	 cells,	 which	 was	expected	 given	 that	 there	 was	 no	 differential	 expression	 of	 cyclin-dependent	
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kinases	 or	 their	 inhibitors.	 However,	 given	 the	 location	 of	 these	 cells	 in	 the	subaortic	mesenchyme,	 i.e.	 in	 close	 proximity	 to	where	HSCs	 emerge,	 it	would	still	 be	 interesting	 to	 further	 investigate	 the	 role	 of	 these	 cells	 in	 HSC	 and	progenitor	 generation,	 possibly	 via	 the	 Gata3-dependent	 secretion	 of	 HSC	supportive	factors.	
The	role	of	Gata3	as	a	cell	cycle	regulator	could	potentially	explain	its	role	as	a	tumour	suppressor	gene	in	several	types	of	cancer.	In	breast	cancer,	certain	types	 of	 renal	 carcinoma,	 and	 certain	 types	 of	 leukaemia,	 Gata3	was	 found	 to	stop	cancer	progression	and	dissemination,	and	its	absence	was	associated	with	poor	prognosis	and	more	aggressive	disease	(Kouros-Mehr:	2008;	Cooper:	2008;	Zhang:	2012).	
In	addition,	given	our	 findings	of	Gata3	association	with	more	quiescent	cells,	 and	 the	 presence	 of	 upregulated	 cyclin	 dependent	 kinase	 inhibitors	 in	Gata3-expressing	 cells,	 one	would	 expect	Gata3	 deletion	 to	 result	 in	 acute	 cell	proliferation,	 in	contrary	to	our	 findings	 in	CFU-C	assays,	where	the	absence	of	
Gata3	led	to	a	severe	reduction	in	colony	counts.	However,	considering	what	was	reported	 before	 by	 Frelin	 et	 al	 (2013),	 that	 Gata3	 has	 to	 translocate	 from	 the	cytoplasm	to	the	nucleus	to	be	active	and	functional	in	the	cell,	my	results	remain	within	 context.	 Taken	 together,	 this	 indicates	 a	 very	 complex	 relationship	between	Gata3,	cell	differentiation	and	the	cell	cycle.		
In	 summary,	 Gata3	 is	 essential	 for	 the	 development	 of	 several	 types	 of	cells,	organs	and	tissues,	and	its	disruption	during	development	results	in	severe	defects	 and	 impairment	 in	 those	 systems,	 leading	 to	 embryonic	 death	 at	midgestation	following	germline	deletion.	In	the	haematopoietic	system,	we	have	found	that	Gata3-expressing	cells	are	enriched	for	haemogenic	endothelium	and	play	a	critical	role	in	the	formation	of	haematopoietic	stem	and	progenitors	cells.		In	 addition,	 we	 observed	 that	 Gata3	 marks	 specific	 stages	 along	 the	developmental	 pathway	 towards	 the	 generation	 of	 dHSCs.	 Within	 the	 HSC	microenvironment,	Gata3	plays	a	major	role	in	the	development	of	various	cells	and	 systems,	 which,	 as	 in	 the	 case	 of	 the	 SNS,	 can	 indirectly	 impact	 on	 the	
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haematopoietic	system.	Many	of	these	effects	may	be	linked	to	the	involvement	of	Gata3	in	cell	cycle	regulation.		
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